WO2001078675A1 - Use of natural substances in the production of cosmetic preparations - Google Patents

Use of natural substances in the production of cosmetic preparations Download PDF

Info

Publication number
WO2001078675A1
WO2001078675A1 PCT/EP2001/001171 EP0101171W WO0178675A1 WO 2001078675 A1 WO2001078675 A1 WO 2001078675A1 EP 0101171 W EP0101171 W EP 0101171W WO 0178675 A1 WO0178675 A1 WO 0178675A1
Authority
WO
WIPO (PCT)
Prior art keywords
acid
extracts
acids
oil
use according
Prior art date
Application number
PCT/EP2001/001171
Other languages
German (de)
French (fr)
Inventor
Gilles Pauly
Philippe Moser
Louis Danoux
Original Assignee
Cognis France, S.A.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cognis France, S.A. filed Critical Cognis France, S.A.
Priority to EP01905732A priority Critical patent/EP1272155A1/en
Priority to AU2001233739A priority patent/AU2001233739A1/en
Priority to JP2001575977A priority patent/JP2003530419A/en
Publication of WO2001078675A1 publication Critical patent/WO2001078675A1/en

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/045Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07Retinol compounds, e.g. vitamin A
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • A61K31/203Retinoic acids ; Salts thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/473Quinolines; Isoquinolines ortho- or peri-condensed with carbocyclic ring systems, e.g. acridines, phenanthridines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783Angiosperms [Magnoliophyta]
    • A61K8/9789Magnoliopsida [dicotyledons]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/16Emollients or protectives, e.g. against radiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74Biological properties of particular ingredients
    • A61K2800/78Enzyme modulators, e.g. Enzyme agonists
    • A61K2800/782Enzyme inhibitors; Enzyme antagonists

Definitions

  • the invention is in the fields of cosmetics and pharmacy and relates on the one hand to the use of certain plant extracts for the production of cosmetic preparations and on the other hand to the use of the extracts as active substances for increasing the activity of certain enzymes in the metabolism and to a method for evaluating active substances against skin aging.
  • the active ingredients developed by the cosmetics industry can basically be divided into two groups.
  • active ingredients that protect the cells against oxidative stress or proteolysis (protective effect), on the other active ingredients that stimulate cell regeneration (healing effect).
  • protection effect on the other active ingredients that stimulate cell regeneration (healing effect).
  • active ingredients include, for example, enzymes that counteract damage by UV light or environmental toxins, but also those that prevent the synthesis of essential cell components, e.g. Promote structural proteins, membrane lipids or DNA.
  • Cosmetic preparations on the market already contain substances such as DNA fragments that stimulate IL-6 or P53 activity, proteins to stimulate collagen synthesis or ribosomes from E. coli to stimulate the growth of keratinocytes.
  • G6PDH Glucose 6-phosphate dehydrogenase
  • G6PDH is an enzyme that catalyzes the first steps of the so-called "pentose route”.
  • G6P glucose 6-phosphate
  • 6PG 6-phosphogluconate
  • NADPH coenzyme Nicotinamide adenine dinucleotide phosphate
  • the reduced form of this coenzyme can catalyze a variety of enzymatic reactions such as the recycling of glutathione or lipid synthesis.
  • the last step of the pentose route also provides the most important precursor for DNA, deoxyribose
  • G6PDH and 6-phosphatogluconate dehydrogenase (6PGDH) as well as a number of other glycolysis enzymes (eg aldolase) are in the upper layers of human skin.
  • 6PGDH 6-phosphatogluconate dehydrogenase
  • aldolase a number of other glycolysis enzymes
  • the object of the present patent application was therefore to provide those active substances which stimulate the activity of G6PDH in the fibroblasts, if possible without negatively influencing the DNA content of the cells.
  • the invention relates to the use of natural substances selected from the group formed by extracts of plants from the Solanaceae family, the Amaranthaceae family and the Monimiaceae family for the production of cosmetic preparations.
  • Another object of the invention is the use of natural substances selected from the group formed by extracts of plants from the Solanaceae family, the Amaranthaceae family and the Monimiaceae family as active ingredients for producing an agent for increasing the G6PDH activity in the metabolism.
  • the extracts of the plants mentioned and the active principles contained therein fulfill the task in an excellent manner.
  • the G6PDH activity could be increased by up to 140% without the DNA content having decreased significantly.
  • the substances are therefore ideally suited for the production of cosmetic preparations, especially skin treatment agents and in particular agents against skin aging.
  • Plants of the Geni Physalis, Achyranthes and / or Peumus Plants of the Geni Physalis, Achyranthes and / or Peumus.
  • extracts of Physalis minimal, Achyranthes bidentata, Achyranthes aspera and / or Peumus boldo are used according to the invention.
  • Physalis minima Linn which belongs to the family of the Solanaceae, is an annual herb that reaches a height of 15 to 30 cm and is found wild in India, Ceylon, Afghanistan as well as in the tropical zones of Africa and Australia. Its fruits have a diuretic effect, while leaves and roots are used for medicinal purposes, e.g. against snake bites and scorpion stings. The bitter substances and steroid components of the leaves have now largely been cleared up.
  • the steroids are essentially Physalin A, Physalin B, Physalin C, Physalin D, 5ß, 6ß-Epoxyphysalin, Dihydroxyphysalin B, Whitaphysalin A, Whitaphysalin B and Whitaphysalin C. Furthermore phenolic acids, chlorogenic acids as well as flavon derivatives such as quercitin-3-O-galactoside.
  • Achyranthes bidentata and Achyranthes aspera These plants belong to the Amaranthaceae family and are annual plants that grow up to 1 m tall and are native to Asia, especially Korea, China, Vietnam, Japan and India. The plants are widely used in traditional medicine and are used, for example, as a diuretic and antirheumatic, but also for toothache or menstrual cramps. The leaves and seeds of the two plants are edible and are mainly in India consumed as vegetables and the seeds as grain for baking.
  • Known ingredients include saponins, steroids, sterols (sitosterol), polysaccharides, alkaloids, phenolic acids (caffeic acid), quinones and flavone derivatives (rutin, isoquercetin, astragalin).
  • Peumus boldus The Peumus boldus plant belongs to the Monimiaceae family.
  • the aporphine alkaloid boldin can be extracted from the leaves and bark, which is the essential active component of these extracts and which can be used according to the invention as a natural substance.
  • extracts are accordingly used according to the invention which contain active ingredients which are selected from the group formed by carotenoids, flavone derivatives, phenolic acids, chlorogenic acids, steroids, aporphine alkaloids, sterols and terpenes.
  • the carotenoids, flavone derivatives, phenolic acids, chlorogenic acids, steroids, aporphine alkaloids, sterols and terpenes which can be extracted from the preferred plants Geni Physali, Achyranthes and Peumus, are preferably used.
  • the preferred active substances include the steroids Physalin A, Physalin B, Physalin C, Physalin D, 5 ⁇ , 6ß-epoxyphysalin, dihydroxyphysalin B and the steroids Whitaphysalin A, Whitaphysalin B, Whitaphysalin C. All steroids mentioned as preferred to the steroid lactones.
  • active ingredients from the genus Physalis are phenolic acids such as chlorogenic acids and caffeic acid, carotenoids, and flavone derivatives such as quercitin-3-O-galactoside.
  • the active substances preferred according to the invention include saponins, steroids, sterols, polysaccharides, alkaloids, phenolic acids (caffeic acid), quinones, terpenes and flavone derivatives such as, for example, rutin, isoquercetin or astragalin.
  • the active substances preferred according to the invention include the aporphine alkaloids, in particular boldine.
  • the extracts of the plants mentioned in particular extracts of the plants Physalis minima, Achyranthes bidentata, Achyranthes aspera and Peumus boldo, the active substances alone or as a mixture in combination of at least two active substances extracted from the plants mentioned can be used as natural substances in the sense of the invention and their preferred selection or the active ingredients can be used alone or in combination of at least two active ingredients extracted from other plants or synthetically produced.
  • the amount of natural substances or extracts used can be in the range from 0.001 to 5, preferably 0.005 to 1 and in particular 0.01 to 0.5% by weight, based on the composition.
  • the extracts can be prepared in a manner known per se, ie for example by aqueous, alcoholic or aqueous-alcoholic extraction of the plants or parts of plants.
  • suitable conventional extraction methods such as maceration, remaceration, digestion, movement maceration, vortex extraction, ultrasound extraction, countercurrent extraction, percolation, repercolation, evacolation (extraction under reduced pressure), diacolation and solid-liquid extraction under continuous reflux , which is carried out in a Soxhlet extractor, which is familiar to a person skilled in the art and in principle all can be used, for the sake of simplicity, for example, on Hager's Handbook of Pharmaceutical Practice, (5th edition, vol. 2, pp.
  • Fresh plants or parts of plants can be used as the starting material, but usually dried plants and / or parts of plants are used, which can be mechanically comminuted before extraction. All comminution methods known to the person skilled in the art are suitable here, freeze grinding being mentioned as an example.
  • Organic solvents, water (preferably hot water at a temperature of above 80 ° C. and in particular above 95 ° C.) or mixtures of organic solvents and water, in particular low molecular weight alcohols with more or less high water contents, can be used as solvents for carrying out the extractions become.
  • Extraction with methanol, ethanol, pentane, hexane, heptane, acetone, propylene glycols, polyethylene glycols and ethyl acetate as well as mixtures thereof and their aqueous mixtures is particularly preferred.
  • the extraction is usually carried out at 20 to 100 ° C, preferably at 30 to 90 ° C, in particular at 60 to 80 ° C.
  • the extraction takes place under an inert gas atmosphere to avoid oxidation of the active ingredients of the extract. This is particularly important for extractions at temperatures above 40 ° C.
  • the extraction times are set by the person skilled in the art depending on the starting material, the extraction process, the extraction temperature, the ratio of solvent to raw material, etc. provides.
  • the crude extracts obtained can optionally be subjected to further customary steps, such as purification, concentration and / or decolorization. If desired, the extracts produced in this way can, for example, be subjected to a selective separation of individual undesirable ingredients.
  • the extracts are subjected to fractionation. Fractionation by liquid chromatography on synthetic resins based on ion exchange resins or adsorber resins, in particular on Amberlite XAD, is particularly preferred. The fractionation is preferably carried out using a step gradient of the eluent.
  • Preferred solvent mixtures which can be used as eluents with a step gradient are water / methanol, water / ethanol, water / isopropanol and methanol / acetone.
  • a mixture of 20% by weight of aqueous methanol is preferably started and the mixture is gradually changed to 100% by weight of methanol.
  • different fractions are obtained, which can be classified according to the mixing ratio of the solvent mixture.
  • differently polar ingredients of the extract are eluted and fractionated.
  • the extraction can take place to any degree of extraction, but is usually carried out to exhaustion.
  • the present invention encompasses the knowledge that the extraction conditions and the yields of the final extracts can be selected by the person skilled in the art depending on the desired field of use.
  • the extracts can also serve as starting materials for the production of the above-mentioned pure active ingredients, provided that these cannot be produced more easily and inexpensively by synthetic means.
  • the active substance content in the extracts can be 5 to 100, preferably 50 to 95% by weight.
  • the extracts themselves can be present as aqueous and / or preparations dissolved in organic solvents and as spray-dried or freeze-dried solids.
  • suitable organic solvents in this context are the aliphatic alcohols with 1 to 6 carbon atoms (e.g. ethanol), ketones (e.g. acetone), halogenated hydrocarbons (e.g. chloroform or methylene chloride), lower esters or polyols (e.g. glycerol or glycols).
  • the natural substances and / or extracts mentioned are used as agents against skin aging.
  • Another term for this type of remedy is anti aging.
  • These signs of aging include any type of wrinkles and wrinkles. Treatments include slowing skin aging.
  • the increase in G6PDH activity in the metabolism leads to the use of the natural substances according to the invention as agents against skin aging.
  • the signs of aging can have a variety of causes.
  • Another object of the invention is the use of natural products selected from the group formed by carotenoids, in particular retinol and retinoic acid, flavone derivatives, phenolic acids, chlorogenic acids, steroids, aporphine alkaloids, sterols and terpenes as active ingredients for the preparation of an agent for Increase in G6PDH activity in metabolism.
  • the natural substances can be extracted from other plants or produced synthetically.
  • the amount of natural substances used can be in the range from 0.001 to 5, preferably 0.005 to 1 and in particular 0.01 to 0.5% by weight, based on the composition.
  • the present invention further relates to a method for determining the effectiveness of an agent against skin aging, in which the influence of the active ingredient on the activity of glucose-6-phosphate dehydrogenase in fibroblasts is determined.
  • the extracts to be used according to the invention can be used to produce cosmetic and / or pharmaceutical preparations, such as, for example, creams, gels, lotions, alcoholic and aqueous / alcoholic solutions, emulsions, wax / fat compositions, stick preparations, powders or ointments.
  • cosmetic and / or pharmaceutical preparations such as, for example, creams, gels, lotions, alcoholic and aqueous / alcoholic solutions, emulsions, wax / fat compositions, stick preparations, powders or ointments.
  • agents can also be used as further auxiliaries and additives, mild surfactants, oil bodies, emulsifiers, pearlescent waxes, consistency agents, thickeners, superfatting agents, stabilizers, polymers, silicone compounds, fats, waxes, lecithins, phospholipids, biogenic active ingredients, UV light protection factors, antioxidants, Contain deodorants, antiperspirants, antidandruff agents, film formers, swelling agents, insect repellents, self-tanners, tyrosine inhibitors (depigmentation agents), hydro tropes, solubilizers, preservatives, perfume oils, dyes and the like.
  • mild surfactants oil bodies, emulsifiers, pearlescent waxes, consistency agents, thickeners, superfatting agents, stabilizers, polymers, silicone compounds, fats, waxes, lecithins, phospholipids, biogenic active ingredients, UV light protection factors, antioxidants, Contain deodorants, antiperspirants, antid
  • Anionic, nonionic, cationic and / or amphoteric or amphoteric surfactants may be present as surface-active substances, the proportion of which in the compositions is usually about 1 to 70, preferably 5 to 50 and in particular 10 to 30% by weight.
  • anionic surfactants are soaps, alkyl benzene sulfonates, alkane sulfonates, olefin sulfonates, alkyl ether sulfonates, glycerol ether sulfonates, ⁇ -methyl ester sulfonates, sulfo fatty acids, alkyl sulfates, fatty alcohol ether sulfates, glycerin ether sulfates, fatty acid ether sulfates, ether ether sulfates (mon) sulfates, mono- and dialkylsulfosuccinates, mono- and dialkylsulfosuccinamates, sulfotriglycerides, amide soaps, ether carboxylic acids and their salts, fatty acid isethionates, fatty acid sarcosines, fatty acid taurides, N-acylamino acids, such as
  • anionic surfactants contain polyglycol ether chains, these can have a conventional, but preferably a narrow, homolog distribution.
  • Typical examples of nonionic surfactants are fatty alcohol polyglycol ethers, alkylphenol polyglycol ethers, fatty acid polyglycol esters, fatty acid amide polyglycol ethers, fatty amine polyglycol ethers, alkoxylated triglycerides, mixed ethers or mixed formals, optionally partially oxidized alk (en) yl oligoglycosides or alkyl glucoramide acid derivatives (especially glucoronic acid), vegetable glucoronic acid derivatives (GLC), glucoronic acid derivatives (GLC) Wheat-based products), polyol fatty acid esters, sugar esters, sorbitan esters, polysorbates and amine oxides.
  • nonionic surfactants contain polyglycol ether chains, they can have a conventional, but preferably a narrow, homolog distribution.
  • cationic surfactants are quaternary ammonium compounds, such as, for example, dimethyldistearylammonium chloride, and esterquats, in particular quaternized fatty acid trialkanolamine ester salts.
  • amphoteric or zwitterionic surfactants are alkyl betaines, alkyl amido betaines, aminopropionates, aminoglycinates, imidazolinium betaines and sulfobetaines. The surfactants mentioned are exclusively known compounds.
  • Typical examples of particularly suitable mild, ie particularly skin-compatible, surfactants are fatty alcohol polyglycol ether sulfates, monoglyceride sulfates, mono- and / or dialkyl sulfosuccinates, fatty acid isethionates, fatty acid sarcosinates, fatty acid taurides, fatty acid glutamates, ⁇ -olefin sulfonates, alkyl acid fatty acid amide carboxamides, alkyl carboxyl amide carboxamides, alkyl carboxyl amide carboxamides, alkyl carboxyl amide carboxylates, amyl carboxylic acid amides, alkyl carboxyl amide carboxylic acids or protein fatty acid condensates, the latter preferably based on wheat proteins.
  • Suitable oil bodies are, for example, Guerbet alcohols preferably containing 8 to 10 carbon atoms, esters of linear C6-C22-fatty acids with linear or branched C 6 -C come based on fatty alcohols having 6 to 18, 2 2-fatty alcohols or esters of branched C6-Ci3-carboxylic acids with linear or branched C6-C22-fatty alcohols, such as myristyl myristate, myristyl palmitate, myristyl stearate, Myristy- lisostearat, myristyl, Myristylbehenat, Myristylerucat, cetyl myristate, cetyl palmitate, cetyl stearate, Cetylisostearat, cetyl oleate, cetyl behenate, Cetylerucat, Stearyimyristat, stearyl palmitate, stearyl stearate, Stearylisostearat, stearyl
  • esters of linear C6-C22 fatty acids with branched alcohols in particular 2-ethylhexanol
  • esters of Ci8-C38 alkylhydroxycarboxylic acids with linear or branched C6-C 2 2 fatty alcohols cf.
  • esters of linear and / or branched fatty acids with polyhydric alcohols such as propylene glycol, dimer diol or trimer triol
  • polyhydric alcohols such as propylene glycol, dimer diol or trimer triol
  • Guerbet alcohols triglycerides based on C ⁇ -cio fatty acids
  • liquid mono- / di- / triglyceride mixtures based on C6 -Ci8 fatty acids
  • esters of C ⁇ -C ⁇ fatty alcohols and / or Guerbet alcohols with aromatic carboxylic acids especially benzoic acid, esters of C2-C12 dicarboxylic acids with linear or branched alcohols with 1 to 22 carbon atoms or polyols with 2 to 10 carbon atoms and 2 to 6 hydroxyl groups, vegetable oils, branched primary alcohols, substituted cyclohexanes, linear and branched C ⁇ -C ⁇ ⁇ fatty alcohol carbonates, such as dicapryly
  • Suitable emulsifiers are nonionic surfactants from at least one of the following groups:
  • Partial esters of polyglycerol (average degree of self-condensation 2 to 8), polyethylene glycol (molecular weight 400 to 5000), trimethylolpropane, pentaerythritol, sugar alcohols (e.g. sorbitol), alkyl glucosides (e.g. methyl glucoside, butyl glucoside, lauryl glucoside) and polyglucosides (e.g. cellulose) / or unsaturated, linear or branched fatty acids with 12 to 22 carbon atoms and / or hydroxycarboxylic acids with 3 to 18 carbon atoms and their adducts with 1 to 30 moles of ethylene oxide;
  • Block copolymers e.g. Polyethylene glycol 30 dipolyhydroxystearate;
  • Polymer emulsifiers e.g. Pemulen types (TR-1, TR-2) from Goodrich;
  • the adducts of ethylene oxide and / or of propylene oxide with fatty alcohols, fatty acids, alkylphenols or with castor oil are known, commercially available products. These are homolog mixtures whose average degree of alkoxylation is the ratio of the amounts of ethylene oxide and / or propylene oxide and Substrate with which the addition reaction is carried out corresponds. Ci2 / i8 fatty acid monoesters and diesters of adducts of ethylene oxide with glycerol are known from DE 2024051 PS as refatting agents for cosmetic preparations.
  • Alkyl and / or alkenyl oligoglycosides their preparation and their use are known from the prior art. They are produced in particular by reacting glucose or oligosaccharides with primary alcohols with 8 to 18 carbon atoms.
  • the glycoside residue both monoglycosides in which a cyclic sugar residue is glycosidically bonded to the fatty alcohol and oligomeric glycosides with a degree of oligomerization of up to about 8 are suitable.
  • the degree of oligomerization is a statistical mean value which is based on a homolog distribution customary for such technical products.
  • Suitable partial glycerides are hydroxystearic acid monoglyceride, stearic acid diglyceride hydroxy, isostearic acid, Isostearinklarediglycerid, oleic acid monoglyceride, oleic acid diglyceride, Ricinolklaremoglycerid, Ricinolklarediglycerid, Linolklaremonoglycerid, linoleic acid diglyceride, LinolenTalkremonoglycerid, Linolenchurediglycerid, Erucaklaklamonoglycerid, erucic acid diglyceride, rid Weinchuremonoglycerid, Weinklarediglycerid, Citronenklamonoglycerid, Citronendiglyce-, Malic acid monoglyceride, malic acid diglyceride and their technical mixtures, which may still contain minor amounts of triglyceride from the manufacturing process.
  • sorbitan sorbitan sorbitan sesquiisostearate, Sorbitan, sorbitan triisostearate, sorbitan monooleate, sorbitan, sorbitan, sorbitan come tanmonoerucat, Sorbitansesquierucat, Sorbitandierucat, Sorbitantrierucat, Sorbitanmonoricinoleat, sorting bitansesquiricinoleat, Sorbitandiricinoleat, Sorbitantriricinoleat, Sorbitanmonohydroxystearat, sorbitan sesquihydroxystearat, Sorbitandihydroxystearat, Sorbitantrihydroxystearat, Sorbitanmonotartrat , Sorbitane sesquitartrate, sorbitan ditartrate, sorbitan tritartrate, sorbitan
  • polyglycerol esters are polyglyceryl-2 dipolyhydroxystearates (Dehymuls® PGPH), polyglycerol-3-diisostearates (Lameform® TGI), polyglyceryl-4 isostearates (Isolan® Gl 34), polyglyceryl-3 oleates, diisostearoyl polyglyearylate-3 (Isolan® PDI), Polyglyceryl-3 Methylglucose Distearate (Tego Care® 450), Polyglyceryl-3 Beeswax (Cera Bellina®), Polyglyceryl-4 Caprate (Polyglycerol Caprate T2010 / 90), Polyglyceryl-3 Cetyl Ether (Chimexane® NL) , Polyglyceryl-3 Distearate (Cremophor® GS 32) and Polyglyceryl Polyricinoleate (Admul® WOL 1403) Polyglyceryl Dimerate Is
  • polystyrene resin examples include the mono-, di- and triesters of trimethylolpropane or pentaerythritol with lauric acid, coconut fatty acid, tallow fatty acid, palmitic acid, stearic acid, oleic acid, behenic acid and the like which are optionally reacted with 1 to 30 mol of ethylene oxide.
  • Zwitterionic surfactants can also be used as emulsifiers.
  • Zwitterionic surfactants are surface-active compounds that contain at least one quaternary ammonium group and at least one carboxylate and one sulfonate group in the molecule.
  • Particularly suitable zwitterionic surfactants are the so-called betaines such as the N-aikyl-N, N-dimethylammonium glycinate, for example the cocoalkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinate, for example the cocoacylaminopropyldimethylammonium methylglycinate, and 2-carboxylate -3-hydroxyethylimidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and the cocoacylaminoethylhydroxyethylcarboxymethylglycinate.
  • betaines such as the N-aikyl-N, N-dimethylammonium glycinate, for example the cocoalkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinate, for example
  • Suitable emulsifiers are ampholytic surfactants.
  • Ampholytic surfactants are surface-active compounds which, in addition to a C ⁇ -alkyl or -acyl group, contain at least one free amino group and at least one -COOH or -S ⁇ 3H group in the molecule and are capable of forming internal salts.
  • ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each with about 8 to 18 carbon atoms in the alkyl group.
  • Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate.
  • cationic surfactants are also suitable as emulsifiers, those of the esterquat type, preferably methylquaternized difatty acid triethanolamine ester salts, being particularly preferred.
  • Typical examples of fats are glycerides, i.e. Solid or liquid vegetable or animal products, which consist essentially of mixed glycerol esters of higher fatty acids, come as waxes, among others. natural waxes, e.g. Candelilla wax, camauba wax, japan wax, esparto grass wax, cork wax, guaruma wax, rice germ oil wax, sugar cane wax, ouricury wax, montan wax, beeswax, shellac wax, walrate, lanolin (wool wax), pretzel fat, ceresin, ozokerite (earth wax), petrolatum, paraffin waxes, microfax waxes chemically modified waxes (hard waxes), e.g.
  • natural waxes e.g. Candelilla wax, camauba wax, japan wax, esparto grass wax, cork wax, guaruma wax, rice germ oil wax, sugar cane wax, ouricury wax, montan
  • Montanester waxes Montanester waxes, Sasol waxes, hydrogenated jojoba waxes and synthetic waxes, such as Polyalkylene waxes and polyethylene glycol waxes in question.
  • fat-like substances such as lecithins and phospholipids can also be used as additives.
  • lecithin those glycerophospholipids which are formed from fatty acids, glycerol, phosphoric acid and choline by esterification. Lecithins are therefore often used in the professional world as phosphatidylcholines (PC).
  • Examples of natural lecithins are the cephalins, which are also referred to as phosphatidic acids and are derivatives of 1,2-diacyl-sn-glycerol-3-phosphoric acids.
  • phospholipids are usually understood to be mono- and preferably diesters of phosphoric acid with glycerol (glycerol phosphates), which are generally classed as fats.
  • glycerol phosphates glycerol phosphates
  • sphingosines or sphingolipids are also suitable.
  • Pearlescent waxes are: alkylene glycol esters, especially ethylene glycol distearate; Fatty acid alkanolamides, especially coconut fatty acid diethanolamide; Partial glycerides, especially stearic acid monoglyceride; Esters of polyvalent, optionally hydroxy-substituted carboxylic acids with fatty alcohols with 6 to 22 carbon atoms, especially long-chain esters of tartaric acid; Fatty substances, such as, for example, fatty alcohols, fatty ketones, fatty aldehydes, fatty ethers and fatty carbonates, which have a total of at least 24 carbon atoms, especially lauron and distearyl ether; Fatty acids such as stearic acid, hydroxystearic acid or behenic acid, ring opening products of olefin epoxides with 12 to 22 carbon atoms with fatty alcohols with 12 to 22 carbon atoms and / or polyols with 2 to 15 carbon atoms
  • Suitable consistency agents are primarily fatty alcohols or hydroxyfatty alcohols with 12 to 22 and preferably 16 to 18 carbon atoms and also partial glycerides, fatty acids or hydroxyfatty acids. A combination of these substances with alkyl oligoglucosides and / or fatty acid N-methylglucamides of the same chain length and / or polyglycerol poly-12-hydroxystearates is preferred.
  • Suitable thickeners are, for example, Aerosil types (hydrophilic silicas), polysaccharides, in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl cellulose, and also higher molecular weight polyethylene glycol mono- and diesters of fatty acids, polyacrylates, ( eg Carbopole® and Pemulen types from Goodrich; Synthalene® from Sigma; Keltrol types from Kelco; Sepigel types from Seppic; Salcare types from Allied Colloids), polyacrylamides, polymers, polyvinyl alcohol and polyvinyl pyrrolidone, surfactants such as, for example ethoxylated fatty acid glycerides, esters of fatty acids with polyols such as pentaerythritol or trimethylolpropane, fatty alcohol ethoxylates with a narrow homolog distribution or alkyl oligo
  • Substances such as, for example, lanolin and lecithin and polyethoxylated or acylated lanolin and lecithin derivatives, polyol fatty acid esters, monoglycerides and fatty acid alkanolamides can be used as superfatting agents, the latter simultaneously serving as foam stabilizers.
  • Metal salts of fatty acids such as e.g. Magnesium, aluminum and / or zinc stearate or ricinoleate can be used.
  • Suitable cationic polymers are, for example, cationic cellulose derivatives, such as, for example, a quaternized hydroxyethyl cellulose, which is available under the name Polymer JR 400® from Amerchol, cationic starch, copolymers of diallylammonium salts and acrylamides, quaternized vinylpyrrolidone / vinylimidazole polymers, such as, for example, Luviquat® ( BASF), condensation products of polyglycols and amines, quaternized collagen polypeptides, such as lauryldimonium hydroxypropyl hydrolyzed collagen (Lamequat®L / Grünau), quaternized wheat polypeptides, polyethyleneimine, cationic silicone polymers such as amodimethicones, copolymers of adipic acid and dimethyla- minohydroxypropyldiethylenetriamine (Cartaretine® / Sandoz), copolymers of acrylic acid with dimethyldial
  • Anionic, zwitterionic, amphoteric and nonionic polymers include, for example, vinyl acetate / crotonic acid copolymers, vinyl pyrrolidone / vinyl acrylate copolymers, vinyl acetate / butyl maleate / isobomylacrylate copolymers, methyl vinyl ether / maleic anhydride copolymers and polyesters and their esters, uncrosslinked , Acrylamidopropyl-trimethylammonium chloride / acrylate copolymers, octylacrylamide / methyl methacrylate / tert-butylaminoethyl methacrylate / 2-hydroxypropyl methacrylate copolymers, polyvinyl pyrrolidone, vinyl pyrrolidone / vinyl acetate copolymers, vinyl pyrrolidone / dimethylaminoethyl methacrylate and optionally derivatized / vinyl aminomethyl
  • Suitable silicone compounds are, for example, dimethylpolysiloxanes, methylphenylpolysiloxanes, cyclic silicones and amino-, fatty acid-, alcohol-, polyether-, epoxy-, fluorine-, glycoside- and / or alkyl-modified silicone compounds, which can be both liquid and resinous at room temperature.
  • Simethicones which are mixtures of dimethicones with an average chain length of 200 to 300 dimethylsiloxane units and hydrogenated silicates, are also suitable.
  • a detailed overview of suitable volatile silicones can also be found by Todd et al. in Cosm.Toil. 91, 27 (1976).
  • UV light protection factors are understood to mean, for example, organic substances (light protection filters) which are liquid or crystalline at room temperature and which are able to absorb ultraviolet rays and release the absorbed energy in the form of longer-wave radiation, for example heat.
  • UVB filters can be oil-soluble or water-soluble. Examples of oil-soluble substances are: > 3-benzylidene camphor or 3-benzylidene norcampher and its derivatives, for example 3- (4-methylbenzylidene) camphor as described in EP 0693471 B1;
  • 4-aminobenzoic acid derivatives preferably 2-ethyl-hexyl 4- (dimethylamino) benzoate, 2-octyl 4- (dimethylamino) benzoate and amyl 4- (dimethylamino) benzoate;
  • esters of cinnamic acid preferably 4-methoxycinnamic acid 2-ethylhexyl ester, 4-methoxycinnamic acid propyl ester, 4-methoxycinnamic acid isoamyl ester 2-cyano-3,3-phenylcinnamic acid 2-ethylhexyl ester (octocrylene);
  • esters of salicylic acid preferably salicylic acid 2-ethylhexyl ester, salicylic acid 4-iso-propylbenzyl ester, salicylic acid homomethyl ester;
  • benzophenone preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone;
  • esters of benzalmalonic acid preferably 4-methoxybenzmalonic acid di-2-ethylhexyl ester;
  • Triazine derivatives e.g. 2,4,6-trianilino- (p-carbo-2'-ethyl-1'-hexyloxy) -1, 3,5-triazine and octyl triazone, as described in EP 0818450 A1 or dioctyl butamido triazone (Uvasorb ® HEB);
  • UV-A filters -4'-methoxydibenzoyl-methane (Parsol® 1789), 1-phenyl-3- (4'-isopropylphenyl) propane-1,3-dione and enamine compounds as described in DE 19712033 A1 (BASF).
  • the UV-A and UV-B filters can of course also be used in mixtures.
  • Particularly favorable combinations consist of the derivatives of benzoylmethane, for example 4-tert-butyl-4'-methoxydibenzoylmethane (Parsol® 1789) and 2-cyano-3,3-phenylcinnamic acid-2-ethyl-hexyl ester (octocrylene) in combination with Esters of cinnamic acid, preferably 2-ethylhexyl 4-methoxycinnamate and / or propyl 4-methoxycinnamate and / or isoamyl 4-methoxycinnamate.
  • benzoylmethane for example 4-tert-butyl-4'-methoxydibenzoylmethane (Parsol® 1789) and 2-cyano-3,3-phenylcinnamic acid-2-ethyl-hexyl ester (octocrylene) in combination with Esters of cinnamic acid, preferably 2-ethylhex
  • water-soluble filters such as 2-phenylbenzimidazole-5-sulfonic acid and their alkali, alkaline earth, ammonium, alkylammonium, alkanolammonium and glucammonium salts.
  • insoluble light protection pigments namely finely dispersed metal oxides or salts, are also suitable for this purpose.
  • suitable metal oxides are, in particular, zinc oxide and titanium dioxide and, in addition, oxides of iron, zirconium, silicon, manganese, aluminum and cerium and mixtures thereof.
  • Silicates (talc), barium sulfate or zinc stearate can be used as salts.
  • the oxides and salts are used in the form of the pigments for skin-care and skin-protecting emulsions and decorative cosmetics.
  • the particles should have an average diameter of less than 100 nm, preferably between 5 and 50 nm and in particular between 15 and 30 nm. They can have a spherical shape, but it is also possible to use particles which have an ellipsoidal shape or a shape which differs from the spherical shape in some other way.
  • the pigments can also be surface-treated, ie hydrophilized or hydrophobicized. Typical examples are coated titanium dioxides such as titanium dioxide T 805 (Degussa) or Eusolex® T2000 (Merck).
  • Silicones and in particular trialkoxyoctylsilanes or simethicones, are particularly suitable as hydrophobic coating agents. So-called micro- or nanopigments are preferably used in sunscreens. Micronized zinc oxide is preferably used. Other suitable UV light protection filters are in the overview by P.Finkel in S ⁇ FW-Journal 122, 543 (1996) and Parf.Kosm. 3, 11 (1999).
  • secondary light stabilizers of the antioxidant type can also be used, which interrupt the photochemical reaction chain which is triggered when UV radiation penetrates the skin.
  • Typical examples are amino acids (e.g. glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (e.g. urocanic acid) and their derivatives, peptides such as D, L-camosine, D-camosine, L-carnosine and their derivatives (e.g.
  • Carotenoids eg ⁇ -carotene, ⁇ -carotene, lycopene
  • carbotenoids eg ⁇ -carotene, ⁇ -carotene, lycopene
  • chlorogenic acid and their derivatives lipoic acid and their derivatives (eg dihydroliponic acid)
  • aurothioglucose propylthiouracil and other thiols (eg thioredoxin, glutathione, cysteine, Cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, ⁇ -linoleyl, cholesteryl and glyceryl esters) and their salts , Dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and its derivatives (est
  • ⁇ -hydroxy fatty acids e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g. citric acid, lactic acid, malic acid
  • humic acid e.g.
  • ascorbyl palmitate Mg-ascorbyl phosphate , Ascorbyl acetate), tocopherols and derivatives (eg vitamin E acetate), vitamin A and derivatives (vitamin A palmitate) and coniferyl benzoate of benzoin, rutinic acid and its derivatives, ⁇ -glycosyl rutin, ferulic acid, furfurylidene glucitol, carnosine, butylated hydroxytisolol, , Northern Hydroguajak resin acid, nordihydroguajaretic acid, trihydroxybutyrophenone, uric acid and its derivatives, mannose and its derivatives, superoxide dismutase, zinc and its derivatives (e.g.
  • ZnO, ZnS0 4 selenium and its derivatives (e.g. selenium methionine), stilbenes and their derivatives (e.g. Stilbene oxide, trans-stilbene oxide) and the derivatives (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of these active substances which are suitable according to the invention.
  • Biogenic active substances include, for example, tocopherol, tocopherol acetate, tocopherol palmitate, ascorbic acid, (deoxy) ribonucleic acid and its fragmentation products, retinol, bisabolol, allantoin, phytantriol, panthenol, AHA acids, amino acids, ceramides, pseudoceramides, essential oils and vegetable complexes.
  • deodorants counteract, mask or eliminate body odors.
  • Body odors arise from the action of skin bacteria on apocrine sweat, whereby unpleasant smelling breakdown products are formed.
  • deodorants contain active ingredients which act as germ-inhibiting agents, enzyme inhibitors, odor absorbers or odor maskers.
  • germ-inhibiting agents such as. B.
  • Esterase inhibitors are suitable as enzyme inhibitors. These are preferably trialkyl citrates such as trimethyl citrate, tripropyl citrate, triisopropyl citrate, tributyl citrate and in particular triethyl citrate (Hydagen® CAT).
  • the substances inhibit enzyme activity and thereby reduce odor.
  • esterase inhibitors include sterol sulfates or phosphates, such as, for example, lanosterol, cholesterol, campesterol, stigma- sterol and sitosterol sulfate or phosphate, dicarboxylic acids and their esters, such as, for example, glutaric acid, monoethyl glutarate, Diethyl glutarate, adipic acid, monoethyl adipate, Diethyl adipate, malonic acid and diethyl malonate, hydroxycarboxylic acids and their esters such as citric acid, malic acid, tartaric acid or tartaric acid diethyl ester, and zinc glycinate.
  • sterol sulfates or phosphates such as, for example, lanosterol, cholesterol, campesterol, stigma- sterol and sitosterol sulfate or phosphate
  • dicarboxylic acids and their esters such as, for example, glutaric acid, mono
  • Suitable odor absorbers are substances that absorb odor-forming compounds and can retain them to a large extent. They lower the partial pressure of the individual components and thus also reduce their speed of propagation. It is important that perfumes must remain unaffected. Odor absorbers are not effective against bacteria. They contain, for example, a complex zinc salt of ricinoleic acid or special, largely odorless fragrances, which are known to the person skilled in the art as "fixators", such as, for example, the main component. B. extracts of Labdanum or Styrax or certain abietic acid derivatives. Fragrance agents or perfume oils act as odor maskers and, in addition to their function as odor maskers, give the deodorants their respective fragrance.
  • Perfume oils are, for example, mixtures of natural and synthetic fragrances. Natural fragrances are extracts of flowers, stems and leaves, fruits, fruit peels, roots, woods, herbs and grasses, needles and branches as well as resins and balms. Animal raw materials, such as civet and castoreum, are also suitable. Typical synthetic fragrance compounds are products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type. Fragrance compounds of the ester type are e.g.
  • ethers include, for example, benzyl ethyl ether, the aldehydes e.g.
  • the linear alkanals with 8 to 18 carbon atoms citral, citronellal, citronellyloxyacetaldehyde, cyclamenaldehyde, hydroxycitronellal, lilial and bourgeonal, to the ketones e.g. the Jonone and methylcedryl ketone, the alcohols anethole, citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and terpineol, the hydrocarbons mainly include the terpenes and balsams. However, preference is given to using mixtures of different fragrances which together produce an appealing fragrance.
  • Essential oils of lower volatility which are mostly used as aroma components, are also suitable as perfume oils, e.g. Sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, labdanum oil and lavandin oil.
  • perfume oils e.g. Sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, labdanum oil and lavandin oil.
  • Antiperspirants reduce sweat formation by influencing the activity of the eccrine sweat glands and thus counteract armpit wetness and body odor.
  • Aqueous or anhydrous formulations of antiperspirants typically contain the following ingredients:
  • non-aqueous solvents such as As ethanol, propylene glycol and / or glycerin.
  • Salts of aluminum, zirconium or zinc are particularly suitable as astringent antiperspirant active ingredients.
  • suitable antiperspirant active ingredients are e.g. Aluminum chloride, aluminum chlorohydrate, aluminum dichlorohydrate, aluminum sesquichlorohydrate and their complex compounds e.g. B. with propylene glycol-1, 2nd Aluminum hydroxyallantoinate, aluminum chloride tartrate, aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate and their complex compounds z. B. with amino acids such as glycine.
  • customary oil-soluble and water-soluble auxiliaries can be present in smaller amounts in antiperspirants.
  • oil soluble aids can e.g. his:
  • water-soluble additives are e.g. Preservatives, water-soluble fragrances, pH adjusters, e.g. Buffer mixtures, water soluble thickeners, e.g. water-soluble natural or synthetic polymers such as e.g. Xanthan gum, hydroxyethyl cellulose, polyvinyl pyrrolidone or high molecular weight polyethylene oxides.
  • Common film formers are, for example, chitosan, microcrystalline chitosan, quaternized chitosan, polyvinylpyrrolidone, vinylpyrrolidone-vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives, collagen, hyaluronic acid or its salts and similar compounds.
  • Antidandruff agents are, for example, chitosan, microcrystalline chitosan, quaternized chitosan, polyvinylpyrrolidone, vinylpyrrolidone-vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives, collagen, hyaluronic acid or its salts and similar compounds.
  • Piroctone olamine (1-hydroxy-4-methyl-6- (2,4,4-trimythylpentyl) -2- (IH) -pyridinone monoethanolamine salt), Baypival® (Climbazole), Ketoconazol®, (4-acetyl-1 - ⁇ - 4- [2- (2.4-dichlorophenyl) r-2- (1 H -imidazol-1-ylmethyl) -1, 3-dioxylan-c-4-ylmethoxyphenyl ⁇ piperazine, ketoconazole, elubiol, selenium disulfide, sulfur colloidal , Sulfur polyethylene glycol sorbitan monooleate, sulfur Ricinolpolyehtoxylat, sulfur tar distillates, salicylic acid (or in combination with hexachlorophene), undexylenic acid monoethanolamide sulfosuccinate sodium salt, Lamepon® UD (protein undecylenic acid pyrithione, magnesium
  • Montmorillonites, clay minerals, pemules and alkyl-modified carbopol types can serve as swelling agents for aqueous phases. Further suitable polymers or swelling agents can be found in the overview by R. Lochhead in Cosm.Toil. 108, 95 (1993).
  • Possible insect repellents are N, N-diethyl-m-toluamide, 1, 2-pentanediol or ethyl butylacetylaminopropionate
  • Dihydroxyacetone is suitable as a self-tanner.
  • Arbutin, ferulic acid, kojic acid, coumaric acid and ascorbic acid (vitamin C) can be used as tyrosine inhibitors, which prevent the formation of melanin and are used in depigmenting agents.
  • Hydrotropes such as ethanol, isopropyl alcohol, or polyols can also be used to improve the flow behavior.
  • Polyols that come into consideration here preferably have 2 to 15 carbon atoms and at least two hydroxyl groups.
  • the polyols can also contain further functional groups, in particular amino groups, or be modified with nitrogen. Typical examples are >Glycerin;
  • Alkylene glycols such as ethylene glycol, diethylene glycol, propylene glycol, butylene glycol, hexylene glycol and polyethylene glycols with an average molecular weight of 100 to 1,000 daltons;
  • Methyl compounds such as in particular trimethylolethane, trimethylolpropane, trimethylolbutane, pentaerythritol and dipentaerythritol;
  • Sugar alcohols with 5 to 12 carbon atoms such as sorbitol or mannitol,
  • Dialcohol amines such as diethanolamine or 2-amino-1, 3-propanediol.
  • Suitable preservatives are, for example, phenoxyethanol, formaldehyde solution, parabens, pentanediol or sorbic acid and the other classes of substances listed in Appendix 6, Parts A and B of the Cosmetics Regulation.
  • Perfume oils include mixtures of natural and synthetic fragrances. Natural fragrances are extracts of flowers (lily, lavender, roses, jasmine, neroli, ylang-ylang), stems and leaves (geranium, patchouli, petitgrain), fruits (anise, coriander, caraway, juniper), fruit peel (bergamot, lemon, Oranges), roots (mace, angelica, celery, cardamom, costus, iris, calmus), wood (pine, sandal, guaiac, cedar, rosewood), herbs and grasses (tarragon, lemongrass, sage, thyme), Needles and twigs (spruce, fir, pine, mountain pine), resins and balms (galbanum, elemi, benzoin, myrrh, olibanum, opoponax).
  • Typical synthetic fragrance compounds are products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type. Fragrance compounds of the ester type are, for example, benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinylacetate, phenylethyl acetate, linalyl benzoate, benzyl formate, ethyl methylphenylglycinate, allylcyclohexyl benzylatepylpropionate, allyl cyclohexyl propyl pionate.
  • the ethers include, for example, benzyl ethyl ether, the aldehydes, for example, the linear alkali nals with 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamenaldehyde, hydroxycitronellal, lilial and bourgeonal, to the ketones eg the jonones, ⁇ -isomethylionone and methylcedrylketone, to the alcohols anethole, citronellol, eugenol, isoleugenol, isoeugenol , Phenylethyl alcohol and terpineol, the hydrocarbons mainly include the terpenes and balms.
  • fragrance oils of lower volatility which are mostly used as aroma components, are also suitable as perfume oils, for example sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, labolanum oil and lavandin oil.
  • bergamot oil dihydromyrcenol, lilial, lyral, citronellol, phenylethyl alcohol, ⁇ -hexylcinnamaldehyde, geraniol, benzyl acetone, cyclamen aldehyde, linalool, Boisambrene Forte, Ambroxan, indole, hedione, Sandelice, lemon oil, mandarin oil, orange oil, allyl amyl glycolate, Cyclovertal, lavandin oil, muscatel Sage oil, ß-damascone, geranium oil bourbon, cyclohexyl salicylate, Vertofix Coeur, Iso-E-Super, Fixolide NP, evernyl, iraldein gamma, phenylacetic acid, geranyl acetate, benzyl acetate, rose oxide, romilllate, irot
  • the dyes which can be used are those substances which are suitable and approved for cosmetic purposes, as compiled, for example, in the publication "Cosmetic Dyes” by the Dye Commission of the German Research Foundation, Verlag Chemie, Weinheim, 1984, pp. 81-106. These dyes are usually used in concentrations of 0.001 to 0.1% by weight, based on the mixture as a whole.
  • the total proportion of auxiliaries and additives can be 1 to 50, preferably 5 to 40,% by weight, based on the composition.
  • the agents can be produced by customary cold or hot processes; the phase inversion temperature method is preferably used.
  • Example 1 Preparation of an extract from Physalis minima.
  • 200 g of crushed Physalis minima leaves were dispersed in 2 l of 70% by weight aqueous methanol.
  • the mixture was extracted under reflux and constant agitation over a period of 1 h, then cooled, filtered through a filter with a mesh size of 0.45 ⁇ m, the methanol was distilled off at 30 ° C. under reduced pressure and the remaining aqueous phase was lyophilized.
  • the yield based on the leaves was 15.8% by weight.
  • the extract was then subjected to fractionation by liquid chromatography on Amberiite XAD 1180. Elution was carried out with a step gradient from 20% by weight aqueous methanol to 100% methanol. The extract without fractionation and three different fractions were then tested.
  • Example 2 Preparation of an extract from Achyranthes bidentata.
  • 300 g of shredded leaves and stems of Achyranthes bidentata were dispersed in 3 l of 96% strength by weight aqueous ethanol in a glass reactor.
  • the mixture was extracted under reflux with constant agitation for a period of 1 h, then cooled, and the solution was filtered through a filter with a mesh size of 0.45 ⁇ m.
  • the remaining residue was extracted a second time under the same conditions.
  • the filtrates were combined, 1.5% by weight of activated carbon was added to decolorize and the mixture was filtered again.
  • the resultant slightly brownish filtrate was freed then at 40 C C under reduced pressure of ethanol and the aqueous phase up to an active substance content of 50 wt .-% evaporated.
  • the yield based on the feed was 7.6% by weight.
  • the extract was then subjected to fractionation by liquid chromatography on Amberiite XAD 1180. Elution was carried out with a step gradient from 20% by weight aqueous methanol to 100% by weight methanol. An extract without fractionation and the fraction with 100% by weight of methanol were then tested.
  • G6PDH activity was determined according to that of Garidelli de Quincenet in Annual DermatolNenereol. 107 (12), 1163-1170 (1980).
  • G ⁇ PDH activity was determined according to that of ⁇ atsuko Okada and Yukio Kitano in: Arch. Derma- tol. Res., 271 (3): 341-346, 1981 described method by in vitro determination of the enzymatic activity of glucose-6-phosphate dehydrogenase in human fibroblasts
  • the DNA content was determined by the method described by Desaulniers in Toxic In Vitro 12 (4), 409-422 (1998).
  • the incubation time of the fibroblasts was 3 days and 6 days in each case.
  • the results are summarized in Table 2. The mean is given in each case of 4 attempts at triple determination
  • the extracts and the methanol fraction of the extract of the plant Achyranthes bidentata show an increase in activity at a concentration of 0.005% by weight after 3 and after 6 days of incubation.
  • the fraction from the methanol fractionation is already at a concentration of 0.0003%. -% Effective

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Dermatology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Toxicology (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Disclosed is the use of natural substances from the group formed by plant extracts from the solananaceae, from amaranthaceae and monimiaceae family in the production of cosmetic preparations. The invention also relates to the use thereof as active ingredients in the production of an agent for increasing G6PDH activity in metabolism.

Description

VERWENDUNG VON NATURSTOFFEN ZUR HERSTELLUNG KOSMETI SCHEN ZUBEREITUNGEN USE OF NATURAL SUBSTANCES FOR THE PRODUCTION OF COSMETIC PREPARATIONS
Gebiet der ErfindungField of the Invention
Die Erfindung befindet sich auf den Gebieten der Kosmetik und der Pharmazie und betrifft einerseits die Verwendung von bestimmten Pflanzenextrakten zur Herstellung von kosmetischen Zubereitungen und andererseits die Verwendung der Extrakte als Wirkstoffe zur Steigerung der Aktivität bestimmter Enzyme im Stoffwechsel sowie ein Verfahren zur Bewertung von Wirkstoffen gegen die Hautalterung.The invention is in the fields of cosmetics and pharmacy and relates on the one hand to the use of certain plant extracts for the production of cosmetic preparations and on the other hand to the use of the extracts as active substances for increasing the activity of certain enzymes in the metabolism and to a method for evaluating active substances against skin aging.
Stand der TechnikState of the art
Obschon die Hautalterung viele Ursachen hat, lassen sich die von der Kosmetikindustrie dagegen entwickelten Wirkstoffe grundsätzlich in zwei Gruppen einteilen. Auf der einen Seite finden sich aktive Ingredienzien, die die Zellen vor oxidativen Streß oder Proteolyse schützen (schützender Effekt), auf der anderen Wirkstoffe, die die Zellregeneration stimulieren (heilender Effekt). Gerade letztere haben in den letzten Jahren an Bedeutung gewonnen, obschon ihre Entwicklung ein genaues Verständnis der biochemischen Vorgänge in der Haut voraussetzt. Zu diesen Wirkstoffen zählen beispielsweise Enzyme, die einer Schädigung durch UV-Licht oder Umweltgifte entgegenwirken, aber auch solche, die die Synthese essentieller Zellbestandteile, wie z.B. Strukturproteine, embranlipide oder DNA fördern. So finden sich in kosmetischen Zubereitungen des Marktes schon heute Stoffe, beispielsweise DNA- Fragmente, die die IL-6 oder P53-Aktivität anregen, Proteine zur Stimulierung der Kollagensynthese oder Ribosomen von E.coli zur Anregung des Wachstums von Keratinozyten.Although skin aging has many causes, the active ingredients developed by the cosmetics industry, on the other hand, can basically be divided into two groups. On the one hand there are active ingredients that protect the cells against oxidative stress or proteolysis (protective effect), on the other active ingredients that stimulate cell regeneration (healing effect). The latter in particular have gained in importance in recent years, although their development requires a precise understanding of the biochemical processes in the skin. These active ingredients include, for example, enzymes that counteract damage by UV light or environmental toxins, but also those that prevent the synthesis of essential cell components, e.g. Promote structural proteins, membrane lipids or DNA. Cosmetic preparations on the market already contain substances such as DNA fragments that stimulate IL-6 or P53 activity, proteins to stimulate collagen synthesis or ribosomes from E. coli to stimulate the growth of keratinocytes.
Der vorliegenden Patentanmeldung liegt jedoch ein anderer Befund zugrunde. Glucose 6-Phosphat Dehydrogenase (G6PDH) ist ein Enzym, welches die ersten Schritte des sogenannten „Pentosewegs" katalysiert. Während des ersten Schrittes, der Umwandlung von Glucose 6-Phosphat (G6P) in 6- Phosphogluconat (6PG), benötigt G6PDH als Coenzym Nicotinamid-Adenin-Dinucleotidphosphat (NADP), welches zu NADPH2 reduziert wird. Die reduzierte Form dieses Coenzyms kann eine Vielzahl von enzymatischen Reaktionen wie beispielsweise das Recycling von Glutathion oder die Lipidsynthe- se katalysieren. Der letzte Schritt des Pentosewegs liefert zudem die wichtigste Vorstufe für die DNA, die Desoxyribose. Nach den Untersuchungen von Weber und Körting in J.Invest.Dermatol. 42, 167- 169 (1964) sind G6PDH und 6-Phosphatogluconat Dehydrogenase (6PGDH) ebenso wie eine Reihe von anderen Glycolyseenzymen (z.B. Aldolase) in den oberen Schichten der menschlichen Haut anzutreffen. Aufgrund einer Vielzahl weiterer Untersuchungen hat die Anmelderin gefunden, dass G6DPH nicht nur eine wichtige Rolle im Metabolismus der Haut spielt, sondern auch in-vitro als Modellsystem für die Wirksamkeit von Wirkstoffen gegen die Hautalterung dienen kann.However, the present patent application is based on another finding. Glucose 6-phosphate dehydrogenase (G6PDH) is an enzyme that catalyzes the first steps of the so-called "pentose route". During the first step, the conversion of glucose 6-phosphate (G6P) into 6-phosphogluconate (6PG), G6PDH needs as coenzyme Nicotinamide adenine dinucleotide phosphate (NADP), which is reduced to NADPH 2. The reduced form of this coenzyme can catalyze a variety of enzymatic reactions such as the recycling of glutathione or lipid synthesis. The last step of the pentose route also provides the most important precursor for DNA, deoxyribose According to the investigations by Weber and Körting in J. Invest.Dermatol. 42, 167-169 (1964), G6PDH and 6-phosphatogluconate dehydrogenase (6PGDH) as well as a number of other glycolysis enzymes (eg aldolase) are in the upper layers of human skin. Based on a large number of further studies, the applicant has found that G6DPH not only plays an important role in the metabolism of the skin, but can also serve as an in-vitro model system for the effectiveness of active ingredients against skin aging.
Die Aufgabe der vorliegenden Patentanmeldung hat daher darin bestanden, solche Wirkstoffe zur Verfügung zu stellen, die die Aktivität von G6PDH in den Fibroblasten anregt, möglichst ohne den DNA- Gehalt der Zellen negativ zu beeinflussen.The object of the present patent application was therefore to provide those active substances which stimulate the activity of G6PDH in the fibroblasts, if possible without negatively influencing the DNA content of the cells.
Beschreibung der ErfindungDescription of the invention
Gegenstand der Erfindung ist die Verwendung von Naturstoffen ausgewählt aus der Gruppe, die gebildet wird von Extrakten von Pflanzen aus der Familie der Solanaceae, der Familie Amaranthaceae und der Familie Monimiaceae zur Herstellung von kosmetischen Zubereitungen. Ein weitere Gegenstand der Erfindung ist die Verwendung von Naturstoffen ausgewählt aus der Gruppe, die gebildet wird von Extrakten von Pflanzen aus der Familie der Solanaceae, der Familie Amaranthaceae und der Familie Monimiaceae als Wirkstoffe zur Herstellung eines Mittels zur Steigerung der G6PDH-Aktivität im Stoffwechsel.The invention relates to the use of natural substances selected from the group formed by extracts of plants from the Solanaceae family, the Amaranthaceae family and the Monimiaceae family for the production of cosmetic preparations. Another object of the invention is the use of natural substances selected from the group formed by extracts of plants from the Solanaceae family, the Amaranthaceae family and the Monimiaceae family as active ingredients for producing an agent for increasing the G6PDH activity in the metabolism.
Überraschenderweise wurde gefunden, dass die Extrakte der genannten Pflanzen bzw. die darin enthaltenen wirksamen Prinzipien die gestellte Aufgabe in vorzüglicher Weise erfüllen. Gegenüber dem Standard konnte die G6PDH-Aktivität um bis zu 140 % gesteigert werden, ohne dass der DNA-Gehalt signifikant abgenommen hätte. Die Stoffe sind somit für die Herstellung von kosmetischen Zubereitungen, speziell Hautbehandlungsmitteln und insbesondere Mitteln gegen die Hautalterung bestens geeignet.Surprisingly, it was found that the extracts of the plants mentioned and the active principles contained therein fulfill the task in an excellent manner. Compared to the standard, the G6PDH activity could be increased by up to 140% without the DNA content having decreased significantly. The substances are therefore ideally suited for the production of cosmetic preparations, especially skin treatment agents and in particular agents against skin aging.
Pflanzenextrakteplant extracts
Typische Beispiele für Pflanzen, deren Extrakte im Sinne der Erfindung verwendet werden können, sindTypical examples of plants whose extracts can be used in the sense of the invention are
Pflanzen der Geni Physalis, Achyranthes und/oder Peumus.Plants of the Geni Physalis, Achyranthes and / or Peumus.
In einer besonderen Ausführungsform werden demnach erfindungsgemäß Extrakte von Pflanzen desIn a particular embodiment, extracts of plants of the
Geni Physalis, Achyranthes und/oder Peumus verwendet.Geni Physalis, Achyranthes and / or Peumus used.
In einer weiteren besonderen Ausführungsform werden erfindungsgemäß Extrakte von Physalis mini- ma, Achyranthes bidentata, Achyranthes aspera und/oder Peumus boldo verwendet.In a further particular embodiment, extracts of Physalis minimal, Achyranthes bidentata, Achyranthes aspera and / or Peumus boldo are used according to the invention.
Physalis minima Linn, die zur Familie der Solanaceae gehört, ist ein einjähriges Kraut, das eine Höhe von 15 bis 30 cm erreicht und wild wachsend in Indien, Ceylon, Afghanistan sowie in den tropischen Zonen Afrikas und Australiens anzutreffen ist. Seine Früchte besitzen eine diuretische Wirkung, während Blätter und Wurzeln für medizinische Zwecke benutzt werden, beispielsweise gegen Schlangen- bisse und Skorpionstiche. Die Bitterstoffe und Steroidkomponenten der Blätter sind inzwischen weitgehend aufgeklärt. Es handelt sich bei den Steroiden im wesentlichen um Physalin A, Physalin B, Physa- lin C, Physalin D, 5ß,6ß-Epoxyphysalin, Dihydroxyphysalin B, Whitaphysalin A, Whitaphysalin B und Whitaphysalin C. Desweiteren wurden Phenolsäuren, Chlorogensäuren sowie Flavon-Derivate wie z.B. Quercitin-3-O-galactosid gefunden.Physalis minima Linn, which belongs to the family of the Solanaceae, is an annual herb that reaches a height of 15 to 30 cm and is found wild in India, Ceylon, Afghanistan as well as in the tropical zones of Africa and Australia. Its fruits have a diuretic effect, while leaves and roots are used for medicinal purposes, e.g. against snake bites and scorpion stings. The bitter substances and steroid components of the leaves have now largely been cleared up. The steroids are essentially Physalin A, Physalin B, Physalin C, Physalin D, 5ß, 6ß-Epoxyphysalin, Dihydroxyphysalin B, Whitaphysalin A, Whitaphysalin B and Whitaphysalin C. Furthermore phenolic acids, chlorogenic acids as well as flavon derivatives such as quercitin-3-O-galactoside.
Achyranthes bidentata und Achyranthes aspera: Diese Pflanzen gehören zur Familie der Amaranthaceae und sind einjährige, bis zu 1 m Höhe aufrecht wachsende Pflanzen, welche in Asien, besonders in Korea, China, Vietnam, Japan und Indien beheimatet sind. Die Pflanzen finden breite Verwendung in der traditionellen Medizin und werden beispielsweise eingesetzt als Diureticum und Antir- heumaticum aber auch gegen Zahnschmerzen oder Menstruationsbeschwerden. Die Blätter und Samen der beiden Pflanzen sind essbar und werden v.a. in Indien als Gemüse und die Samen als Korn zum Backen verzehrt. Zu den bekannten Inhaltsstoffen zählen Saponine, Steroide, Sterole (Sitosterol), Polysaccharide, Alkaloide, phenolische Säuren (Kaffeesäure), Quinone und Flavon-Derivate (Rutin, Isoquercetin, Astragalin).Achyranthes bidentata and Achyranthes aspera: These plants belong to the Amaranthaceae family and are annual plants that grow up to 1 m tall and are native to Asia, especially Korea, China, Vietnam, Japan and India. The plants are widely used in traditional medicine and are used, for example, as a diuretic and antirheumatic, but also for toothache or menstrual cramps. The leaves and seeds of the two plants are edible and are mainly in India consumed as vegetables and the seeds as grain for baking. Known ingredients include saponins, steroids, sterols (sitosterol), polysaccharides, alkaloids, phenolic acids (caffeic acid), quinones and flavone derivatives (rutin, isoquercetin, astragalin).
Peumus boldus: Die Pflanze Peumus boldus zählt zur Familie der Monimiaceae. Aus den Blättern und Rinde kann das aporphine Alkaloid Boldin extrahiert werden, welches den wesentlichen aktiven Bestandteil dieser Extrakte ausmacht und welches erfindungsgemäß als Naturstoff verwendet werden kann.Peumus boldus: The Peumus boldus plant belongs to the Monimiaceae family. The aporphine alkaloid boldin can be extracted from the leaves and bark, which is the essential active component of these extracts and which can be used according to the invention as a natural substance.
In einer besonderen Ausführungsform werden demnach erfindungsgemäß Extrakte eingesetzt, die aktive Wirkstoffe enthalten, die ausgewählt sind aus der Gruppe, die gebildet wird von Carotinoiden, Flavon-Derivaten, phenolische Säuren, Chlorogensäuren, Steroiden, aporphinen Alkaloiden, Sterolen und Terpenen.In a particular embodiment, extracts are accordingly used according to the invention which contain active ingredients which are selected from the group formed by carotenoids, flavone derivatives, phenolic acids, chlorogenic acids, steroids, aporphine alkaloids, sterols and terpenes.
Erfindungsgemäß werden bevorzugt die Carotinoide, Flavon-Derivaten, phenolische Säuren, Chlorogensäuren, Steroide, aporphine Alkaloide, Sterole und Terpene eingesetzt, die sich aus den bevorzugten Pflanzen Geni Physali, Achyranthes und Peumus extrahieren lassen. Für die Pflanzen der Gattung Physalis zählen zu den bevorzugten Wirkstoffen die Steroide Physalin A, Physalin B, Physalin C, Physalin D, 5ß,6ß-Epoxyphysalin, Dihydroxyphysalin B und die Steroide Whitaphysalin A, Whitaphysalin B, Whitaphysalin C. Alle bevorzugt genannten Steroide zählen zu den Steroid-Iactonen. Weiterhin bevorzugte Wirkstoffe aus der Gattung Physalis sind phenolische Säuren wie Chlorogensäuren und Kaffeesäure, Carotinoide, sowie Flavon-Derivate wie beispielsweise Quercitin-3-O-galactosid. Für die Pflanzen der Gattung Achyranthes zählen zu den erfindungsgemäß bevorzugten Wirkstoffen Saponine, Steroide, Sterole, Polysaccharide, Alkaloide, phenolische Säuren (Kaffeesäure), Quinone, Terpene und Flavon-Derivate wie beispielsweise Rutin, Isoquercetin oder Astragalin. Besonders bevorzugt ist die Verwendung von Sterolen und Terpenen aus Achyranthes, insbesondere aus Achyranthes bidentata.According to the invention, the carotenoids, flavone derivatives, phenolic acids, chlorogenic acids, steroids, aporphine alkaloids, sterols and terpenes, which can be extracted from the preferred plants Geni Physali, Achyranthes and Peumus, are preferably used. For the plants of the genus Physalis, the preferred active substances include the steroids Physalin A, Physalin B, Physalin C, Physalin D, 5β, 6ß-epoxyphysalin, dihydroxyphysalin B and the steroids Whitaphysalin A, Whitaphysalin B, Whitaphysalin C. All steroids mentioned as preferred to the steroid lactones. Further preferred active ingredients from the genus Physalis are phenolic acids such as chlorogenic acids and caffeic acid, carotenoids, and flavone derivatives such as quercitin-3-O-galactoside. For the plants of the genus Achyranthes, the active substances preferred according to the invention include saponins, steroids, sterols, polysaccharides, alkaloids, phenolic acids (caffeic acid), quinones, terpenes and flavone derivatives such as, for example, rutin, isoquercetin or astragalin. The use of sterols and terpenes from Achyranthes, in particular from Achyranthes bidentata, is particularly preferred.
Für die Pflanzen der Gattung Peumus zählen zu den erfindungsgemäß bevorzugten Wirkstoffen die aporphinen Alkaloide, insbesondere Boldin. Als Naturstoffe im Sinne der Erfindung können die Extrakte der genannten Pflanzen, insbesondere Extrakte der Pflanzen Physalis minima, Achyranthes bidentata, Achyranthes aspera und Peumus bol- do, die aktiven Wirkstoffe allein oder als Mischung in Kombination von mindestens zwei aktiven Wirkstoffen extrahiert aus den genannten Pflanzen und deren bevorzugter Auswahl oder die aktiven Wirkstoffe allein oder in Kombination von mindestens zwei aktiven Wirkstoffen extrahiert aus weiteren Pflanzen oder synthetisch hergestellt eingesetzt werden.For the plants of the genus Peumus, the active substances preferred according to the invention include the aporphine alkaloids, in particular boldine. The extracts of the plants mentioned, in particular extracts of the plants Physalis minima, Achyranthes bidentata, Achyranthes aspera and Peumus boldo, the active substances alone or as a mixture in combination of at least two active substances extracted from the plants mentioned can be used as natural substances in the sense of the invention and their preferred selection or the active ingredients can be used alone or in combination of at least two active ingredients extracted from other plants or synthetically produced.
Die Einsatzmenge der Naturstoffe bzw. der Extrakte kann dabei im Bereich von 0,001 bis 5, vorzugsweise 0,005 bis 1 und insbesondere 0,01 bis 0,5 Gew.-% - bezogen auf die Mittel - betragen.The amount of natural substances or extracts used can be in the range from 0.001 to 5, preferably 0.005 to 1 and in particular 0.01 to 0.5% by weight, based on the composition.
Extraktionextraction
Die Herstellung der Extrakte kann in an sich bekannter Weise erfolgen, d.h. beispielsweise durch wäßrigen, alkoholischen oder wäßrig-alkoholischen Auszug der Pflanzen bzw. Pflanzenteile. Bezüglich der geeigneten herkömmlichen Extraktionsverfahren wie der Mazeration, der Remazeration, der Digestion, der Bewegungsmazeration, der Wirbelextraktion, Ultraschallextraktion, der Gegenstromextraktion, der Perkolation, der Reperkolation, der Evakolation (Extraktion unter vermindertem Druck), der Diakolation und Festflüssig-Extraktion unter kontinuierlichem Rückfluß, die in einem Soxhlet-Extraktor durchgeführt wird, die dem Fachmann geläufig und im Prinzip alle anwendbar sind, sei der Einfachheit halber beispielsweise auf Hagers Handbuch der Pharmazeutischen Praxis, (5. Auflage, Bd. 2, S. 1026-1030, Springer Verlag, Berlin-Heidelberg-New-York 1991) verwiesen. Für den großtechnischen Einsatz vorteilhaft ist die Perkolationsmethode. Als Ausgangsmaterial können frische Pflanzen oder Pflanzenteile eingesetzt werden, üblicherweise wird jedoch von getrockneten Pflanzen und/oder Pflanzenteilen ausgegangen, die vor der Extraktion mechanisch zerkleinert werden können. Hierbei eignen sich alle dem Fachmann bekannten Zerkleinerungsmethoden, als Beispiel sei die Gefriermahlung genannt. Als Lösungsmittel für die Durchführung der Extraktionen können organische Lösungsmittel, Wasser (vorzugsweise heißes Wasser einer Temperatur von über 80 °C und insbesondere von über 95 °C) oder Gemische aus organischen Lösungsmitteln und Wasser, insbesondere niedermolekulare Alkohole mit mehr oder weniger hohen Wassergehalten, verwendet werden. Besonders bevorzugt ist die Extraktion mit Methanol, Ethanol, Pentan, Hexan, Heptan, Aceton, Propylenglykolen, Polyethylenglykolen sowie Ethylacetat sowie Mischungen hieraus sowie deren wäßrige Gemische. Die Extraktion erfolgt in der Regel bei 20 bis 100 °C, bevorzugt bei 30 bis 90 °C, insbesondere bei 60 bis 80 °C. In einer bevorzugten Ausführungsform erfolgt die Extraktion unter Inertgasatmosphäre zur Vermeidung der Oxidation der Wirkstoffe des Extraktes. Dies ist insbesondere bei Extraktionen bei Temperaturen über 40 CC von Bedeutung. Die Extraktionszeiten werden vom Fachmann in Abhängigkeit vom Ausgangsmaterial, dem Extraktionsverfahren, der Extraktionstemperatur, vom Verhältnis Lösungsmittel zu Rohstoff u.a. einge- stellt. Nach der Extraktion können die erhaltenen Rohextrakte gegebenenfalls weiteren üblichen Schritten, wie beispielsweise Aufreinigung, Konzentration und/oder Entfärbung unterzogen werden. Falls wünschenswert, können die so hergestellten Extrakte beispielsweise einer selektiven Abtrennung einzelner unerwünschter Inhaltsstoffe, unterzogen werden. In einer bevorzugten Ausführungsform werden die Extrakte einer Fraktionierung unterzogen. Besonders bevorzugt ist die Fraktionierung durch Flüssigchromatographie an Kunstharzen auf Basis von loneneaustauscherharzen oder von Adsorber- harzen, insbesondere an Amberlite XAD. Die Fraktionierung erfolgt bevorzugt mit einem Stufengradienten des Eluierungsmittels. Bevorzugte Lösungsmittelgemische, die mit einem Stufengradient als Eluierungsmittel eingesetzt werden können, sind Wasser/Methanol, Wasser/Ethanol, Was- ser/lsopropanol und Methanol/Aceton. Im Falle der wässrigen Mischungen wird bevorzugt mit einer Mischung von 20 Gew.-% wäßrigen Methanol begonnen und die Mischung stufenweise bis 100 Gew.- % Methanol verändert. Auf diesem Wege erhält man unterschiedliche Fraktionen, die nach dem Mischungsverhältnis des Lösungsmittelgemisches eingeteilt werden können. Je nach Polarität des Lösungsmittelgemisches werden unterschiedlich polare Inhaltsstoffe des Extraktes eluiert und fraktioniert. Die Extraktion kann bis zu jedem beliebigen Extraktionsgrad erfolgen, wird aber gewöhnlich bis zur Erschöpfung durchgeführt. Typische Ausbeuten (= Trockensubstanzmenge des Extraktes bezogen auf eingesetzte Rohstoffmenge) bei der Extraktion getrockneter Blätter liegen im Bereich von 3 bis 15, insbesondere 6 bis 10 Gew.-%. Die vorliegende Erfindung umfaßt die Erkenntnis, dass die Extraktionsbedingungen sowie die Ausbeuten der Endextrakte vom Fachmann ja nach gewünschtem Einsatzgebiet gewählt werden können. Diese Extrakte, die in der Regel Aktivsubstanzgehalte (= Feststoffgehalte) im Bereich von 0,5 bis 10 Gew.-% aufweisen, können als solche eingesetzt werden, es ist jedoch ebenfalls möglich, das Lösungsmittel durch Trocknung, insbesondere durch Sprüh- oder Gefriertrocknung zu entfernen. Die Extrakte können auch als Ausgangsstoffe für die Gewinnung der oben genannten reinen Wirkstoffe dienen, sofern diese nicht auf synthetischem Wege einfacher und kostengünstiger hergestellt werden können.The extracts can be prepared in a manner known per se, ie for example by aqueous, alcoholic or aqueous-alcoholic extraction of the plants or parts of plants. Regarding the suitable conventional extraction methods such as maceration, remaceration, digestion, movement maceration, vortex extraction, ultrasound extraction, countercurrent extraction, percolation, repercolation, evacolation (extraction under reduced pressure), diacolation and solid-liquid extraction under continuous reflux , which is carried out in a Soxhlet extractor, which is familiar to a person skilled in the art and in principle all can be used, for the sake of simplicity, for example, on Hager's Handbook of Pharmaceutical Practice, (5th edition, vol. 2, pp. 1026-1030, Springer Verlag , Berlin-Heidelberg-New-York 1991). The percolation method is advantageous for large-scale use. Fresh plants or parts of plants can be used as the starting material, but usually dried plants and / or parts of plants are used, which can be mechanically comminuted before extraction. All comminution methods known to the person skilled in the art are suitable here, freeze grinding being mentioned as an example. Organic solvents, water (preferably hot water at a temperature of above 80 ° C. and in particular above 95 ° C.) or mixtures of organic solvents and water, in particular low molecular weight alcohols with more or less high water contents, can be used as solvents for carrying out the extractions become. Extraction with methanol, ethanol, pentane, hexane, heptane, acetone, propylene glycols, polyethylene glycols and ethyl acetate as well as mixtures thereof and their aqueous mixtures is particularly preferred. The extraction is usually carried out at 20 to 100 ° C, preferably at 30 to 90 ° C, in particular at 60 to 80 ° C. In a preferred embodiment, the extraction takes place under an inert gas atmosphere to avoid oxidation of the active ingredients of the extract. This is particularly important for extractions at temperatures above 40 ° C. The extraction times are set by the person skilled in the art depending on the starting material, the extraction process, the extraction temperature, the ratio of solvent to raw material, etc. provides. After the extraction, the crude extracts obtained can optionally be subjected to further customary steps, such as purification, concentration and / or decolorization. If desired, the extracts produced in this way can, for example, be subjected to a selective separation of individual undesirable ingredients. In a preferred embodiment, the extracts are subjected to fractionation. Fractionation by liquid chromatography on synthetic resins based on ion exchange resins or adsorber resins, in particular on Amberlite XAD, is particularly preferred. The fractionation is preferably carried out using a step gradient of the eluent. Preferred solvent mixtures which can be used as eluents with a step gradient are water / methanol, water / ethanol, water / isopropanol and methanol / acetone. In the case of the aqueous mixtures, a mixture of 20% by weight of aqueous methanol is preferably started and the mixture is gradually changed to 100% by weight of methanol. In this way, different fractions are obtained, which can be classified according to the mixing ratio of the solvent mixture. Depending on the polarity of the solvent mixture, differently polar ingredients of the extract are eluted and fractionated. The extraction can take place to any degree of extraction, but is usually carried out to exhaustion. Typical yields (= amount of dry matter of the extract based on the amount of raw material used) in the extraction of dried leaves are in the range from 3 to 15, in particular 6 to 10,% by weight. The present invention encompasses the knowledge that the extraction conditions and the yields of the final extracts can be selected by the person skilled in the art depending on the desired field of use. These extracts, which as a rule have active substance contents (= solids contents) in the range from 0.5 to 10% by weight, can be used as such, but it is also possible to add the solvent by drying, in particular by spray or freeze drying remove. The extracts can also serve as starting materials for the production of the above-mentioned pure active ingredients, provided that these cannot be produced more easily and inexpensively by synthetic means.
Demzufolge kann der Wirkstoffgehalt in den Extrakten 5 bis 100, vorzugsweise 50 bis 95 Gew.-% betragen. Die Extrakte selbst können als wäßrige und/oder in organischen Lösungsmitteln gelöste Zubereitungen sowie als sprüh- bzw. gefriergetrocknete Feststoffe vorliegen. Als organische Lösungsmittel kommen in diesem Zusammenhang beispielsweise die aliphatischen Alkohole mit 1 bis 6 Kohlenstoffatomen (z.B. Ethanol), Ketone (z.B. Aceton), Halogenkohlenwasserstoffe (z.B. Chloroform oder Methylenchlorid), niedere Ester oder Polyole (z.B. Glycerin oder Glycole) in Frage.Accordingly, the active substance content in the extracts can be 5 to 100, preferably 50 to 95% by weight. The extracts themselves can be present as aqueous and / or preparations dissolved in organic solvents and as spray-dried or freeze-dried solids. Examples of suitable organic solvents in this context are the aliphatic alcohols with 1 to 6 carbon atoms (e.g. ethanol), ketones (e.g. acetone), halogenated hydrocarbons (e.g. chloroform or methylene chloride), lower esters or polyols (e.g. glycerol or glycols).
In einer bevorzugten Ausführungsform der Erfindung werden die genannten Naturstoffe und/oder Extrakte verwendet als Mittel gegen Hautalterung. Eine andere Bezeichnung für diese Art der Mittel ist auch anti-ageing Mittel. Zu diesen Alterserscheinungen zählen beispielsweise jede Art der Fältchen- und Faltenbildung. Die Behandlungen schließen eine Verlangsamung von Altersprozessen der Haut mit ein. Die Steigerung der G6PDH Aktivität im Stoffwechsel führt zur Verwendung der erfindungsgemäßen Naturstoffe als Mittel gegen die Hautalterung. Die Alterserscheinungen können die unterschiedlichsten Ursachen aufweisen. Ein weiterer Gegenstand der Erfindung ist die Verwendung von Naturstoffen ausgewählt aus der Gruppe, die gebildet wird von Carotinoiden, insbesondere Retinol und Retinolsäure, Flavon-Derivaten, phenolische Säuren, Chlorogensäuren, Steroiden, aporphinen Alkaloiden, Sterolen und Terpenen als Wirkstoffe zur Herstellung eines Mittels zur Steigerung der G6PDH-Aktivität im Stoffwechsel. Die Naturstoffe können aus weiteren Pflanzen extrahiert werden, oder auf synthetischem Wege hergestellt werden. Die Einsatzmenge der Naturstoffe kann dabei im Bereich von 0,001 bis 5, vorzugsweise 0,005 bis 1 und insbesondere 0,01 bis 0,5 Gew.-% - bezogen auf die Mittel - betragen.In a preferred embodiment of the invention, the natural substances and / or extracts mentioned are used as agents against skin aging. Another term for this type of remedy is anti aging. These signs of aging include any type of wrinkles and wrinkles. Treatments include slowing skin aging. The increase in G6PDH activity in the metabolism leads to the use of the natural substances according to the invention as agents against skin aging. The signs of aging can have a variety of causes. Another object of the invention is the use of natural products selected from the group formed by carotenoids, in particular retinol and retinoic acid, flavone derivatives, phenolic acids, chlorogenic acids, steroids, aporphine alkaloids, sterols and terpenes as active ingredients for the preparation of an agent for Increase in G6PDH activity in metabolism. The natural substances can be extracted from other plants or produced synthetically. The amount of natural substances used can be in the range from 0.001 to 5, preferably 0.005 to 1 and in particular 0.01 to 0.5% by weight, based on the composition.
Ein weiterer Gegenstand der vorliegenden Erfindung betrifft ein Verfahren zur Bestimmung der Wirksamkeit eines Mittels gegen Hautalterung, bei dem man den Einfluß des Wirkstoffes auf die Aktivität von Glucose-6-Phosphat-Dehydrogenase in Fibroblasten bestimmt.The present invention further relates to a method for determining the effectiveness of an agent against skin aging, in which the influence of the active ingredient on the activity of glucose-6-phosphate dehydrogenase in fibroblasts is determined.
Gewerbliche AnwendbarkeitIndustrial applicability
Die erfindungsgemäß zu verwendenden Extrakte können zur Herstellung von kosmetischen und/oder pharmazeutischen Zubereitungen, wie beispielsweise Cremes, Gele, Lotionen, alkoholische und wäßrig/alkoholische Lösungen, Emulsionen, Wachs/Fett-Massen, Stiftpräparaten, Pudern oder Salben dienen. Diese Mittel können ferner als weitere Hilfs- und Zusatzstoffe milde Tenside, Ölkörper, Emulgato- ren, Perlglanzwachse, Konsistenzgeber, Verdickungsmittel, Überfettungsmittel, Stabilisatoren, Polymere, Siliconverbindungen, Fette, Wachse, Lecithine, Phospholipide, biogene Wirkstoffe, UV- Lichtschutzfaktoren, Antioxidantien, Deodorantien, Antitranspirantien, Antischuppenmittel, Filmbildner, Quellmittel, Insektenrepellentien, Selbstbräuner, Tyrosininhibitoren (Depigmentierungsmittel), Hydro- trope, Solubilisatoren, Konservierungsmittel, Parfümöle, Farbstoffe und dergleichen enthalten.The extracts to be used according to the invention can be used to produce cosmetic and / or pharmaceutical preparations, such as, for example, creams, gels, lotions, alcoholic and aqueous / alcoholic solutions, emulsions, wax / fat compositions, stick preparations, powders or ointments. These agents can also be used as further auxiliaries and additives, mild surfactants, oil bodies, emulsifiers, pearlescent waxes, consistency agents, thickeners, superfatting agents, stabilizers, polymers, silicone compounds, fats, waxes, lecithins, phospholipids, biogenic active ingredients, UV light protection factors, antioxidants, Contain deodorants, antiperspirants, antidandruff agents, film formers, swelling agents, insect repellents, self-tanners, tyrosine inhibitors (depigmentation agents), hydro tropes, solubilizers, preservatives, perfume oils, dyes and the like.
Tensidesurfactants
Als oberflächenaktive Stoffe können anionische, nichtionische, kationische und/oder amphotere bzw. amphotere Tenside enthalten sein, deren Anteil an den Mitteln üblicherweise bei etwa 1 bis 70, vorzugsweise 5 bis 50 und insbesondere 10 bis 30 Gew.-% beträgt. Typische Beispiele für anionische Tenside sind Seifen, Alkylbenzolsulfonate, Alkansulfonate, Olefinsulfonate, Alkylethersulfonate, Glyce- rinethersulfonate, α-Methylestersulfonate, Sulfofettsäuren, Alkylsulfate, Fettalkoholethersulfate, Glyce- rinethersulfate, Fettsäureethersulfate, Hydroxymischethersulfate, Monoglycerid(ether)sulfate, Fettsäu- reamid(ether)sulfate, Mono- und Dialkylsulfosuccinate, Mono- und Dialkylsulfosuccinamate, Sulfotri- glyceride, Amidseifen, Ethercarbonsäuren und deren Salze, Fettsäureisethionate, Fettsäuresarcosi- nate, Fettsäuretauride, N-Acylaminosäuren, wie beispielsweise Acyllactylate, Acyltartrate, Acylgluta- mate und Acylaspartate, Alkyloligoglucosidsulfate, Proteinfettsäurekondensate (insbesondere pflanz- liehe Produkte auf Weizenbasis) und Alkyl(ether)phosphate. Sofern die anionischen Tenside Polygly- coletherketten enthalten, können diese eine konventionelle, vorzugsweise jedoch eine eingeengte Homologenverteilung aufweisen. Typische Beispiele für nichtionische Tenside sind Fettalko- holpolyglycolether, Alkylphenolpolyglycolether, Fettsäurepolyglycolester, Fettsäureamidpolyglycolether, Fettaminpolyglycolether, alkoxylierte Triglyceride, Mischether bzw. Mischformale, gegebenenfalls partiell oxidierte Alk(en)yloligoglykoside bzw. Glucoronsäurederivate, Fettsäure-N-alkylglucamide, Protein- hydrolysate (insbesondere pflanzliche Produkte auf Weizenbasis), Polyolfettsäureester, Zuckerester, Sorbitanester, Polysorbate und Aminoxide. Sofern die nichtionischen Tenside Polyglycoletherketten enthalten, können diese eine konventionelle, vorzugsweise jedoch eine eingeengte Homologenverteilung aufweisen. Typische Beispiele für kationische Tenside sind quartäre Ammoniumverbindungen, wie beispielsweise das Dimethyldistearylammoniumchlorid, und Esterquats, insbesondere quaternierte Fettsäuretrialkanolaminestersalze. Typische Beispiele für amphotere bzw. zwitterionische Tenside sind Alkylbetaine, Alkylamidobetaine, Aminopropionate, Aminoglycinate, Imidazoliniumbetaine und Sulfo- betaine. Bei den genannten Tensiden handelt es sich ausschließlich um bekannte Verbindungen. Hinsichtlich Struktur und Herstellung dieser Stoffe sei auf einschlägige Übersichtsarbeiten beispielsweise J.Falbe (ed.), "Surfactants in Consumer Products", Springer Verlag, Berlin, 1987, S. 54-124 oder J.Falbe (ed.), "Katalysatoren, Tenside und Mineralöladditive", Thieme Verlag, Stuttgart, 1978, S. 123-217 verwiesen. Typische Beispiele für besonders geeignete milde, d.h. besonders hautverträgliche Tenside sind Fettalkoholpolyglycolethersulfate, Monoglyceridsulfate, Mono- und/oder Dialkyl- sulfosuccinate, Fettsäureisethionate, Fettsäuresarcosinate, Fettsäuretauride, Fettsäureglutamate, α- Olefinsulfonate, Ethercarbonsäuren, Alkyloligoglucoside, Fettsäureglucamide, Alkylamidobetaine, Am- phoacetale und/oder Proteinfettsäurekondensate, letztere vorzugsweise auf Basis von Weizenproteinen.Anionic, nonionic, cationic and / or amphoteric or amphoteric surfactants may be present as surface-active substances, the proportion of which in the compositions is usually about 1 to 70, preferably 5 to 50 and in particular 10 to 30% by weight. Typical examples of anionic surfactants are soaps, alkyl benzene sulfonates, alkane sulfonates, olefin sulfonates, alkyl ether sulfonates, glycerol ether sulfonates, α-methyl ester sulfonates, sulfo fatty acids, alkyl sulfates, fatty alcohol ether sulfates, glycerin ether sulfates, fatty acid ether sulfates, ether ether sulfates (mon) sulfates, mono- and dialkylsulfosuccinates, mono- and dialkylsulfosuccinamates, sulfotriglycerides, amide soaps, ether carboxylic acids and their salts, fatty acid isethionates, fatty acid sarcosines, fatty acid taurides, N-acylamino acids, such as acyl lactylates, acyl sulfate glucosate fucylates, acyl glutolate fats (especially vegetable see wheat-based products) and alkyl (ether) phosphates. If the anionic surfactants contain polyglycol ether chains, these can have a conventional, but preferably a narrow, homolog distribution. Typical examples of nonionic surfactants are fatty alcohol polyglycol ethers, alkylphenol polyglycol ethers, fatty acid polyglycol esters, fatty acid amide polyglycol ethers, fatty amine polyglycol ethers, alkoxylated triglycerides, mixed ethers or mixed formals, optionally partially oxidized alk (en) yl oligoglycosides or alkyl glucoramide acid derivatives (especially glucoronic acid), vegetable glucoronic acid derivatives (GLC), glucoronic acid derivatives (GLC) Wheat-based products), polyol fatty acid esters, sugar esters, sorbitan esters, polysorbates and amine oxides. If the nonionic surfactants contain polyglycol ether chains, they can have a conventional, but preferably a narrow, homolog distribution. Typical examples of cationic surfactants are quaternary ammonium compounds, such as, for example, dimethyldistearylammonium chloride, and esterquats, in particular quaternized fatty acid trialkanolamine ester salts. Typical examples of amphoteric or zwitterionic surfactants are alkyl betaines, alkyl amido betaines, aminopropionates, aminoglycinates, imidazolinium betaines and sulfobetaines. The surfactants mentioned are exclusively known compounds. With regard to the structure and manufacture of these substances, reference is made to relevant reviews, for example, J.Falbe (ed.), "Surfactants in Consumer Products", Springer Verlag, Berlin, 1987, pp. 54-124 or J.Falbe (ed.), "Catalysts, Tenside und Mineralöladditive ", Thieme Verlag, Stuttgart, 1978, pp. 123-217. Typical examples of particularly suitable mild, ie particularly skin-compatible, surfactants are fatty alcohol polyglycol ether sulfates, monoglyceride sulfates, mono- and / or dialkyl sulfosuccinates, fatty acid isethionates, fatty acid sarcosinates, fatty acid taurides, fatty acid glutamates, α-olefin sulfonates, alkyl acid fatty acid amide carboxamides, alkyl carboxyl amide carboxamides, alkyl carboxyl amide carboxamides, alkyl carboxyl amide carboxylates, amyl carboxylic acid amides, alkyl carboxyl amide carboxylic acids or protein fatty acid condensates, the latter preferably based on wheat proteins.
Ölkörperoil body
Als Ölkörper kommen beispielsweise Guerbetalkohole auf Basis von Fettalkoholen mit 6 bis 18, vorzugsweise 8 bis 10 Kohlenstoffatomen, Ester von linearen C6-C22-Fettsäuren mit linearen oder verzweigten C6-C22-Fettalkoholen bzw. Ester von verzweigten C6-Ci3-Carbonsäuren mit linearen oder verzweigten C6-C22-Fettalkoholen, wie z.B. Myristylmyristat, Myristylpalmitat, Myristylstearat, Myristy- lisostearat, Myristyloleat, Myristylbehenat, Myristylerucat, Cetylmyristat, Cetylpalmitat, Cetylstearat, Cetylisostearat, Cetyloleat, Cetylbehenat, Cetylerucat, Stearyimyristat, Stearylpalmitat, Stearylstearat, Stearylisostearat, Stearyloleat, Stearylbehenat, Stearylerucat, Isostearylmyristat, Isostearylpalmitat, Isostearylstearat, Isostearylisostearat, Isostearyloleat, Isostearylbehenat, Isostearyloleat, Oleylmyristat, Oleylpalmitat, Oleylstearat, Oleylisostearat, Oleyloleat, Oleylbehenat, Oleylerucat, Behenylmyristat, Behenylpalmitat, Behenylstearat, Behenylisostearat, Behenyloleat, Behenylbehenat, Behenylerucat, Erucylmyristat, Erucylpalmitat, Erucylstearat, Erucylisostearat, Erucyloleat, Erucylbehenat und Erucy- lerucat. Daneben eignen sich Ester von linearen C6-C22-Fettsäuren mit verzweigten Alkoholen, insbesondere 2-Ethylhexanol, Ester von Ci8-C38-Alkylhydroxycarbonsäuren mit linearen oder verzweigten C6-C22-Fettalkoholen (vgl. DE 19756377 A1), insbesondere Dioctyl Malate, Ester von linearen und/oder verzweigten Fettsäuren mit mehrwertigen Alkoholen (wie z.B. Propylenglycol, Dimerdiol oder Trimertri- ol) und/oder Guerbetalkoholen, Triglyceride auf Basis Cδ-Cio-Fettsäuren, flüssige Mono-/Di- /Triglycerid misch ungen auf Basis von C6-Ci8-Fettsäuren, Ester von Cδ-C∑∑-Fettalkoholen und/oder Guerbetalkoholen mit aromatischen Carbonsäuren, insbesondere Benzoesäure, Ester von C2-C12- Dicarbonsäuren mit linearen oder verzweigten Alkoholen mit 1 bis 22 Kohlenstoffatomen oder Polyolen mit 2 bis 10 Kohlenstoffatomen und 2 bis 6 Hydroxylgruppen, pflanzliche Öle, verzweigte primäre Alkohole, substituierte Cyclohexane, lineare und verzweigte Cδ-C∑-Fettalkoholcarbonate, wie z.B. Dica- prylyl Carbonate (Cetiol® CC), Guerbetcarbonate auf Basis von Fettalkoholen mit 6 bis 18, vorzugsweise 8 bis 10 C Atomen, Ester der Benzoesäure mit linearen und/oder verzweigten C6-C22-Alkoholen (z.B. Finsolv® TN), lineare oder verzweigte, symmetrische oder unsymmetrische Dialkylether mit 6 bis 22 Kohlenstoffatomen pro Alkylgruppe, wie z.B. Dicaprylyl Ether (Cetiol® OE), Ringöffnungsprodukte von epoxidierten Fettsäureestern mit Polyolen, Siliconöle (Cyclomethicone, Siliciummethicontypen u.a.) und/oder aliphatische bzw. naphthenische Kohlenwasserstoffe, wie z.B. wie Squalan, Squalen oder Dialkylcyclohexane in Betracht.Suitable oil bodies are, for example, Guerbet alcohols preferably containing 8 to 10 carbon atoms, esters of linear C6-C22-fatty acids with linear or branched C 6 -C come based on fatty alcohols having 6 to 18, 2 2-fatty alcohols or esters of branched C6-Ci3-carboxylic acids with linear or branched C6-C22-fatty alcohols, such as myristyl myristate, myristyl palmitate, myristyl stearate, Myristy- lisostearat, myristyl, Myristylbehenat, Myristylerucat, cetyl myristate, cetyl palmitate, cetyl stearate, Cetylisostearat, cetyl oleate, cetyl behenate, Cetylerucat, Stearyimyristat, stearyl palmitate, stearyl stearate, Stearylisostearat, stearyl oleate, stearyl behenate, Stearylerucat, isostearyl, isostearyl palmitate, Isostearylstearat, isostearyl isostearate, Isostearyloleat, isostearyl behenate, Isostearyloleat, oleyl myristate, oleyl palmitate, oleyl stearate, oleyl isostearate, oleyl oleate, Oleylbehenat, oleyl erucate, behenyl myristate, behenyl palmitate, behenyl, Behenylisostearat, behenyl oleate, Behenylbeh enate, behenyl erucate, erucyl myristate, erucyl palmitate, erucyl stearate, erucyl isostearate, erucyl oleate, erucyl behenate and erucyl lerucat. In addition, esters of linear C6-C22 fatty acids with branched alcohols, in particular 2-ethylhexanol, esters of Ci8-C38 alkylhydroxycarboxylic acids with linear or branched C6-C 2 2 fatty alcohols (cf. DE 19756377 A1), in particular dioctyl malates, are suitable, Esters of linear and / or branched fatty acids with polyhydric alcohols (such as propylene glycol, dimer diol or trimer triol) and / or Guerbet alcohols, triglycerides based on Cδ-cio fatty acids, liquid mono- / di- / triglyceride mixtures based on C6 -Ci8 fatty acids, esters of Cδ-C ∑∑ fatty alcohols and / or Guerbet alcohols with aromatic carboxylic acids, especially benzoic acid, esters of C2-C12 dicarboxylic acids with linear or branched alcohols with 1 to 22 carbon atoms or polyols with 2 to 10 carbon atoms and 2 to 6 hydroxyl groups, vegetable oils, branched primary alcohols, substituted cyclohexanes, linear and branched Cδ-C∑ fatty alcohol carbonates, such as dicapryly l carbonates (Cetiol® CC), Guerbet carbonates based on fatty alcohols with 6 to 18, preferably 8 to 10 C atoms, esters of benzoic acid with linear and / or branched C6-C22 alcohols (eg Finsolv® TN), linear or branched, symmetrical or asymmetrical dialkyl ethers with 6 to 22 carbon atoms per alkyl group, such as dicaprylyl ether (Cetiol® OE), ring opening products of epoxidized fatty acid esters with polyols, silicone oils (cyclomethicones, silicon methicone types etc.) and / or aliphatic or naphthenic hydrocarbons such as squalane, Squalene or dialkylcyclohexanes.
EmulqatorenEmulqatoren
Als Emulgatoren kommen beispielsweise nichtionogene Tenside aus mindestens einer der folgenden Gruppen in Frage:Examples of suitable emulsifiers are nonionic surfactants from at least one of the following groups:
> Anlagerungsprodukte von 2 bis 30 Mol Ethylenoxid und/ oder 0 bis 5 Mol Propylenoxid an lineare Fettalkohole mit 8 bis 22 C-Atomen, an Fettsäuren mit 12 bis 22 C-Atomen, an Alkylphenole mit 8 bis 15 C-Atomen in der Alkylgruppe sowie Alkylamine mit 8 bis 22 Kohlenstoffatomen im Alkylrest;> Adducts of 2 to 30 moles of ethylene oxide and / or 0 to 5 moles of propylene oxide with linear fatty alcohols with 8 to 22 carbon atoms, with fatty acids with 12 to 22 carbon atoms, with alkylphenols with 8 to 15 carbon atoms in the alkyl group and Alkylamines with 8 to 22 carbon atoms in the alkyl radical;
> Alkyl- und/oder Alkenyloligoglykoside mit 8 bis 22 Kohlenstoffatomen im Alk(en)ylrest und deren ethoxylierte Analoga;> Alkyl and / or alkenyl oligoglycosides with 8 to 22 carbon atoms in the alk (en) yl radical and their ethoxylated analogs;
> Anlagerungsprodukte von 1 bis 15 Mol Ethylenoxid an Ricinusöl und/oder gehärtetes Ricinusöl;> Adducts of 1 to 15 moles of ethylene oxide with castor oil and / or hardened castor oil;
> Anlagerungsprodukte von 15 bis 60 Mol Ethylenoxid an Ricinusöl und/oder gehärtetes Ricinusöl;> Adducts of 15 to 60 moles of ethylene oxide with castor oil and / or hardened castor oil;
> Partialester von Glycerin und/oder Sorbitan mit ungesättigten, linearen oder gesättigten, verzweigten Fettsäuren mit 12 bis 22 Kohlenstoffatomen und/oder Hydroxycarbonsäuren mit 3 bis 18 Kohlenstoffatomen sowie deren Addukte mit 1 bis 30 Mol Ethylenoxid;> Partial esters of glycerol and / or sorbitan with unsaturated, linear or saturated, branched fatty acids with 12 to 22 carbon atoms and / or hydroxycarboxylic acids with 3 to 18 carbon atoms and their adducts with 1 to 30 moles of ethylene oxide;
> Partialester von Polyglycerin (durchschnittlicher Eigenkondensationsgrad 2 bis 8), Polyethylengly- col (Molekulargewicht 400 bis 5000), Trimethylolpropan, Pentaerythrit, Zuckeralkoholen (z.B. Sorbit), Alkylglucosiden (z.B. Methylglucosid, Butylglucosid, Laurylglucosid) sowie Polyglucosiden (z.B. Cellulose) mit gesättigten und/oder ungesättigten, linearen oder verzweigten Fettsäuren mit 12 bis 22 Kohlenstoffatomen und/oder Hydroxycarbonsäuren mit 3 bis 18 Kohlenstoffatomen sowie deren Addukte mit 1 bis 30 Mol Ethylenoxid;> Partial esters of polyglycerol (average degree of self-condensation 2 to 8), polyethylene glycol (molecular weight 400 to 5000), trimethylolpropane, pentaerythritol, sugar alcohols (e.g. sorbitol), alkyl glucosides (e.g. methyl glucoside, butyl glucoside, lauryl glucoside) and polyglucosides (e.g. cellulose) / or unsaturated, linear or branched fatty acids with 12 to 22 carbon atoms and / or hydroxycarboxylic acids with 3 to 18 carbon atoms and their adducts with 1 to 30 moles of ethylene oxide;
> Mischester aus Pentaerythrit, Fettsäuren, Citronensäure und Fettalkohol gemäß DE 1165574 PS und/oder Mischester von Fettsäuren mit 6 bis 22 Kohlenstoffatomen, Methylglucose und Polyolen, vorzugsweise Glycerin oder Polyglycerin.> Mixed esters of pentaerythritol, fatty acids, citric acid and fatty alcohol according to DE 1165574 PS and / or mixed esters of fatty acids with 6 to 22 carbon atoms, methyl glucose and polyols, preferably glycerol or polyglycerol.
> Mono-, Di- und Trialkylphosphate sowie Mono-, Di- und/oder Tri-PEG-alkylphosphate und deren Salze;> Mono-, di- and trialkyl phosphates and mono-, di- and / or tri-PEG-alkyl phosphates and their salts;
> Wollwachsalkohole; Polysiloxan-Polyalkyl-Polyether-Copolymere bzw. entsprechende Derivate;> Wool wax alcohols; Polysiloxane-polyalkyl-polyether copolymers or corresponding derivatives;
> Block-Copolymere z.B. Polyethylenglycol-30 Dipolyhydroxystearate;> Block copolymers e.g. Polyethylene glycol 30 dipolyhydroxystearate;
> Polymeremulgatoren, z.B. Pemulen-Typen (TR-1 ,TR-2) von Goodrich;> Polymer emulsifiers, e.g. Pemulen types (TR-1, TR-2) from Goodrich;
> Polyalkylenglycole sowie> Polyalkylene glycols as well
> Glycerincarbonat.> Glycerine carbonate.
Die Anlagerungsprodukte von Ethylenoxid und/oder von Propylenoxid an Fettalkohole, Fettsäuren, Al- kylphenole oder an Ricinusöl stellen bekannte, im Handel erhältliche Produkte dar. Es handelt sich dabei um Homologengemische, deren mittlerer Alkoxylierungsgrad dem Verhältnis der Stoffmengen von Ethylenoxid und/ oder Propylenoxid und Substrat, mit denen die Anlagerungsreaktion durchgeführt wird, entspricht. Ci2/i8-Fettsäuremono- und -diester von Anlagerungsprodukten von Ethylenoxid an Glycerin sind aus DE 2024051 PS als Rückfettungsmittel für kosmetische Zubereitungen bekannt.The adducts of ethylene oxide and / or of propylene oxide with fatty alcohols, fatty acids, alkylphenols or with castor oil are known, commercially available products. These are homolog mixtures whose average degree of alkoxylation is the ratio of the amounts of ethylene oxide and / or propylene oxide and Substrate with which the addition reaction is carried out corresponds. Ci2 / i8 fatty acid monoesters and diesters of adducts of ethylene oxide with glycerol are known from DE 2024051 PS as refatting agents for cosmetic preparations.
Alkyl- und/oder Alkenyloligoglycoside, ihre Herstellung und ihre Verwendung sind aus dem Stand der Technik bekannt. Ihre Herstellung erfolgt insbesondere durch Umsetzung von Glucose oder Oligosac- chariden mit primären Alkoholen mit 8 bis 18 Kohlenstoffatomen. Bezüglich des Glycosidrestes gilt, daß sowohl Monoglycoside, bei denen ein cyclischer Zuckerrest glycosidisch an den Fettalkohol gebunden ist, als auch oligomere Glycoside mit einem Oligomerisationsgrad bis vorzugsweise etwa 8 geeignet sind. Der Oligomerisierungsgrad ist dabei ein statistischer Mittelwert, dem eine für solche technischen Produkte übliche Homologenverteilung zugrunde liegt.Alkyl and / or alkenyl oligoglycosides, their preparation and their use are known from the prior art. They are produced in particular by reacting glucose or oligosaccharides with primary alcohols with 8 to 18 carbon atoms. Regarding the glycoside residue, both monoglycosides in which a cyclic sugar residue is glycosidically bonded to the fatty alcohol and oligomeric glycosides with a degree of oligomerization of up to about 8 are suitable. The degree of oligomerization is a statistical mean value which is based on a homolog distribution customary for such technical products.
Typische Beispiele für geeignete Partialglyceride sind Hydroxystearinsäuremonoglycerid, Hydroxy- stearinsäurediglycerid, Isostearinsäuremonoglycerid, Isostearinsäurediglycerid, Ölsäuremonoglycerid, Ölsäurediglycerid, Ricinolsäuremoglycerid, Ricinolsäurediglycerid, Linolsäuremonoglycerid, Linolsäure- diglycerid, Linolensäuremonoglycerid, Linolensäurediglycerid, Erucasäuremonoglycerid, Erucasäure- diglycerid, Weinsäuremonoglycerid, Weinsäurediglycerid, Citronensäuremonoglycerid, Citronendiglyce- rid, Äpfelsäuremonoglycerid, Äpfelsäurediglycerid sowie deren technische Gemische, die untergeordnet aus dem Herstellungsprozeß noch geringe Mengen an Triglycerid enthalten können. Ebenfalls geeignet sind Anlagerungsprodukte von 1 bis 30, vorzugsweise 5 bis 10 Mol Ethylenoxid an die genannten Partialglyceride. Als Sorbitanester kommen Sorbitanmonoisostearat, Sorbitansesquiisostearat, Sorbitandiisostearat, Sorbitantriisostearat, Sorbitanmonooleat, Sorbitansesquioleat, Sorbitandioleat, Sorbitantrioleat, Sorbi- tanmonoerucat, Sorbitansesquierucat, Sorbitandierucat, Sorbitantrierucat, Sorbitanmonoricinoleat, Sor- bitansesquiricinoleat, Sorbitandiricinoleat, Sorbitantriricinoleat, Sorbitanmonohydroxystearat, Sorbitan- sesquihydroxystearat, Sorbitandihydroxystearat, Sorbitantrihydroxystearat, Sorbitanmonotartrat, Sor- bitansesquitartrat, Sorbitanditartrat, Sorbitantritartrat, Sorbitanmonocitrat, Sorbitansesquicitrat, Sorbi- tandicitrat, Sorbitantricitrat, Sorbitanmonomaleat, Sorbitansesquimaleat, Sorbitandimaleat, Sorbitantri- maleat sowie deren technische Gemische. Ebenfalls geeignet sind Anlagerungsprodukte von 1 bis 30, vorzugsweise 5 bis 10 Mol Ethylenoxid an die genannten Sorbitanester.Typical examples of suitable partial glycerides are hydroxystearic acid monoglyceride, stearic acid diglyceride hydroxy, isostearic acid, Isostearinsäurediglycerid, oleic acid monoglyceride, oleic acid diglyceride, Ricinolsäuremoglycerid, Ricinolsäurediglycerid, Linolsäuremonoglycerid, linoleic acid diglyceride, Linolensäuremonoglycerid, Linolensäurediglycerid, Erucasäuremonoglycerid, erucic acid diglyceride, rid Weinsäuremonoglycerid, Weinsäurediglycerid, Citronensäuremonoglycerid, Citronendiglyce-, Malic acid monoglyceride, malic acid diglyceride and their technical mixtures, which may still contain minor amounts of triglyceride from the manufacturing process. Addition products of 1 to 30, preferably 5 to 10, mol of ethylene oxide onto the partial glycerides mentioned are also suitable. As sorbitan sorbitan, sorbitan sesquiisostearate, Sorbitan, sorbitan triisostearate, sorbitan monooleate, sorbitan, sorbitan, sorbitan come tanmonoerucat, Sorbitansesquierucat, Sorbitandierucat, Sorbitantrierucat, Sorbitanmonoricinoleat, sorting bitansesquiricinoleat, Sorbitandiricinoleat, Sorbitantriricinoleat, Sorbitanmonohydroxystearat, sorbitan sesquihydroxystearat, Sorbitandihydroxystearat, Sorbitantrihydroxystearat, Sorbitanmonotartrat , Sorbitane sesquitartrate, sorbitan ditartrate, sorbitan tritartrate, sorbitan monocitrate, sorbitan sesquicitrate, sorbitan citrate, sorbitan tricitrate, sorbitan monomaleate, sorbitan sesquimaleate, sorbitan malate, sorbitan tri- maleate and their technical gem. Addition products of 1 to 30, preferably 5 to 10, mol of ethylene oxide onto the sorbitan esters mentioned are also suitable.
Typische Beispiele für geeignete Polyglycerinester sind Polyglyceryl-2 Dipolyhydroxystearate (Dehy- muls® PGPH), Polyglycerin-3-Diisostearate (Lameform® TGI), Polyglyceryl-4 Isostearate (Isolan® Gl 34), Polyglyceryl-3 Oleate, Diisostearoyl Polyglyceryl-3 Diisostearate (Isolan® PDI), Polyglyceryl-3 Methylglucose Distearate (Tego Care® 450), Polyglyceryl-3 Beeswax (Cera Bellina®), Polyglyceryl-4 Caprate (Polyglycerol Caprate T2010/90), Polyglyceryl-3 Cetyl Ether (Chimexane® NL), Polyglyceryl-3 Distearate (Cremophor® GS 32) und Polyglyceryl Polyricinoleate (Admul® WOL 1403) Polyglyceryl Dimerate Isostearate sowie deren Gemische. Beispiele für weitere geeignete Polyolester sind die gegebenenfalls mit 1 bis 30 Mol Ethylenoxid umgesetzten Mono-, Di- und Triester von Trimethylolpropan oder Pentaerythrit mit Laurinsäure, Kokosfettsäure, Taigfettsäure, Palmitinsäure, Stearinsäure, Ölsäu- re, Behensäure und dergleichen.Typical examples of suitable polyglycerol esters are polyglyceryl-2 dipolyhydroxystearates (Dehymuls® PGPH), polyglycerol-3-diisostearates (Lameform® TGI), polyglyceryl-4 isostearates (Isolan® Gl 34), polyglyceryl-3 oleates, diisostearoyl polyglyearylate-3 (Isolan® PDI), Polyglyceryl-3 Methylglucose Distearate (Tego Care® 450), Polyglyceryl-3 Beeswax (Cera Bellina®), Polyglyceryl-4 Caprate (Polyglycerol Caprate T2010 / 90), Polyglyceryl-3 Cetyl Ether (Chimexane® NL) , Polyglyceryl-3 Distearate (Cremophor® GS 32) and Polyglyceryl Polyricinoleate (Admul® WOL 1403) Polyglyceryl Dimerate Isostearate and their mixtures. Examples of other suitable polyol esters are the mono-, di- and triesters of trimethylolpropane or pentaerythritol with lauric acid, coconut fatty acid, tallow fatty acid, palmitic acid, stearic acid, oleic acid, behenic acid and the like which are optionally reacted with 1 to 30 mol of ethylene oxide.
Weiterhin können als Emulgatoren zwitterionische Tenside verwendet werden. Als zwitterionische Tenside werden solche oberflächenaktiven Verbindungen bezeichnet, die im Molekül mindestens eine quartäre Ammoniumgruppe und mindestens eine Carboxylat- und eine Sulfonatgruppe tragen. Besonders geeignete zwitterionische Tenside sind die sogenannten Betaine wie die N-Aikyl-N,N-dimethylam- moniumglycinate, beispielsweise das Kokosalkyldimethylammoniumglycinat, N-Acylaminopropyl-N,N- dimethylammoniumglycinate, beispiels-weise das Kokosacylaminopropyldimethylammoniumglycinat, und 2-Alkyl-3-carboxylmethyl-3-hydroxyethylimidazoline mit jeweils 8 bis 18 C-Atomen in der Alkyl- oder Acylgruppe sowie das Kokosacylaminoethylhydroxyethylcarboxymethylglycinat. Besonders bevorzugt ist das unter der CTFA-Bezeichnung Cocamidopropyl Betaine bekannte Fettsäureamid-Derivat. Ebenfalls geeignete Emulgatoren sind ampholytische Tenside. Unter ampholytischen Tensiden werden solche oberflächenaktiven Verbindungen verstanden, die außer einer Cβ -Alkyl- oder -Acylgruppe im Molekül mindestens eine freie Aminogruppe und mindestens eine -COOH- oder -Sθ3H-Gruppe enthalten und zur Ausbildung innerer Salze befähigt sind. Beispiele für geeignete ampholytische Tenside sind N-Alkylglycine, N-Alkylpropionsäuren, N-Alkylaminobuttersäuren, N-Alkyliminodipropionsäuren, N-Hy- droxyethyl-N-alkylamidopropylglycine, N-Alkyltaurine, N-Alkylsarcosine, 2-Alkylaminopropionsäuren und Alkylaminoessigsäuren mit jeweils etwa 8 bis 18 C-Atomen in der Alkylgruppe. Besonders bevorzugte ampholytische Tenside sind das N-Kokosalkylaminopropionat, das Kokosacylaminoethylaminopropio- nat und das Ci2/i8-Acylsarcosin. Schließlich kommen auch Kationtenside als Emulgatoren in Betracht, wobei solche vom Typ der Esterquats, vorzugsweise methylquaternierte Difettsäuretriethanolaminester- Salze, besonders bevorzugt sind.Zwitterionic surfactants can also be used as emulsifiers. Zwitterionic surfactants are surface-active compounds that contain at least one quaternary ammonium group and at least one carboxylate and one sulfonate group in the molecule. Particularly suitable zwitterionic surfactants are the so-called betaines such as the N-aikyl-N, N-dimethylammonium glycinate, for example the cocoalkyldimethylammonium glycinate, N-acylaminopropyl-N, N-dimethylammonium glycinate, for example the cocoacylaminopropyldimethylammonium methylglycinate, and 2-carboxylate -3-hydroxyethylimidazolines each having 8 to 18 carbon atoms in the alkyl or acyl group and the cocoacylaminoethylhydroxyethylcarboxymethylglycinate. The fatty acid amide derivative known under the CTFA name of Cocamidopropyl Betaine is particularly preferred. Suitable emulsifiers are ampholytic surfactants. Ampholytic surfactants are surface-active compounds which, in addition to a Cβ-alkyl or -acyl group, contain at least one free amino group and at least one -COOH or -Sθ3H group in the molecule and are capable of forming internal salts. Examples of suitable ampholytic surfactants are N-alkylglycines, N-alkylpropionic acids, N-alkylaminobutyric acids, N-alkyliminodipropionic acids, N-hydroxyethyl-N-alkylamidopropylglycines, N-alkyltaurines, N-alkylsarcosines, 2-alkylaminopropionic acids and alkylaminoacetic acids each with about 8 to 18 carbon atoms in the alkyl group. Particularly preferred ampholytic surfactants are N-cocoalkylaminopropionate, cocoacylaminoethylaminopropionate. nat and the Ci2 / i8 acyl sarcosine. Finally, cationic surfactants are also suitable as emulsifiers, those of the esterquat type, preferably methylquaternized difatty acid triethanolamine ester salts, being particularly preferred.
Fette und WachseFats and waxes
Typische Beispiele für Fette sind Glyceride, d.h. feste oder flüssige pflanzliche oder tierische Produkte, die im wesentlichen aus gemischten Glycerinestern höherer Fettsäuren bestehen, als Wachse kommen u.a. natürliche Wachse, wie z.B. Candelillawachs, Camaubawachs, Japanwachs, Espartograswachs, Korkwachs, Guarumawachs, Reiskeimölwachs, Zuckerrohrwachs, Ouricurywachs, Montanwachs, Bienenwachs, Schellackwachs, Walrat, Lanolin (Wollwachs), Bürzelfett, Ceresin, Ozokerit (Erdwachs), Petrolatum, Paraffinwachse, Mikrowachse; chemisch modifizierte Wachse (Hartwachse), wie z.B. Montanesterwachse, Sasolwachse, hydrierte Jojobawachse sowie synthetische Wachse, wie z.B. Po- lyalkylenwachse und Polyethylenglycolwachse in Frage. Neben den Fetten kommen als Zusatzstoffe auch fettähnliche Substanzen, wie Lecithine und Phospholipide in Frage. Unter der Bezeichnung Lecit- hine versteht der Fachmann diejenigen Glycero-Phospholipide, die sich aus Fettsäuren, Glycerin, Phosphorsäure und Cholin durch Veresterung bilden. Lecithine werden in der Fachwelt daher auch häufig als Phosphatidylcholine (PC). Als Beispiele für natürliche Lecithine seien die Kephaline genannt, die auch als Phosphatidsäuren bezeichnet werden und Derivate der 1 ,2-Diacyl-sn-glycerin-3- phosphorsäuren darstellen. Dem gegenüber versteht man unter Phospholipiden gewöhnlich Mono- und vorzugsweise Diester der Phosphorsäure mit Glycerin (Glycerinphosphate), die allgemein zu den Fetten gerechnet werden. Daneben kommen auch Sphingosine bzw. Sphingolipide in Frage.Typical examples of fats are glycerides, i.e. Solid or liquid vegetable or animal products, which consist essentially of mixed glycerol esters of higher fatty acids, come as waxes, among others. natural waxes, e.g. Candelilla wax, camauba wax, japan wax, esparto grass wax, cork wax, guaruma wax, rice germ oil wax, sugar cane wax, ouricury wax, montan wax, beeswax, shellac wax, walrate, lanolin (wool wax), pretzel fat, ceresin, ozokerite (earth wax), petrolatum, paraffin waxes, microfax waxes chemically modified waxes (hard waxes), e.g. Montanester waxes, Sasol waxes, hydrogenated jojoba waxes and synthetic waxes, such as Polyalkylene waxes and polyethylene glycol waxes in question. In addition to fats, fat-like substances such as lecithins and phospholipids can also be used as additives. The person skilled in the art understands the term lecithin those glycerophospholipids which are formed from fatty acids, glycerol, phosphoric acid and choline by esterification. Lecithins are therefore often used in the professional world as phosphatidylcholines (PC). Examples of natural lecithins are the cephalins, which are also referred to as phosphatidic acids and are derivatives of 1,2-diacyl-sn-glycerol-3-phosphoric acids. In contrast, phospholipids are usually understood to be mono- and preferably diesters of phosphoric acid with glycerol (glycerol phosphates), which are generally classed as fats. In addition, sphingosines or sphingolipids are also suitable.
PerlqlanzwachsePerlqlanzwachse
Als Perlglanzwachse kommen beispielsweise in Frage: Alkylenglycolester, speziell Ethylenglycoldi- stearat; Fettsäurealkanolamide, speziell Kokosfettsäurediethanolamid; Partialglyceride, speziell Stea- rinsäuremonoglycerid; Ester von mehrwertigen, gegebenenfalls hydroxysubstituierte Carbonsäuren mit Fettalkoholen mit 6 bis 22 Kohlenstoff atomen, speziell langkettige Ester der Weinsäure; Fettstoffe, wie beispielsweise Fettalkohole, Fettketone, Fettaldehyde, Fettether und Fettcarbonate, die in Summe mindestens 24 Kohlenstoffatome aufweisen, speziell Lauron und Distearylether; Fettsäuren wie Stearinsäure, Hydroxystearinsäure oder Behensäure, Ringöffnungsprodukte von Olefinepoxiden mit 12 bis 22 Kohlenstoffatomen mit Fettalkoholen mit 12 bis 22 Kohlenstoffatomen und/oder Polyolen mit 2 bis 15 Kohlenstoffatomen und 2 bis 10 Hydroxylgruppen sowie deren Mischungen.Pearlescent waxes, for example, are: alkylene glycol esters, especially ethylene glycol distearate; Fatty acid alkanolamides, especially coconut fatty acid diethanolamide; Partial glycerides, especially stearic acid monoglyceride; Esters of polyvalent, optionally hydroxy-substituted carboxylic acids with fatty alcohols with 6 to 22 carbon atoms, especially long-chain esters of tartaric acid; Fatty substances, such as, for example, fatty alcohols, fatty ketones, fatty aldehydes, fatty ethers and fatty carbonates, which have a total of at least 24 carbon atoms, especially lauron and distearyl ether; Fatty acids such as stearic acid, hydroxystearic acid or behenic acid, ring opening products of olefin epoxides with 12 to 22 carbon atoms with fatty alcohols with 12 to 22 carbon atoms and / or polyols with 2 to 15 carbon atoms and 2 to 10 hydroxyl groups and mixtures thereof.
n Konsistenzqener und Verdickunqsmitteln Consistency and thickening agents
Als Konsistenzgeber kommen in erster Linie Fettalkohole oder Hydroxyfettalkohole mit 12 bis 22 und vorzugsweise 16 bis 18 Kohlenstoffatomen und daneben Partialglyceride, Fettsäuren oder Hydroxyfett- säuren in Betracht. Bevorzugt ist eine Kombination dieser Stoffe mit Alkyloligoglucosiden und/oder Fettsäure-N-methylglucamiden gleicher Kettenlänge und/oder Polyglycerinpoly-12-hydroxystearaten. Geeignete Verdickungsmittel sind beispielsweise Aerosil-Typen (hydrophile Kieselsäuren), Polysaccharide, insbesondere Xanthan-Gum, Guar-Guar, Agar-Agar, Alginate und Tylosen, Carboxymethyl- cellulose und Hydroxyethylcellulose, ferner höhermolekulare Polyethylenglycolmono- und -diester von Fettsäuren, Polyacrylate, (z.B. Carbopole® und Pemulen-Typen von Goodrich; Synthalene® von Sig- ma; Keltrol-Typen von Kelco; Sepigel-Typen von Seppic; Salcare-Typen von Allied Colloids), Polyacry- lamide, Polymere, Polyvinylalkohol und Polyvinylpyrrolidon, Tenside wie beispielsweise ethoxylierte Fettsäureglyceride, Ester von Fettsäuren mit Polyolen wie beispielsweise Pentaerythrit oder Trimethy- lolpropan, Fettalkoholethoxylate mit eingeengter Homologenverteilung oder Alkyloligoglucoside sowie Elektrolyte wie Kochsalz und Ammoniumchlorid.Suitable consistency agents are primarily fatty alcohols or hydroxyfatty alcohols with 12 to 22 and preferably 16 to 18 carbon atoms and also partial glycerides, fatty acids or hydroxyfatty acids. A combination of these substances with alkyl oligoglucosides and / or fatty acid N-methylglucamides of the same chain length and / or polyglycerol poly-12-hydroxystearates is preferred. Suitable thickeners are, for example, Aerosil types (hydrophilic silicas), polysaccharides, in particular xanthan gum, guar guar, agar agar, alginates and tyloses, carboxymethyl cellulose and hydroxyethyl cellulose, and also higher molecular weight polyethylene glycol mono- and diesters of fatty acids, polyacrylates, ( eg Carbopole® and Pemulen types from Goodrich; Synthalene® from Sigma; Keltrol types from Kelco; Sepigel types from Seppic; Salcare types from Allied Colloids), polyacrylamides, polymers, polyvinyl alcohol and polyvinyl pyrrolidone, surfactants such as, for example ethoxylated fatty acid glycerides, esters of fatty acids with polyols such as pentaerythritol or trimethylolpropane, fatty alcohol ethoxylates with a narrow homolog distribution or alkyl oligoglucosides as well as electrolytes such as table salt and ammonium chloride.
ÜberfettunqsmittelÜberfettunqsmittel
Als Überfettungsmittel können Substanzen wie beispielsweise Lanolin und Lecithin sowie polyethoxy- lierte oder acylierte Lanolin- und Lecithinderivate, Polyolfettsäureester, Monoglyceride und Fettsäureal- kanolamide verwendet werden, wobei die letzteren gleichzeitig als Schaumstabilisatoren dienen.Substances such as, for example, lanolin and lecithin and polyethoxylated or acylated lanolin and lecithin derivatives, polyol fatty acid esters, monoglycerides and fatty acid alkanolamides can be used as superfatting agents, the latter simultaneously serving as foam stabilizers.
Stabilisatorenstabilizers
Als Stabilisatoren können Metallsalze von Fettsäuren, wie z.B. Magnesium-, Aluminium- und/oder Zink- stearat bzw. -ricinoleat eingesetzt werden.Metal salts of fatty acids, such as e.g. Magnesium, aluminum and / or zinc stearate or ricinoleate can be used.
Polymerepolymers
Geeignete kationische Polymere sind beispielsweise kationische Cellulosederivate, wie z.B. eine quaternierte Hydroxyethylcellulose, die unter der Bezeichnung Polymer JR 400® von Amerchol erhältlich ist, kationische Stärke, Copolymere von Diallylammoniumsalzen und Acrylamiden, quaternierte Vinyl- pyrrolidon/Vinylimidazol-Polymere, wie z.B. Luviquat® (BASF), Kondensationsprodukte von Poly- glycolen und Aminen, quaternierte Kollagenpolypeptide, wie beispielsweise Lauryldimonium Hydroxy- propyl Hydrolyzed Collagen (Lamequat®L/Grünau), quaternierte Weizenpolypeptide, Polyethylenimin, kationische Siliconpolymere, wie z.B. Amodimethicone, Copolymere der Adipinsäure und Dimethyla- minohydroxypropyldiethylentriamin (Cartaretine®/Sandoz), Copolymere der Acrylsäure mit Dimethyl- diallylammoniumchlorid (Merquat® 550/Chemviron), Polyaminopolyamide, wie z.B. beschrieben in der FR 2252840 A sowie deren vernetzte wasserlöslichen Polymere, kationische Chitinderivate wie beispielsweise quaterniertes Chitosan, gegebenenfalls mikrokristallin verteilt, Kondensationsprodukte aus Dihalogenalkylen, wie z.B. Dibrombutan mit Bisdialkylaminen, wie z.B. Bis-Dimethylamino-1,3-propan, kationischer Guar-Gum, wie z.B. Jaguar® CBS, Jaguar® C-17, Jaguar® C-16 der Firma Celanese, quaternierte Ammoniumsalz-Polymere, wie z.B. Mirapol® A-15, Mirapol® AD-1 , Mirapol® AZ-1 der Firma Miranol.Suitable cationic polymers are, for example, cationic cellulose derivatives, such as, for example, a quaternized hydroxyethyl cellulose, which is available under the name Polymer JR 400® from Amerchol, cationic starch, copolymers of diallylammonium salts and acrylamides, quaternized vinylpyrrolidone / vinylimidazole polymers, such as, for example, Luviquat® ( BASF), condensation products of polyglycols and amines, quaternized collagen polypeptides, such as lauryldimonium hydroxypropyl hydrolyzed collagen (Lamequat®L / Grünau), quaternized wheat polypeptides, polyethyleneimine, cationic silicone polymers such as amodimethicones, copolymers of adipic acid and dimethyla- minohydroxypropyldiethylenetriamine (Cartaretine® / Sandoz), copolymers of acrylic acid with dimethyldiallylammonium chloride (Merquat® 550 / Chemviron), polyaminopolyamides, as described for example in FR 2252840 A and their crosslinked water-soluble polymers, cationic chitin derivatives such as quaternized chitosan, optionally microcrystalline, optionally microcrystalline Condensation products from dihaloalkylene, such as, for example, dibromobutane with bisdialkylamines, such as, for example, bis-dimethylamino-1,3-propane, cationic guar gum, such as, for example, Jaguar® CBS, Jaguar® C-17, Jaguar® C-16 from Celanese, quaternized ammonium salt -Polymers, such as Mirapol® A-15, Mirapol® AD-1, Mirapol® AZ-1 from Miranol.
Als anionische, zwitterionische, amphotere und nichtionische Polymere kommen beispielsweise Vinyla- cetat/Crotonsäure-Copolymere, Vinylpyrrolidon/Vinylacrylat-Copolymere, Vinyl- acetat/Butylmaleat/lsobomylacrylat-Copolymere, Methylvinylether/Maleinsäureanhydrid-Copolymere und deren Ester, unvernetzte und mit Polyolen vernetzte Polyacrylsäuren, Acrylamidopropyl- trimethylammoniumchlorid/ Acrylat-Copolymere, Octylacrylamid/Methylmeth-acry- lat/tert.Butylaminoethylmethacrylat/2-Hydroxypropylmethacrylat-Copolymere, Polyvinylpyrrolidon, Vinyl- pyrrolidon/Vinylacetat-Copolymere, Vinylpyrrolidon/ Dimethylaminoethylmethacrylat/Vinylcaprolactam- Terpolymere sowie gegebenenfalls derivatisierte Celluloseether und Silicone in Frage. Weitere geeignete Polymere und Verdickungsmittel sind in Cosm.Toil. 108, 95 (1993) aufgeführt.Anionic, zwitterionic, amphoteric and nonionic polymers include, for example, vinyl acetate / crotonic acid copolymers, vinyl pyrrolidone / vinyl acrylate copolymers, vinyl acetate / butyl maleate / isobomylacrylate copolymers, methyl vinyl ether / maleic anhydride copolymers and polyesters and their esters, uncrosslinked , Acrylamidopropyl-trimethylammonium chloride / acrylate copolymers, octylacrylamide / methyl methacrylate / tert-butylaminoethyl methacrylate / 2-hydroxypropyl methacrylate copolymers, polyvinyl pyrrolidone, vinyl pyrrolidone / vinyl acetate copolymers, vinyl pyrrolidone / dimethylaminoethyl methacrylate and optionally derivatized / vinyl aminomethyl acrylate methacrylate in question. Other suitable polymers and thickeners are in Cosm.Toil. 108, 95 (1993).
SiliconverbindunqenSilicone Compounds
Geeignete Siliconverbindungen sind beispielsweise Dimethylpolysiloxane, Methylphenylpolysiloxane, cyclische Silicone sowie amino-, fettsäure-, alkohol-, polyether-, epoxy-, fluor-, glykosid- und/oder al- kylmodifizierte Siliconverbindungen, die bei Raumtemperatur sowohl flüssig als auch harzförmig vorliegen können. Weiterhin geeignet sind Simethicone, bei denen es sich um Mischungen aus Dimethico- nen mit einer durchschnittlichen Kettenlänge von 200 bis 300 Dimethylsiloxan-Einheiten und hydrierten Silicaten handelt. Eine detaillierte Übersicht über geeignete flüchtige Silicone findet sich zudem von Todd et al. in Cosm.Toil. 91, 27 (1976).Suitable silicone compounds are, for example, dimethylpolysiloxanes, methylphenylpolysiloxanes, cyclic silicones and amino-, fatty acid-, alcohol-, polyether-, epoxy-, fluorine-, glycoside- and / or alkyl-modified silicone compounds, which can be both liquid and resinous at room temperature. Simethicones, which are mixtures of dimethicones with an average chain length of 200 to 300 dimethylsiloxane units and hydrogenated silicates, are also suitable. A detailed overview of suitable volatile silicones can also be found by Todd et al. in Cosm.Toil. 91, 27 (1976).
UV-Lichtschutzfilter und AntioxidantienUV light protection filters and antioxidants
Unter UV-Lichtschutzfaktoren sind beispielsweise bei Raumtemperatur flüssig oder kristallin vorliegende organische Substanzen (Lichtschutzfilter) zu verstehen, die in der Lage sind, ultraviolette Strahlen zu absorbieren und die aufgenommene Energie in Form längerwelliger Strahlung, z.B. Wärme wieder abzugeben. UVB-Filter können öllöslich oder wasserlöslich sein. Als öllösliche Substanzen sind z.B. zu nennen: > 3-Benzylidencampher bzw. 3-Benzylidennorcampher und dessen Derivate, z.B. 3-(4-Methylbenzy- liden)campher wie in der EP 0693471 B1 beschrieben;UV light protection factors are understood to mean, for example, organic substances (light protection filters) which are liquid or crystalline at room temperature and which are able to absorb ultraviolet rays and release the absorbed energy in the form of longer-wave radiation, for example heat. UVB filters can be oil-soluble or water-soluble. Examples of oil-soluble substances are: > 3-benzylidene camphor or 3-benzylidene norcampher and its derivatives, for example 3- (4-methylbenzylidene) camphor as described in EP 0693471 B1;
> 4-Aminobenzoesäurederivate, vorzugsweise 4-(Dimethylamino)benzoesäure-2-ethyl-hexylester, 4- (Dimethylamino)benzoesäure-2-octylester und 4-(Dimethylamino)benzoe-säureamylester;> 4-aminobenzoic acid derivatives, preferably 2-ethyl-hexyl 4- (dimethylamino) benzoate, 2-octyl 4- (dimethylamino) benzoate and amyl 4- (dimethylamino) benzoate;
> Ester der Zimtsäure, vorzugsweise 4-Methoxyzimtsäure-2-ethylhexylester, 4-Methoxy- zimtsäurepropylester, 4-Methoxyzimtsäureisoamylester 2-Cyano-3,3-phenylzimtsäure-2- ethylhexylester (Octocrylene);> Esters of cinnamic acid, preferably 4-methoxycinnamic acid 2-ethylhexyl ester, 4-methoxycinnamic acid propyl ester, 4-methoxycinnamic acid isoamyl ester 2-cyano-3,3-phenylcinnamic acid 2-ethylhexyl ester (octocrylene);
> Ester der Salicylsäure, vorzugsweise Salicylsäure-2-ethylhexylester, Salicylsäure-4-iso-propylben- zylester, Salicylsäurehomomenthylester;> Esters of salicylic acid, preferably salicylic acid 2-ethylhexyl ester, salicylic acid 4-iso-propylbenzyl ester, salicylic acid homomethyl ester;
> Derivate des Benzophenons, vorzugsweise 2-Hydroxy-4-methoxybenzophenon, 2-Hydroxy-4-me- thoxy-4'-methylbenzophenon, 2,2'-Dihydroxy-4-methoxybenzophenon;> Derivatives of benzophenone, preferably 2-hydroxy-4-methoxybenzophenone, 2-hydroxy-4-methoxy-4'-methylbenzophenone, 2,2'-dihydroxy-4-methoxybenzophenone;
> Ester der Benzalmalonsäure, vorzugsweise 4-Methoxybenzmalonsäuredi-2-ethylhexyl-ester;> Esters of benzalmalonic acid, preferably 4-methoxybenzmalonic acid di-2-ethylhexyl ester;
> Triazinderivate, wie z.B. 2,4,6-Trianilino-(p-carbo-2'-ethyl-1'-hexyloxy)-1 ,3,5-triazin und Octyl Tria- zon, wie in der EP 0818450 A1 beschrieben oder Dioctyl Butamido Triazone (Uvasorb® HEB);> Triazine derivatives, e.g. 2,4,6-trianilino- (p-carbo-2'-ethyl-1'-hexyloxy) -1, 3,5-triazine and octyl triazone, as described in EP 0818450 A1 or dioctyl butamido triazone (Uvasorb ® HEB);
> Propan-1 ,3-dione, wie z.B. 1-(4-tert.Butylphenyl)-3-(4'methoxyphenyl)propan-1 ,3-dion;> Propane-1,3-dione, e.g. 1- (4-tert-butylphenyl) -3- (4'methoxyphenyl) propane-1,3-dione;
> Ketotricyclo(5.2.1.0)decan-Derivate, wie in der EP 0694521 B1 beschrieben.> Ketotricyclo (5.2.1.0) decane derivatives, as described in EP 0694521 B1.
Als wasserlösliche Substanzen kommen in Frage:Possible water-soluble substances are:
> 2-Phenylbenzimidazol-5-sulfonsäure und deren Alkali-, Erdalkali-, Ammonium-, Alkylammonium-, Alkanolammonium- und Glucammoniumsalze;> 2-phenylbenzimidazole-5-sulfonic acid and its alkali, alkaline earth, ammonium, alkylammonium, alkanolammonium and glucammonium salts;
> Sulfonsäurederivate von Benzophenonen, vorzugsweise 2-Hydroxy-4-methoxybenzo-phenon-5- sulfonsäure und ihre Salze;> Sulfonic acid derivatives of benzophenones, preferably 2-hydroxy-4-methoxybenzo-phenon-5-sulfonic acid and its salts;
> Sulfonsäurederivate des 3-Benzylidencamphers, wie z.B. 4-(2-Oxo-3-bornylidenme- thyl)benzolsulfonsäure und 2-Methyl-5-(2-oxo-3-bornyliden)sulfonsäure und deren Salze.> Sulfonic acid derivatives of 3-benzylidene camphor, e.g. 4- (2-oxo-3-bornylidene methyl) benzenesulfonic acid and 2-methyl-5- (2-oxo-3-bornylidene) sulfonic acid and their salts.
Als typische UV-A-Filter kommen insbesondere Derivate des Benzoylmethans in Frage, wie beispielsweise 1-(4'-tert.Butylphenyl)-3-(4'-methoxyphenyl)propan-1 ,3-dion, 4-tert.-Butyl-4'-methoxydibenzoyl- methan (Parsol® 1789), 1-Phenyl-3-(4'-isopropylphenyl)-propan-1,3-dion sowie Enaminverbindungen, wie beschrieben in der DE 19712033 A1 (BASF). Die UV-A und UV-B-Filter können selbstverständlich auch in Mischungen eingesetzt werden. Besonders günstige Kombinationen bestehen aus den Derivate des Benzoylmethans,, z.B. 4-tert.-Butyl-4'-methoxydibenzoylmethan (Parsol® 1789) und 2-Cyano- 3,3-phenylzimtsäure-2-ethyl-hexylester (Octocrylene) in Kombination mit Ester der Zimtsäure, vorzugsweise 4-Methoxyzimtsäure-2-ethylhexylester und/oder 4-Methoxyzimtsäurepropylester und/oder 4- Methoxyzimtsäureisoamylester. Vorteilhaft werden deartige Kombinationen mit wasserlöslichen Filtern wie z.B. 2-Phenylbenzimidazol-5-sulfonsäure und deren Alkali-, Erdalkali-, Ammonium-, Alkylammonium-, Alkanolammonium- und Glucammoniumsalze kombiniert. Neben den genannten löslichen Stoffen kommen für diesen Zweck auch unlösliche Lichtschutzpigmente, nämlich feindisperse Metalloxide bzw. Salze in Frage. Beispiele für geeignete Metalloxide sind insbesondere Zinkoxid und Titandioxid und daneben Oxide des Eisens, Zirkoniums, Siliciums, Mangans, Aluminiums und Cers sowie deren Gemische. Als Salze können Silicate (Talk), Bariumsulfat oder Zinkstearat eingesetzt werden. Die Oxide und Salze werden in Form der Pigmente für hautpflegende und hautschützende Emulsionen und dekorative Kosmetik verwendet. Die Partikel sollten dabei einen mittleren Durchmesser von weniger als 100 nm, vorzugsweise zwischen 5 und 50 nm und insbesondere zwischen 15 und 30 nm aufweisen. Sie können eine sphärische Form aufweisen, es können jedoch auch solche Partikel zum Einsatz kommen, die eine ellipsoide oder in sonstiger Weise von der sphärischen Gestalt abweichende Form besitzen. Die Pigmente können auch oberflächenbehandelt, d.h. hydrophilisiert oder hydrophobiert vorliegen. Typische Beispiele sind gecoatete Titandioxide, wie z.B. Titandioxid T 805 (Degussa) oder Eusolex® T2000 (Merck). Als hydrophobe Coatingmittel kommen dabei vor allem Silicone und dabei speziell Trialkoxyoctylsilane oder Simethicone in Frage. In Sonnenschutzmitteln werden bevorzugt sogenannte Mikro- oder Nanopigmente eingesetzt. Vorzugsweise wird mikronisiertes Zinkoxid verwendet. Weitere geeignete UV-Lichtschutzfilter sind der Übersicht von P.Finkel in SÖFW-Journal 122, 543 (1996) sowie Parf.Kosm. 3, 11 (1999) zu entnehmen.Derivatives of benzoylmethane, such as 1- (4'-tert-butylphenyl) -3- (4'-methoxyphenyl) propane-1,3-dione, 4-tert-butyl, are particularly suitable as typical UV-A filters -4'-methoxydibenzoyl-methane (Parsol® 1789), 1-phenyl-3- (4'-isopropylphenyl) propane-1,3-dione and enamine compounds as described in DE 19712033 A1 (BASF). The UV-A and UV-B filters can of course also be used in mixtures. Particularly favorable combinations consist of the derivatives of benzoylmethane, for example 4-tert-butyl-4'-methoxydibenzoylmethane (Parsol® 1789) and 2-cyano-3,3-phenylcinnamic acid-2-ethyl-hexyl ester (octocrylene) in combination with Esters of cinnamic acid, preferably 2-ethylhexyl 4-methoxycinnamate and / or propyl 4-methoxycinnamate and / or isoamyl 4-methoxycinnamate. Such combinations are advantageously combined with water-soluble filters such as 2-phenylbenzimidazole-5-sulfonic acid and their alkali, alkaline earth, ammonium, alkylammonium, alkanolammonium and glucammonium salts. In addition to the soluble substances mentioned, insoluble light protection pigments, namely finely dispersed metal oxides or salts, are also suitable for this purpose. Examples of suitable metal oxides are, in particular, zinc oxide and titanium dioxide and, in addition, oxides of iron, zirconium, silicon, manganese, aluminum and cerium and mixtures thereof. Silicates (talc), barium sulfate or zinc stearate can be used as salts. The oxides and salts are used in the form of the pigments for skin-care and skin-protecting emulsions and decorative cosmetics. The particles should have an average diameter of less than 100 nm, preferably between 5 and 50 nm and in particular between 15 and 30 nm. They can have a spherical shape, but it is also possible to use particles which have an ellipsoidal shape or a shape which differs from the spherical shape in some other way. The pigments can also be surface-treated, ie hydrophilized or hydrophobicized. Typical examples are coated titanium dioxides such as titanium dioxide T 805 (Degussa) or Eusolex® T2000 (Merck). Silicones, and in particular trialkoxyoctylsilanes or simethicones, are particularly suitable as hydrophobic coating agents. So-called micro- or nanopigments are preferably used in sunscreens. Micronized zinc oxide is preferably used. Other suitable UV light protection filters are in the overview by P.Finkel in SÖFW-Journal 122, 543 (1996) and Parf.Kosm. 3, 11 (1999).
Neben den beiden vorgenannten Gruppen primärer Lichtschutzstoffe können auch sekundäre Lichtschutzmittel vom Typ der Antioxidantien eingesetzt werden, die die photochemische Reaktionskette unterbrechen, welche ausgelöst wird, wenn UV-Strahlung in die Haut eindringt. Typische Beispiele hierfür sind Aminosäuren (z.B. Glycin, Histidin, Tyrosin, Tryptophan) und deren Derivate, Imidazole (z.B. Urocaninsäure) und deren Derivate, Peptide wie D,L-Camosin, D-Camosin, L-Carnosin und deren Derivate (z.B. Anserin), Carotinoide, Carotine (z.B. α-Carotin, ß-Carotin, Lycopin) und deren Derivate, Chlorogensäure und deren Derivate, Liponsäure und deren Derivate (z.B. Dihydroliponsäure), Auro- thioglucose, Propylthiouracil und andere Thiole (z.B. Thioredoxin, Glutathion, Cystein, Cystin, Cystamin und deren Glycosyl-, N-Acetyl-, Methyl-, Ethyl-, Propyl-, Amyl-, Butyl- und Lauryl-, Palmitoyl-, Oleyl-, γ- Linoleyl-, Cholesteryl- und Glycerylester) sowie deren Salze, Dilaurylthiodipropionat, Distearylthiodipro- pionat, Thiodipropionsäure und deren Derivate (Ester, Ether, Peptide, Lipide, Nukleotide, Nukleoside und Salze) sowie Sulfoximinverbindungen (z.B. Buthioninsulfoximine, Homocysteinsulfoximin, Butionin- sulfone, Penta-, Hexa-, Heptathioninsulfoximin) in sehr geringen verträglichen Dosierungen (z.B. pmol bis μmol/kg), ferner (Metall)-Chelatoren (z.B. α-Hydroxyfettsäuren, Palmitinsäure, Phytinsäure, Lac- toferrin), α-Hydroxysäuren (z.B. Citronensäure, Milchsäure, Äpfelsäure), Huminsäure, Gallensäure, Gallenextrakte, Bilirubin, Biliverdin, EDTA, EGTA und deren Derivate, ungesättigte Fettsäuren und deren Derivate (z.B. γ-Linolensäure, Linolsäure, Ölsäure), Folsäure und deren Derivate, Ubichinon und Ubichinol und deren Derivate, Vitamin C und Derivate (z.B. Ascorbylpalmitat, Mg-Ascorbylphosphat, Ascorbylacetat), Tocopherole und Derivate (z.B. Vitamin-E-acetat), Vitamin A und Derivate (Vitamin-A- palmitat) sowie Koniferylbenzoat des Benzoeharzes, Rutinsäure und deren Derivate, α-Glycosylrutin, Ferulasäure, Furfurylidenglucitol, Carnosin, Butylhydroxytoluol, Butylhydroxyanisol, Nordihydroguajak- harzsäure, Nordihydroguajaretsäure, Trihydroxybutyrophenon, Harnsäure und deren Derivate, Man- nose und deren Derivate, Superoxid-Dismutase, Zink und dessen Derivate (z.B. ZnO, ZnS04) Selen und dessen Derivate (z.B. Selen-Methionin), Stilbene und deren Derivate (z.B. Stilbenoxid, trans-Stil- benoxid) und die erfindungsgemäß geeigneten Derivate (Salze, Ester, Ether, Zucker, Nukleotide, Nu- kleoside, Peptide und Lipide) dieser genannten Wirkstoffe.In addition to the two aforementioned groups of primary light stabilizers, secondary light stabilizers of the antioxidant type can also be used, which interrupt the photochemical reaction chain which is triggered when UV radiation penetrates the skin. Typical examples are amino acids (e.g. glycine, histidine, tyrosine, tryptophan) and their derivatives, imidazoles (e.g. urocanic acid) and their derivatives, peptides such as D, L-camosine, D-camosine, L-carnosine and their derivatives (e.g. anserine) , Carotenoids, carotenes (eg α-carotene, β-carotene, lycopene) and their derivatives, chlorogenic acid and their derivatives, lipoic acid and their derivatives (eg dihydroliponic acid), aurothioglucose, propylthiouracil and other thiols (eg thioredoxin, glutathione, cysteine, Cystine, cystamine and their glycosyl, N-acetyl, methyl, ethyl, propyl, amyl, butyl and lauryl, palmitoyl, oleyl, γ-linoleyl, cholesteryl and glyceryl esters) and their salts , Dilauryl thiodipropionate, distearyl thiodipropionate, thiodipropionic acid and its derivatives (esters, ethers, peptides, lipids, nucleotides, nucleosides and salts) as well as sulfoximine compounds (eg buthioninsulfoximines, homocysteine sulfoximine, butioninsulfones, penta-, hexa-, heptathioninsulfoninsulfoninsulfoxins) compatible dosages (e.g. pmol to μmol / kg), also (metal) chelators (e.g. α-hydroxy fatty acids, palmitic acid, phytic acid, lactoferrin), α-hydroxy acids (e.g. citric acid, lactic acid, malic acid), humic acid, bile acid, bile extracts, Bilirubin, biliverdin, EDTA, EGTA and their derivatives, unsaturated fatty acids and their derivatives (e.g. γ-linolenic acid, linoleic acid, oleic acid), folic acid and their derivatives, ubiquinone and ubiquinol and their derivatives, vitamin C and derivatives (e.g. ascorbyl palmitate, Mg-ascorbyl phosphate , Ascorbyl acetate), tocopherols and derivatives (eg vitamin E acetate), vitamin A and derivatives (vitamin A palmitate) and coniferyl benzoate of benzoin, rutinic acid and its derivatives, α-glycosyl rutin, ferulic acid, furfurylidene glucitol, carnosine, butylated hydroxytisolol, , Northern Hydroguajak resin acid, nordihydroguajaretic acid, trihydroxybutyrophenone, uric acid and its derivatives, mannose and its derivatives, superoxide dismutase, zinc and its derivatives (e.g. ZnO, ZnS0 4 ) selenium and its derivatives (e.g. selenium methionine), stilbenes and their derivatives (e.g. Stilbene oxide, trans-stilbene oxide) and the derivatives (salts, esters, ethers, sugars, nucleotides, nucleosides, peptides and lipids) of these active substances which are suitable according to the invention.
Bioqene WirkstoffeBioqene active ingredients
Unter biogenen Wirkstoffen sind beispielsweise Tocopherol, Tocopherolacetat, Tocopherolpalmitat, Ascorbinsäure, (Desoxy)Ribonucleinsäure und deren Fragmentierungsprodukte, Retinol, Bisabolol, Allantoin, Phytantriol, Panthenol, AHA-Säuren, Aminosäuren, Ceramide, Pseudoceramide, essentielle Öle, Pflanzenextrakte und Vitaminkomplexe zu verstehen.Biogenic active substances include, for example, tocopherol, tocopherol acetate, tocopherol palmitate, ascorbic acid, (deoxy) ribonucleic acid and its fragmentation products, retinol, bisabolol, allantoin, phytantriol, panthenol, AHA acids, amino acids, ceramides, pseudoceramides, essential oils and vegetable complexes.
Deodorantien und keimhemmende MittelDeodorants and germ inhibitors
Kosmetische Deodorantien (Desodorantien) wirken Körpergerüchen entgegen, überdecken oder beseitigen sie. Körpergerüche entstehen durch die Einwirkung von Hautbakterien auf apokrinen Schweiß, wobei unangenehm riechende Abbauprodukte gebildet werden. Dementsprechend enthalten Deodorantien Wirkstoffe, die als keimhemmende Mittel, Enzyminhibitoren, Geruchsabsorber oder Ge- ruchsüberdecker fungieren. Als keimhemmende Mittel sind grundsätzlich alle gegen grampositive Bakterien wirksamen Stoffe geeignet, wie z. B. 4-Hydroxybenzoesäure und ihre Salze und Ester, N-(4- Chlorphenyl)-N'-(3,4 dichlorphenyl)hamstoff, 2,4,4'-Trichlor-2'-hydroxydiphenylether (Triclosan), 4- Chlor-3,5-dimethyl-phenol, 2,2'-Methylen-bis(6-brom-4-chlorphenol), 3-Methyl-4-(1-methylethyl)-phenol, 2-Benzyl-4-chlorphenol, 3-(4-Chlorphenoxy)-1 ,2-propandiol, 3-lod-2-propinylbutylcarbamat, Chlorhexi- din, 3,4,4 '-Trichlorcarbanilid (TTC), antibakterielle Riechstoffe, Thymol, Thymianöl, Eugenol, Nelkenöl, Menthol, Minzöl, Famesol, Phenoxyethanol, Glycerinmonocaprinat, Glycerinmonocaprylat, Glycerinmo- nolaurat (GML), Diglycerinmonocaprinat (DMC), Salicylsäure-N-alkylamide wie z. B. Salicylsäure-n- octylamid oder Salicylsäure-n-decylamid.Cosmetic deodorants counteract, mask or eliminate body odors. Body odors arise from the action of skin bacteria on apocrine sweat, whereby unpleasant smelling breakdown products are formed. Accordingly, deodorants contain active ingredients which act as germ-inhibiting agents, enzyme inhibitors, odor absorbers or odor maskers. In principle, all substances effective against gram-positive bacteria are suitable as germ-inhibiting agents, such as. B. 4-hydroxybenzoic acid and its salts and esters, N- (4-chlorophenyl) -N ' - (3,4 dichlorophenyl) urea, 2,4,4 ' -Trichlor-2 ' -hydroxydiphenyl ether (triclosan), 4-chlorine -3,5-dimethyl-phenol, 2,2 '-methylene-bis (6-bromo-4-chlorophenol), 3-methyl-4- (1-methylethyl) phenol, 2-benzyl-4-chlorophenol, 3 - (4-chlorophenoxy) -1, 2-propanediol, 3-iodo-2-propynyl butyl carbamate, chlorhexidine, 3,4,4 ' trichlorocarbanilide (TTC), antibacterial fragrances, thymol, thyme oil, eugenol, clove oil, menthol, Mint oil, famesol, phenoxyethanol, glycerol monocaprinate, glycerol monocaprylate, glycerol monolaurate (GML), diglycerol monocaprinate (DMC), salicylic acid N-alkylamides such as B. salicylic acid-n-octylamide or salicylic acid-n-decylamide.
Als Enzyminhibitoren sind beispielsweise Esteraseinhibitoren geeignet. Hierbei handelt es sich vorzugsweise um Trialkylcitrate wie Trimethylcitrat, Tripropylcitrat, Triisopropylcitrat, Tributylcitrat und insbesondere Triethylcitrat (Hydagen® CAT). Die Stoffe inhibieren die Enzymaktivität und reduzieren dadurch die Geruchsbildung. Weitere Stoffe, die als Esteraseinhibitoren in Betracht kommen, sind Sterolsulfate oder -phosphate, wie beispielsweise Lanosterin-, Cholesterin-, Campesterin-, Stigma- sterin- und Sitosterinsulfat bzw -phosphat, Dicarbonsäuren und deren Ester, wie beispielsweise Glut- arsäure, Glutarsäuremonoethylester, Glutarsäurediethylester, Adipinsäure, Adipinsäuremonoethylester, Adipinsäurediethylester, Malonsäure und Malonsäurediethylester, Hydroxycarbnonsäuren und deren Ester wie beispielsweise Citronensäure, Äpfelsäure, Weinsäure oder Weinsäurediethylester, sowie Zinkglycinat.Esterase inhibitors, for example, are suitable as enzyme inhibitors. These are preferably trialkyl citrates such as trimethyl citrate, tripropyl citrate, triisopropyl citrate, tributyl citrate and in particular triethyl citrate (Hydagen® CAT). The substances inhibit enzyme activity and thereby reduce odor. Other substances which can be considered as esterase inhibitors are sterol sulfates or phosphates, such as, for example, lanosterol, cholesterol, campesterol, stigma- sterol and sitosterol sulfate or phosphate, dicarboxylic acids and their esters, such as, for example, glutaric acid, monoethyl glutarate, Diethyl glutarate, adipic acid, monoethyl adipate, Diethyl adipate, malonic acid and diethyl malonate, hydroxycarboxylic acids and their esters such as citric acid, malic acid, tartaric acid or tartaric acid diethyl ester, and zinc glycinate.
Als Geruchsabsorber eignen sich Stoffe, die geruchsbildende Verbindungen aufnehmen und weitgehend festhalten können. Sie senken den Partialdruck der einzelnen Komponenten und verringern so auch ihre Ausbreitungsgeschwindigkeit. Wichtig ist, daß dabei Parfüms unbeeinträchtigt bleiben müssen. Geruchsabsorber haben keine Wirksamkeit gegen Bakterien. Sie enthalten beispielsweise als Hauptbestandteil ein komplexes Zinksalz der Ricinolsäure oder spezielle, weitgehend geruchsneutrale Duftstoffe, die dem Fachmann als "Fixateure" bekannt sind, wie z. B. Extrakte von Labdanum bzw. Styrax oder bestimmte Abietinsäurederivate. Als Geruchsüberdecker fungieren Riechstoffe oder Parfümöle, die zusätzlich zu ihrer Funktion als Geruchsüberdecker den Deodorantien ihre jeweilige Duftnote verleihen. Als Parfümöle seien beispielsweise genannt Gemische aus natürlichen und synthetischen Riechstoffen. Natürliche Riechstoffe sind Extrakte von Blüten, Stengeln und Blättern, Früchten, Fruchtschalen, Wurzeln, Hölzern, Kräutern und Gräsern, Nadeln und Zweigen sowie Harzen und Balsamen. Weiterhin kommen tierische Rohstoffe in Frage, wie beispielsweise Zibet und Castoreum. Typische synthetische Riechstoffverbindungen sind Produkte vom Typ der Ester, Ether, Aldehyde, Keto- ne, Alkohole und Kohlenwasserstoffe. Riechstoffverbindungen vom Typ der Ester sind z.B. Ben- zylacetat, p-tert.-Butylcyclohexylacetat, Linalylacetat, Phenylethylacetat, Linalylbenzoat, Benzylformiat, Allylcyclohexylpropionat, Styrallylpropionat und Benzylsalicylat. Zu den Ethern zählen beispielsweise Benzylethylether, zu den Aldehyden z.B. die linearen Alkanale mit 8 bis 18 Kohlenstoffatomen, Citral, Citronellal, Citronellyloxyacetaldehyd, Cyclamenaldehyd, Hydroxycitronellal, Lilial und Bourgeonal, zu den Ketonen z.B. die Jonone und Methylcedrylketon, zu den Alkoholen Anethol, Citronellol, Eugenol, Isoeugenol, Geraniol, Linalool, Phenylethylalkohol und Terpineol, zu den Kohlenwasserstoffen gehören hauptsächlich die Terpene und Balsame. Bevorzugt werden jedoch Mischungen verschiedener Riechstoffe verwendet, die gemeinsam eine ansprechende Duftnote erzeugen. Auch ätherische Öle geringerer Flüchtigkeit, die meist als Aromakomponenten verwendet werden, eignen sich als Parfümöle, z.B. Salbeiöl, Kamillenöl, Nelkenöl, Melissenöl, Minzenöl, Zimtblätteröl, Lindenblütenöl, Wacholderbeerenöl, Vetiveröl, Olibanöl, Galbanumöl, Labdanumöl und Lavandinöl. Vorzugsweise werden Bergamotteöl, Dihydromyrcenol, Lilial, Lyral, Citronellol, Phenylethylalkohol, α-Hexylzimtaldehyd, Geraniol, Benzyl- aceton, Cyclamenaldehyd, Linalool, Boisambrene Forte, Ambroxan, Indol, Hedione, Sandelice, Citro- nenöl, Mandarinenöl, Orangenöl, Allylamylglycolat, Cyclovertal, Lavandinöl, Muskateller Salbeiöl, ß- Damascone, Geraniumöl Bourbon, Cyclohexylsalicylat, Vertofix Coeur, Iso-E-Super, Fixolide NP, Evernyl, Iraldein gamma, Phenylessigsäure, Geranylacetat, Benzylacetat, Rosenoxid, Romilat, Irotyl und Floramat allein oder in Mischungen, eingesetzt.Suitable odor absorbers are substances that absorb odor-forming compounds and can retain them to a large extent. They lower the partial pressure of the individual components and thus also reduce their speed of propagation. It is important that perfumes must remain unaffected. Odor absorbers are not effective against bacteria. They contain, for example, a complex zinc salt of ricinoleic acid or special, largely odorless fragrances, which are known to the person skilled in the art as "fixators", such as, for example, the main component. B. extracts of Labdanum or Styrax or certain abietic acid derivatives. Fragrance agents or perfume oils act as odor maskers and, in addition to their function as odor maskers, give the deodorants their respective fragrance. Perfume oils are, for example, mixtures of natural and synthetic fragrances. Natural fragrances are extracts of flowers, stems and leaves, fruits, fruit peels, roots, woods, herbs and grasses, needles and branches as well as resins and balms. Animal raw materials, such as civet and castoreum, are also suitable. Typical synthetic fragrance compounds are products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type. Fragrance compounds of the ester type are e.g. Benzyl acetate, p-tert-butylcyclohexyl acetate, linalyl acetate, phenylethyl acetate, linalyl benzoate, benzyl formate, allyl cyclohexyl propionate, styrallyl propionate and benzyl salicylate. The ethers include, for example, benzyl ethyl ether, the aldehydes e.g. the linear alkanals with 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamenaldehyde, hydroxycitronellal, lilial and bourgeonal, to the ketones e.g. the Jonone and methylcedryl ketone, the alcohols anethole, citronellol, eugenol, isoeugenol, geraniol, linalool, phenylethyl alcohol and terpineol, the hydrocarbons mainly include the terpenes and balsams. However, preference is given to using mixtures of different fragrances which together produce an appealing fragrance. Essential oils of lower volatility, which are mostly used as aroma components, are also suitable as perfume oils, e.g. Sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, labdanum oil and lavandin oil. Bergamot oil, dihydromyrcenol, lilial, lyral, citronellol, phenylethyl alcohol, α-hexylcinnamaldehyde, geraniol, benzyl acetone, cyclamenaldehyde, linalool, boisambrene forte, ambroxan, indole, hedione, sandelice, citrone oil, mandarin oil, allyl glycolate, orangalol oil, orangol oil, orangol oil, are preferred , Lavandin oil, muscatel sage oil, ß- damascone, geranium oil bourbon, cyclohexyl salicylate, Vertofix Coeur, Iso-E-Super, Fixolide NP, evernyl, iraldein gamma, phenylacetic acid, geranyl acetate, benzyl acetate, rose oxide, romilate, irotyl and floramate alone or in mixtures, alone or in mixtures, used.
Antitranspirantien (Antiperspirantien) reduzieren durch Beeinflussung der Aktivität der ekkrinen Schweißdrüsen die Schweißbildung, und wirken somit Achselnässe und Körpergeruch entgegen. Wässrige oder wasserfreie Formulierungen von Antitranspirantien enthalten typischerweise folgende Inhaltsstoffe:Antiperspirants (antiperspirants) reduce sweat formation by influencing the activity of the eccrine sweat glands and thus counteract armpit wetness and body odor. Aqueous or anhydrous formulations of antiperspirants typically contain the following ingredients:
> adstringierende Wirkstoffe,> astringent active ingredients,
> Ölkomponenten,> Oil components,
> nichtionische Emulgatoren,> nonionic emulsifiers,
> Coemulgatoren,> Co-emulsifiers,
> Konsistenzgeber,> Consistency generator,
> Hilfsstoffe wie z. B. Verdicker oder Komplexierungsmittel und/oder> Auxiliaries such as B. thickeners or complexing agents and / or
> nichtwässrige Lösungsmittel wie z. B. Ethanol, Propylenglykol und/oder Glycerin.> non-aqueous solvents such as As ethanol, propylene glycol and / or glycerin.
Als adstringierende Antitranspirant-Wirkstoffe eignen sich vor allem Salze des Aluminiums, Zirkoniums oder des Zinks. Solche geeigneten antihydrotisch wirksamen Wirkstoffe sind z.B. Aluminiumchlorid, Aluminiumchlorhydrat, Aluminiumdichlorhydrat, Aluminiumsesquichlorhydrat und deren Komplexverbindungen z. B. mit Propylenglycol-1 ,2. Aluminiumhydroxyallantoinat, Aluminiumchloridtartrat, Aluminium- Zirkonium-Trichlorohydrat, Aluminium-Zirko-nium-tetrachlorohydrat, Aluminium-Zirkonium-pentachlo- rohydrat und deren Komplexverbindungen z. B. mit Aminosäuren wie Glycin. Daneben können in Antitranspirantien übliche öllösliche und wasserlösliche Hilfsmittel in geringeren Mengen enthalten sein. Solche öllöslichen Hilfsmittel können z.B. sein:Salts of aluminum, zirconium or zinc are particularly suitable as astringent antiperspirant active ingredients. Such suitable antiperspirant active ingredients are e.g. Aluminum chloride, aluminum chlorohydrate, aluminum dichlorohydrate, aluminum sesquichlorohydrate and their complex compounds e.g. B. with propylene glycol-1, 2nd Aluminum hydroxyallantoinate, aluminum chloride tartrate, aluminum zirconium trichlorohydrate, aluminum zirconium tetrachlorohydrate, aluminum zirconium pentachlorohydrate and their complex compounds z. B. with amino acids such as glycine. In addition, customary oil-soluble and water-soluble auxiliaries can be present in smaller amounts in antiperspirants. Such oil soluble aids can e.g. his:
> entzündungshemmende, hautschützende oder wohlriechende ätherische Öle,> anti-inflammatory, skin-protecting or fragrant essential oils,
> synthetische hautschützende Wirkstoffe und/oder> synthetic skin-protecting agents and / or
> öllösliche Parfümöle.> Oil-soluble perfume oils.
Übliche wasserlösliche Zusätze sind z.B. Konservierungsmittel, wasserlösliche Duftstoffe, pH-Wert- Stellmittel, z.B. Puffergemische, wasserlösliche Verdickungsmittel, z.B. wasserlösliche natürliche oder synthetische Polymere wie z.B. Xanthan-Gum, Hydroxyethylcellulose, Polyvinylpyrrolidon oder hochmolekulare Polyethylenoxide.Common water-soluble additives are e.g. Preservatives, water-soluble fragrances, pH adjusters, e.g. Buffer mixtures, water soluble thickeners, e.g. water-soluble natural or synthetic polymers such as e.g. Xanthan gum, hydroxyethyl cellulose, polyvinyl pyrrolidone or high molecular weight polyethylene oxides.
Filmbildnerfilm formers
Gebräuchliche Filmbildner sind beispielsweise Chitosan, mikrokristallines Chitosan, quaterniertes Chitosan, Polyvinylpyrrolidon, Vinylpyrrolidon-Vinylacetat-Copolymerisate, Polymere der Acrylsäurereihe, quatemäre Cellulose-Derivate, Kollagen, Hyaluronsäure bzw. deren Salze und ähnliche Verbindungen. AntischuppenwirkstoffeCommon film formers are, for example, chitosan, microcrystalline chitosan, quaternized chitosan, polyvinylpyrrolidone, vinylpyrrolidone-vinyl acetate copolymers, polymers of the acrylic acid series, quaternary cellulose derivatives, collagen, hyaluronic acid or its salts and similar compounds. Antidandruff agents
Als Antischuppenwirkstoffe kommen Pirocton Olamin (1-Hydroxy-4-methyl-6-(2,4,4-trimythylpentyl)-2- (IH)-pyridinonmonoethanolaminsalz), Baypival® (Climbazole), Ketoconazol®, (4-Acetyl-1-{-4-[2-(2.4- dichlorphenyl) r-2-(1 H-imidazol-1 -ylmethyl)-1 ,3-dioxylan-c-4-ylmethoxyphenyl}piperazin, Ketoconazol, Elubiol, Selendisulfid, Schwefel kolloidal, Schwefelpolyehtylenglykolsorbitanmonooleat, Schwefelrizi- nolpolyehtoxylat, Schwfel-teer Destillate, Salicylsäure (bzw. in Kombination mit Hexachlorophen), Un- dexylensäure Monoethanolamid Sulfosuccinat Na-Salz, Lamepon® UD (Protein-Undecylensäurekon- densat), Zinkpyrithion, Aluminiumpyrithion und Magnesiumpyrithion / Dipyrithion-Magnesiumsulfat in Frage.Piroctone olamine (1-hydroxy-4-methyl-6- (2,4,4-trimythylpentyl) -2- (IH) -pyridinone monoethanolamine salt), Baypival® (Climbazole), Ketoconazol®, (4-acetyl-1 - {- 4- [2- (2.4-dichlorophenyl) r-2- (1 H -imidazol-1-ylmethyl) -1, 3-dioxylan-c-4-ylmethoxyphenyl} piperazine, ketoconazole, elubiol, selenium disulfide, sulfur colloidal , Sulfur polyethylene glycol sorbitan monooleate, sulfur Ricinolpolyehtoxylat, sulfur tar distillates, salicylic acid (or in combination with hexachlorophene), undexylenic acid monoethanolamide sulfosuccinate sodium salt, Lamepon® UD (protein undecylenic acid pyrithione, magnesium pyridithione, zinc pyrithione, zinc pyrithione, zinc pyrithione, zinc pyrithione, zinc pyrithione, zinc pyrithione, zinc pyrithione, zinc pyridine, zinc pyridine, zinc pyridine, zinc pyridine, zinc pyridine, zinc pyridine, zinc pyridine, zinc pyridine, zinc pyridine, zinc pyridine, zinc pyridine, zinc pyridine, zinc pyridine, zinc pyridine, Magnesium sulfate in question.
Quellmittelswelling agent
Als Quellmittel für wäßrige Phasen können Montmorillonite, Clay Mineralstoffe, Pemulen sowie alkyl- modifizierte Carbopoltypen (Goodrich) dienen. Weitere geeignete Polymere bzw. Quellmittel können der Übersicht von R.Lochhead in Cosm.Toil. 108, 95 (1993) entnommen werden.Montmorillonites, clay minerals, pemules and alkyl-modified carbopol types (Goodrich) can serve as swelling agents for aqueous phases. Further suitable polymers or swelling agents can be found in the overview by R. Lochhead in Cosm.Toil. 108, 95 (1993).
Insekten-RepellentienInsect repellents
Als Insekten-Repellentien kommen N,N-Diethyl-m-toluamid, 1 ,2-Pentandiol oder Ethyl Butylacetyla- minopropionate in FragePossible insect repellents are N, N-diethyl-m-toluamide, 1, 2-pentanediol or ethyl butylacetylaminopropionate
Selbstbräuner und DepiqmentierunqsmittelSelf-tanners and depiqmentants
Als Selbstbräuner eignet sich Dihydroxyaceton. Als Tyrosinhinbitoren, die die Bildung von Melanin verhindern und Anwendung in Depigmentierungsmitteln finden, kommen beispielsweise Arbutin, Feru- lasäure, Kojisäure, Cumarinsäure und Ascorbinsäure (Vitamin C) in Frage.Dihydroxyacetone is suitable as a self-tanner. Arbutin, ferulic acid, kojic acid, coumaric acid and ascorbic acid (vitamin C) can be used as tyrosine inhibitors, which prevent the formation of melanin and are used in depigmenting agents.
Hydrotropehydrotropes
Zur Verbesserung des Fließverhaltens können ferner Hydrotrope, wie beispielsweise Ethanol, Isopro- pylalkohol, oder Polyole eingesetzt werden. Polyole, die hier in Betracht kommen, besitzen vorzugsweise 2 bis 15 Kohlenstoff atome und mindestens zwei Hydroxylgruppen. Die Polyole können noch weitere funktioneile Gruppen, insbesondere Aminogruppen, enthalten bzw. mit Stickstoff modifiziert sein. Typische Beispiele sind > Glycerin;Hydrotropes, such as ethanol, isopropyl alcohol, or polyols can also be used to improve the flow behavior. Polyols that come into consideration here preferably have 2 to 15 carbon atoms and at least two hydroxyl groups. The polyols can also contain further functional groups, in particular amino groups, or be modified with nitrogen. Typical examples are >Glycerin;
> Alkylenglycole, wie beispielsweise Ethylenglycol, Diethylenglycol, Propylenglycol, Butylenglycol, Hexylenglycol sowie Polyethylenglycole mit einem durchschnittlichen Molekulargewicht von 100 bis 1.000 Dalton;> Alkylene glycols, such as ethylene glycol, diethylene glycol, propylene glycol, butylene glycol, hexylene glycol and polyethylene glycols with an average molecular weight of 100 to 1,000 daltons;
> technische Oligoglyceringemische mit einem Eigenkondensationsgrad von 1 ,5 bis 10 wie etwa technische Diglyceringemische mit einem Diglyceringehalt von 40 bis 50 Gew.-%;> technical oligoglycerol mixtures with a degree of self-condensation of 1.5 to 10 such as technical diglycerol mixtures with a diglycerol content of 40 to 50% by weight;
> Methyolverbindungen, wie insbesondere Trimethylolethan, Trimethylolpropan, Trimethylolbutan, Pentaerythrit und Dipentaerythrit;> Methyl compounds, such as in particular trimethylolethane, trimethylolpropane, trimethylolbutane, pentaerythritol and dipentaerythritol;
> Niedrigalkylglucoside, insbesondere solche mit 1 bis 8 Kohlenstoffen im Alkylrest, wie beispielsweise Methyl- und Butylglucosid;> Lower alkyl glucosides, especially those with 1 to 8 carbons in the alkyl radical, such as methyl and butyl glucoside;
> Zuckeralkohole mit 5 bis 12 Kohlenstoffatomen, wie beispielsweise Sorbit oder Mannit,Sugar alcohols with 5 to 12 carbon atoms, such as sorbitol or mannitol,
> Zucker mit 5 bis 12 Kohlenstoffatomen, wie beispielsweise Glucose oder Saccharose;> Sugar with 5 to 12 carbon atoms, such as glucose or sucrose;
> Aminozucker, wie beispielsweise Glucamin;> Aminosugars such as glucamine;
> Dialkoholamine, wie Diethanolamin oder 2-Amino-1 ,3-propandiol.> Dialcohol amines, such as diethanolamine or 2-amino-1, 3-propanediol.
Konservierungsmittelpreservative
Als Konservierungsmittel eignen sich beispielsweise Phenoxyethanol, Formaldehydlösung, Parabene, Pentandiol oder Sorbinsäure sowie die in Anlage 6, Teil A und B der Kosmetikverordnung aufgeführten weiteren Stoffklassen.Suitable preservatives are, for example, phenoxyethanol, formaldehyde solution, parabens, pentanediol or sorbic acid and the other classes of substances listed in Appendix 6, Parts A and B of the Cosmetics Regulation.
Parfümöleperfume oils
Als Parfümöle seien genannt Gemische aus natürlichen und synthetischen Riechstoffen. Natürliche Riechstoffe sind Extrakte von Blüten (Lilie, Lavendel, Rosen, Jasmin, Neroli, Ylang-Ylang), Stengeln und Blättern (Geranium, Patchouli, Petitgrain), Früchten (Anis, Koriander, Kümmel, Wacholder), Fruchtschalen (Bergamotte, Zitrone, Orangen), Wurzeln (Macis, Angelica, Sellerie, Kardamon, Costus, Iris, Calmus), Hölzern (Pinien-, Sandel-, Guajak-, Zedern-, Rosenholz), Kräutern und Gräsern (Estragon, Lemongras, Salbei, Thymian), Nadeln und Zweigen (Fichte, Tanne, Kiefer, Latschen), Harzen und Balsamen (Galbanum, Elemi, Benzoe, Myrrhe, Olibanum, Opoponax). Weiterhin kommen tierische Rohstoffe in Frage, wie beispielsweise Zibet und Castoreum. Typische synthetische Riechstoffverbindun- gen sind Produkte vom Typ der Ester, Ether, Aldehyde, Ketone, Alkohole und Kohlenwasserstoffe. Riechstoffverbindungen vom Typ der Ester sind z.B. Benzylacetat, Phenoxyethylisobutyrat, p-tert.-Bu- tylcyclohexylacetat, Linalylacetat, Dimethylbenzylcarbinylacetat, Phenylethylacetat, Linalylbenzoat, Benzylformiat, Ethylmethylphenylglycinat, Allylcyclohexylpropionat, Styrallylpropionat und Benzylsa- licylat. Zu den Ethern zählen beispielsweise Benzylethylether, zu den Aldehyden z.B. die linearen Alka- nale mit 8 bis 18 Kohlenstoffatomen, Citral, Citronellal, Citronellyloxyacetaldehyd, Cyclamenaldehyd, Hydroxycitronellal, Lilial und Bourgeonal, zu den Ketonen z.B. die Jonone, α-lsomethylionon und Me- thylcedrylketon, zu den Alkoholen Anethol, Citronellol, Eugenol, Isoeugenol, Geraniol, Linalool, Phenylethylalkohol und Terpineol, zu den Kohlenwasserstoffen gehören hauptsächlich die Terpene und Balsame. Bevorzugt werden jedoch Mischungen verschiedener Riechstoffe verwendet, die gemeinsam eine ansprechende Duftnote erzeugen. Auch ätherische Öle geringerer Flüchtigkeit, die meist als Aromakomponenten verwendet werden, eignen sich als Parfümöle, z.B. Salbeiöl, Kamillenöl, Nelkenöl, Melissenöl, Minzenöl, Zimtblätteröl, Lindenblütenöl, Wacholderbeerenöl, Vetiveröl, Olibanöl, Galbanu- möl, Labolanumöl und Lavandinöl. Vorzugsweise werden Bergamotteöl, Dihydromyrcenol, Lilial, Lyral, Citronellol, Phenylethylalkohol, α-Hexylzimtaldehyd, Geraniol, Benzylaceton, Cyclamenaldehyd, Linalool, Boisambrene Forte, Ambroxan, Indol, Hedione, Sandelice, Citronenöl, Mandarinenöl, Orangenöl, Allylamylglycolat, Cyclovertal, Lavandinöl, Muskateller Salbeiöl, ß-Damascone, Geraniumöl Bourbon, Cyclohexylsalicylat, Vertofix Coeur, Iso-E-Super, Fixolide NP, Evernyl, Iraldein gamma, Phenylessig- säure, Geranylacetat, Benzylacetat, Rosenoxid, Romilllat, Irotyl und Floramat allein oder in Mischungen, eingesetzt.Perfume oils include mixtures of natural and synthetic fragrances. Natural fragrances are extracts of flowers (lily, lavender, roses, jasmine, neroli, ylang-ylang), stems and leaves (geranium, patchouli, petitgrain), fruits (anise, coriander, caraway, juniper), fruit peel (bergamot, lemon, Oranges), roots (mace, angelica, celery, cardamom, costus, iris, calmus), wood (pine, sandal, guaiac, cedar, rosewood), herbs and grasses (tarragon, lemongrass, sage, thyme), Needles and twigs (spruce, fir, pine, mountain pine), resins and balms (galbanum, elemi, benzoin, myrrh, olibanum, opoponax). Animal raw materials, such as civet and castoreum, are also suitable. Typical synthetic fragrance compounds are products of the ester, ether, aldehyde, ketone, alcohol and hydrocarbon type. Fragrance compounds of the ester type are, for example, benzyl acetate, phenoxyethyl isobutyrate, p-tert-butylcyclohexyl acetate, linalyl acetate, dimethylbenzylcarbinylacetate, phenylethyl acetate, linalyl benzoate, benzyl formate, ethyl methylphenylglycinate, allylcyclohexyl benzylatepylpropionate, allyl cyclohexyl propyl pionate. The ethers include, for example, benzyl ethyl ether, the aldehydes, for example, the linear alkali nals with 8 to 18 carbon atoms, citral, citronellal, citronellyloxyacetaldehyde, cyclamenaldehyde, hydroxycitronellal, lilial and bourgeonal, to the ketones eg the jonones, α-isomethylionone and methylcedrylketone, to the alcohols anethole, citronellol, eugenol, isoleugenol, isoeugenol , Phenylethyl alcohol and terpineol, the hydrocarbons mainly include the terpenes and balms. However, preference is given to using mixtures of different fragrances which together produce an appealing fragrance. Essential oils of lower volatility, which are mostly used as aroma components, are also suitable as perfume oils, for example sage oil, chamomile oil, clove oil, lemon balm oil, mint oil, cinnamon leaf oil, linden blossom oil, juniper berry oil, vetiver oil, oliban oil, galbanum oil, labolanum oil and lavandin oil. Preferably, bergamot oil, dihydromyrcenol, lilial, lyral, citronellol, phenylethyl alcohol, α-hexylcinnamaldehyde, geraniol, benzyl acetone, cyclamen aldehyde, linalool, Boisambrene Forte, Ambroxan, indole, hedione, Sandelice, lemon oil, mandarin oil, orange oil, allyl amyl glycolate, Cyclovertal, lavandin oil, muscatel Sage oil, ß-damascone, geranium oil bourbon, cyclohexyl salicylate, Vertofix Coeur, Iso-E-Super, Fixolide NP, evernyl, iraldein gamma, phenylacetic acid, geranyl acetate, benzyl acetate, rose oxide, romilllate, irotyl and floramate alone or in mixtures.
Farbstoffedyes
Als Farbstoffe können die für kosmetische Zwecke geeigneten und zugelassenen Substanzen verwendet werden, wie sie beispielsweise in der Publikation "Kosmetische Färbemittel" der Farbstoffkommission der Deutschen Forschungsgemeinschaft, Verlag Chemie, Weinheim, 1984, S.81-106 zusammengestellt sind. Diese Farbstoffe werden üblicherweise in Konzentrationen von 0,001 bis 0,1 Gew.-%, bezogen auf die gesamte Mischung, eingesetzt.The dyes which can be used are those substances which are suitable and approved for cosmetic purposes, as compiled, for example, in the publication "Cosmetic Dyes" by the Dye Commission of the German Research Foundation, Verlag Chemie, Weinheim, 1984, pp. 81-106. These dyes are usually used in concentrations of 0.001 to 0.1% by weight, based on the mixture as a whole.
Der Gesamtanteil der Hilfs- und Zusatzstoffe kann 1 bis 50, vorzugsweise 5 bis 40 Gew.-% - bezogen auf die Mittel - betragen. Die Herstellung der Mittel kann durch übliche Kalt - oder Heißprozesse erfolgen; vorzugsweise arbeitet man nach der Phaseninversionstemperatur-Methode. The total proportion of auxiliaries and additives can be 1 to 50, preferably 5 to 40,% by weight, based on the composition. The agents can be produced by customary cold or hot processes; the phase inversion temperature method is preferably used.
BeispieleExamples
Beispiel 1 - Herstellung eines Extraktes von Physalis minima. In einem Glasreaktor wurden 200 g zerkleinerte Blätter von Physalis minima in 2 I 70 Gew.-%igem wäßrigem Methanol dispergiert. Die Mischung wurde über einen Zeitraum von 1 h unter Rückfluß und ständiger Bewegung extrahiert, danach abgekühlt, über ein Filter mit einer Maschenweite von 0,45 μm filtriert, der Methanol bei 30 °C unter vermindertem Druck abdestilliert und die verbleibende wäßrige Phase lyophilisiert. Die Ausbeute bezogen auf die Blätter betrug 15,8 Gew.-%.Example 1 - Preparation of an extract from Physalis minima. In a glass reactor, 200 g of crushed Physalis minima leaves were dispersed in 2 l of 70% by weight aqueous methanol. The mixture was extracted under reflux and constant agitation over a period of 1 h, then cooled, filtered through a filter with a mesh size of 0.45 μm, the methanol was distilled off at 30 ° C. under reduced pressure and the remaining aqueous phase was lyophilized. The yield based on the leaves was 15.8% by weight.
Anschließend wurde der Extrakt einer Fraktionierung durch Flüssigchromatographie an Amberiite XAD 1180 unterzogen. Eluiert wurde mit einem Stufengradienten von 20 Gew.-% wäßrigem Methanol bis 100 % Methanol. Der Extrakt ohne Fraktionierung und drei unterschiedliche Fraktionen wurden anschließend getestet.The extract was then subjected to fractionation by liquid chromatography on Amberiite XAD 1180. Elution was carried out with a step gradient from 20% by weight aqueous methanol to 100% methanol. The extract without fractionation and three different fractions were then tested.
Tabelle 1:Table 1:
Zu testende Fraktionen aus dem Extrakt von Physalis minimaFractions to be tested from the extract of Physalis minima
Figure imgf000023_0001
Figure imgf000023_0001
Beispiel 2 - Herstellung eines Extraktes von Achyranthes bidentata. In einem Glasreaktor wurden 300 g zerkleinerte Blätter und Stengel von Achyranthes bidentata in 3 I 96 Gew.-%igem wäßrigem Et- hanol dispergiert. Die Mischung wurde über einen Zeitraum von 1 h unter Rückfluß und ständiger Bewegung extrahiert, danach abgekühlt, und die Lösung über ein Filter mit einer Maschenweite von 0,45 μm filtriert. Der verbliebene Rückstand wurde ein zweites Mal unter den gleichen Bedingungen extrahiert. Die Filtrate wurden vereinigt, zur Entfärbung mit 1,5 Gew.-% Aktivkohle versetzt und abermals filtriert. Das resultierende noch leicht bräunlich gefärbte Filtrat wurde dann bei 40 CC unter vermindertem Druck von Ethanol befreit und die wäßrige Phase bis zu einem Aktivsubstanzgehalt von 50 Gew.-% eingedampft. Die Ausbeute betrug bezogen auf das Einsatzmaterial 7,6 Gew.-%. Anschließend wurde der Extrakt einer Fraktionierung durch Flüssigchromatographie an Amberiite XAD 1180 unterzogen. Eluiert wurde mit einem Stufengradienten von 20 Gew.-% wäßrigem Methanol bis 100 Gew.-% Methanol. Ein Extrakt ohne Fraktionierung und die Fraktion mit 100 Gew.-% Methanol wurden anschließend getestet.Example 2 - Preparation of an extract from Achyranthes bidentata. 300 g of shredded leaves and stems of Achyranthes bidentata were dispersed in 3 l of 96% strength by weight aqueous ethanol in a glass reactor. The mixture was extracted under reflux with constant agitation for a period of 1 h, then cooled, and the solution was filtered through a filter with a mesh size of 0.45 μm. The remaining residue was extracted a second time under the same conditions. The filtrates were combined, 1.5% by weight of activated carbon was added to decolorize and the mixture was filtered again. The resultant slightly brownish filtrate was freed then at 40 C C under reduced pressure of ethanol and the aqueous phase up to an active substance content of 50 wt .-% evaporated. The yield based on the feed was 7.6% by weight. The extract was then subjected to fractionation by liquid chromatography on Amberiite XAD 1180. Elution was carried out with a step gradient from 20% by weight aqueous methanol to 100% by weight methanol. An extract without fractionation and the fraction with 100% by weight of methanol were then tested.
Beispiele 3: Die Bestimmung der G6PDH-Aktivität erfolgte nach dem von Garidelli de Quincenet in Annual DermatolNenereol. 107(12), 1163-1170 (1980) beschriebenen Mikroverfahren. Die Bestimmung der GδPDH-Aktivität erfolgte nach dem von Νatsuko Okada und Yukio Kitano in: Arch. Derma- tol. Res., 271 (3) : 341-346, 1981 beschriebenen Verfahren durch in vitro Bestimmung der enzymati- schen Aktivität der Glucose-6-phosphate Dehydrogenase in humanen FibroblastenExamples 3: The G6PDH activity was determined according to that of Garidelli de Quincenet in Annual DermatolNenereol. 107 (12), 1163-1170 (1980). GδPDH activity was determined according to that of Νatsuko Okada and Yukio Kitano in: Arch. Derma- tol. Res., 271 (3): 341-346, 1981 described method by in vitro determination of the enzymatic activity of glucose-6-phosphate dehydrogenase in human fibroblasts
Der DNA-Gehalt wurde nach der von Desaulniers in Toxic In vitro 12(4), 409-422 (1998) beschriebenen Methode ermittelt Die Inkubationszeit der Fibroblasten betrug jeweils 3 Tage und 6 Tage Die Ergebnisse sind in Tabelle 2 zusammengefaßt Angegeben ist jeweils das Mittel von 4 Versuchen bei Drei- fachbestimmungThe DNA content was determined by the method described by Desaulniers in Toxic In Vitro 12 (4), 409-422 (1998). The incubation time of the fibroblasts was 3 days and 6 days in each case. The results are summarized in Table 2. The mean is given in each case of 4 attempts at triple determination
Tabelle 2Table 2
G6PDH-Aktivität und DNA - Angaben in %-relG6PDH activity and DNA - figures in% rel
Figure imgf000024_0001
Figure imgf000024_0001
Die Ergebnisse in der Tabelle 2 zeigen, dass der Extrakt von Physalis minima mit einer Konzentration von 0,002 Gew -% die Aktivität von G6PDH in humanen Fibroblasten nach 6 Tagen extrem erhöht hat Die Fraktionen 1 und 2 aus den Extrakten von Physalis minima zeigen bei einer Konzentration von 0,002 Gew -% nach 6 Tagen Inkubationszeit eine erhöhte Aktivität der G6PDH und die Fraktion 2 zeigt bereits nach 3 Tagen eine Erhöhung der Aktivität Die Fraktion 3 zeigt im Vergleich bei einer bedeutend niedrigeren Konzentration von nur 0,0003 Gew -% eine Erhöhung der gewünschten Aktivität nach 3 und nach 6 Tagen Inkubation Mit diesen Ergebnissen kann gezeigt werden, dass die Aktivität von G6PDH durch Extrakte der Pflanze Physalis minima erhöht werden kannThe results in Table 2 show that the extract from Physalis minima with a concentration of 0.002% by weight increased the activity of G6PDH in human fibroblasts extremely after 6 days. Fractions 1 and 2 from the extracts from Physalis minima show at a concentration of 0.002% by weight after 6 days of incubation, an increased activity of the G6PDH and fraction 2 shows an increase in activity after only 3 days. In comparison, fraction 3 shows an increase in the desired at a significantly lower concentration of only 0.0003% by weight Activity after 3 and after 6 days of incubation With these results it can be shown that the activity of G6PDH can be increased by extracts of the plant Physalis minima
Die Extrakte und die Methanol-Fraktion des Extraktes der Pflanze Achyranthes bidentata zeigen eine Erhöhung der Aktivität bei einer Konzentration von 0,005 Gew -% nach 3 und nach 6 Tagen Inkubation Die Fraktion aus der Methanol Fraktionierung ist bereits bei einer Konzentration von 0,0003 Gew.-% wirksam Diese Ergebnisse können belegen, dass die Extrakte der Pflanze Achyranthes bidentata die Aktivität von G6PDH stimulieren und erhohen können Tabelle 3The extracts and the methanol fraction of the extract of the plant Achyranthes bidentata show an increase in activity at a concentration of 0.005% by weight after 3 and after 6 days of incubation. The fraction from the methanol fractionation is already at a concentration of 0.0003%. -% Effective These results can show that the extracts of the plant Achyranthes bidentata can stimulate and increase the activity of G6PDH Table 3
Kosmetische Zubereitungen (Wasser, Konservierungsmittel ad 100 Gew.-%)Cosmetic preparations (water, preservative ad 100 wt .-%)
Figure imgf000025_0001
Figure imgf000025_0001
(1 ,2) Softcreme, (3-6) Feuchtigkeitsemulsion, (7-10) Nachtcreme (1, 2) soft cream, (3-6) moisturizing emulsion, (7-10) night cream

Claims

Patentansprüche claims
1. Verwendung von Naturstoffen ausgewählt aus der Gruppe, die gebildet wird von Extrakten von Pflanzen aus der Familie der Solanaceae der Familie Amaranthaceae und der Familie Monimiaceae zur Herstellung von kosmetischen Zubereitungen.1. Use of natural substances selected from the group formed by extracts of plants from the Solanaceae family, the Amaranthaceae family and the Monimiaceae family, for the production of cosmetic preparations.
2. Verwendung von Naturstoffen ausgewählt aus der Gruppe, die gebildet wird von Extrakten von Pflanzen aus der Familie der Solanaceae, der Familie Amaranthaceae und der Familie Monimiaceae als Wirkstoffe zur Herstellung eines Mittels zur Steigerung der G6PDH-Aktivität im Stoffwechsel.2. Use of natural substances selected from the group formed by extracts of plants from the Solanaceae family, the Amaranthaceae family and the Monimiaceae family as active substances for producing an agent for increasing the G6PDH activity in the metabolism.
3. Verwendung nach den Ansprüchen 1 und/oder 2, dadurch gekennzeichnet, dass man Extrakte von Pflanzen des Geni Physalis, Achyranthes und/oder Peumus verwendet.3. Use according to claims 1 and / or 2, characterized in that extracts from plants of the Geni Physalis, Achyranthes and / or Peumus are used.
4. Verwendung nach mindestens einem der Ansprüche 1 bis 3, dadurch gekennzeichnet, dass man Extrakte von Physalis minima, Achyranthes bidentata, Achyranthes aspera und/oder Peumus boldo verwendet.4. Use according to at least one of claims 1 to 3, characterized in that extracts of Physalis minima, Achyranthes bidentata, Achyranthes aspera and / or Peumus boldo are used.
5. Verwendung nach mindestens einem der Ansprüche 1 bis 4, dadurch gekennzeichnet, dass man Extrakte einsetzt, die aktive Wirkstoffe enthalten, die ausgewählt sind aus der Gruppe, die gebildet wird von Carotinoiden, Flavon-Derivaten, phenolische Säuren, Chlorogensäuren, Steroiden, aporphinen Alkaloiden, Sterolen und Terpenen.5. Use according to at least one of claims 1 to 4, characterized in that extracts are used which contain active ingredients which are selected from the group formed by carotenoids, flavone derivatives, phenolic acids, chlorogenic acids, steroids, aporphins Alkaloids, sterols and terpenes.
6. Verwendung nach mindestens einem der Ansprüche 1 bis 5, dadurch gekennzeichnet, dass man die Naturstoffe und/oder die Extrakte in Mengen von 0,001 bis 5 Gew.-% - bezogen auf die Mittel einsetzt.6. Use according to at least one of claims 1 to 5, characterized in that the natural substances and / or the extracts are used in amounts of 0.001 to 5% by weight, based on the composition.
7. Verwendung nach Anspruch 6, dadurch gekennzeichnet, dass der Wirkstoffgehalt in den Extrakten 5 bis 100 Gew.-% beträgt.7. Use according to claim 6, characterized in that the active substance content in the extracts is 5 to 100 wt .-%.
8. Verwendung nach mindestens einem der Ansprüche 1 bis 7, dadurch gekennzeichnet, dass man die Naturstoffe als wäßrige und/oder in organischen Lösungsmittel gelöste Zubereitungen oder sprüh- bzw. gefriergetrocknete Feststoffe einsetzt.8. Use according to at least one of claims 1 to 7, characterized in that the natural substances are used as aqueous and / or preparations dissolved in organic solvents or spray- or freeze-dried solids.
9. Verwendung nach Anspruch 1 und/oder 2 als Mittel gegen die Hautalterung.9. Use according to claim 1 and / or 2 as an agent against skin aging.
10. Verwendung von Naturstoffen ausgewählt aus der Gruppe, die gebildet wird von Carotinoiden, Flavon-Derivaten, phenolische Säuren, Chlorogensäuren, Steroiden, aporphinen Alkaloiden, Sterolen und Terpenen als Wirkstoffe zur Herstellung eines Mittels zur Steigerung der G6PDH- Aktivität im Stoffwechsel.10. Use of natural products selected from the group consisting of carotenoids, flavone derivatives, phenolic acids, chlorogenic acids, steroids, aporphine alkaloids, sterols and terpenes as active ingredients for producing an agent for increasing the G6PDH activity in the metabolism.
11. Verfahren zur Bestimmung der Wirksamkeit eines Mittels gegen Hautalterung, bei dem man den Einfluß des Wirkstoffes auf die Aktivität von Glucose-6-Phosphat-Dehydrogenase in Fibroblasten bestimmt. 11. A method for determining the effectiveness of an anti-aging agent, in which the influence of the active ingredient on the activity of glucose-6-phosphate dehydrogenase in fibroblasts is determined.
PCT/EP2001/001171 2000-04-14 2001-02-03 Use of natural substances in the production of cosmetic preparations WO2001078675A1 (en)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP01905732A EP1272155A1 (en) 2000-04-14 2001-02-03 Use of natural substances in the production of cosmetic preparations
AU2001233739A AU2001233739A1 (en) 2000-04-14 2001-02-03 Use of natural substances in the production of cosmetic preparations
JP2001575977A JP2003530419A (en) 2000-04-14 2001-02-03 Use of natural substances in the manufacture of cosmetic preparations

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00440107.1 2000-04-14
EP00440107A EP1145709A1 (en) 2000-04-14 2000-04-14 Use of natural products to prepare cosmetic compositions

Publications (1)

Publication Number Publication Date
WO2001078675A1 true WO2001078675A1 (en) 2001-10-25

Family

ID=8174116

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2001/001171 WO2001078675A1 (en) 2000-04-14 2001-02-03 Use of natural substances in the production of cosmetic preparations

Country Status (5)

Country Link
US (1) US20030175366A1 (en)
EP (2) EP1145709A1 (en)
JP (1) JP2003530419A (en)
AU (1) AU2001233739A1 (en)
WO (1) WO2001078675A1 (en)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2820978B1 (en) * 2001-02-21 2004-02-13 Sederma Sa NEW SLIMMING COSMETIC COMPOSITIONS CONTAINING BOLDINE
CN1314696C (en) 2001-12-28 2007-05-09 三得利株式会社 2-O-(beta-D-glucopyranosyl)ascorbic acid, process for its production, and foods and cosmetics containing compositions comprising it
DE10207919A1 (en) * 2002-02-23 2003-09-18 Cognis Deutschland Gmbh Anti-Ageingmittel
FR2843963B1 (en) * 2002-08-30 2004-10-22 Sederma Sa NEW NORAPORPHIN-DERIVED MOLECULES
US20060110468A1 (en) * 2004-11-24 2006-05-25 Liang Liu Herbal formulations for arthritis
US7514092B2 (en) * 2004-12-22 2009-04-07 Avon Products, Inc. Compositions and methods of their use for improving the condition and appearance of skin
CN101076254B (en) * 2004-12-22 2012-10-31 雅芳产品公司 Method and composition for reducing the appearance of wrinkles
US8114829B2 (en) 2005-02-22 2012-02-14 Human Matrix Sciences, Llc Elastin protective polyphenolics and methods of using the same
US7566693B2 (en) 2005-02-22 2009-07-28 Human Matrix Sciences, Llc Elastin protective polyphenolics and methods of using the same
US8642578B2 (en) 2005-03-29 2014-02-04 Human Matrix Sciences, Llc Elastin protective polyphenolics and methods of using the same
WO2007030145A2 (en) * 2005-03-29 2007-03-15 Human Matrix Sciences, Llc Elastin protective polyphenolics and methods of using the same
FR2896155A1 (en) * 2006-01-18 2007-07-20 C F E B Sisley Sa Cosmetic/dermatological composition, useful e.g. as anti-aging and/or anti-radicalizing agents to treat skin and hair, comprises a Physalis (ground cherry) calyx extract
BRPI0700767B8 (en) * 2007-02-15 2021-05-25 Ache Laboratorios Farmaceuticos Sa pharmaceutical composition, pharmaceutical product, process for obtaining pharmaceutical compounds and use of such compounds for the treatment of vitiligo
EP2005941A3 (en) * 2007-06-01 2009-04-01 Henkel AG & Co. KGaA Cellular rejuvenation compounds
FR2918570B1 (en) * 2007-07-09 2012-10-05 Engelhard Lyon DIGLYCATION OF AGEs.
MX2011009835A (en) * 2009-03-20 2012-01-25 Himalaya Global Holdings Ltd Herbal cleansing composition and method of preparing the same.
KR101230752B1 (en) 2010-12-03 2013-02-06 주식회사 코리아나화장품 Cosmetic Composition comprising Hispidulin or derivative thereof as an active ingredient
US8287921B1 (en) * 2011-07-24 2012-10-16 Attaur Rahman Formulations against cutaneous leishmaniasis
US8632827B2 (en) * 2011-12-13 2014-01-21 Avon Products, Inc Modulation of thymosin beta-4 in skin
JP6032734B2 (en) * 2012-08-24 2016-11-30 株式会社ナリス化粧品 Wrinkle improver
CN103214497B (en) * 2013-04-15 2015-08-12 沈阳药科大学 Physalin A extraction process and medicinal use
DE102015102020A1 (en) * 2015-02-12 2016-08-18 Renate Wilmanowicz Immunologically active phytogen mixture and its use in prevention and in a process for the treatment of efflorescences
BR102017003318A2 (en) * 2017-02-17 2018-10-30 Aché Laboratórios Farmacêuticos S.A. compounds, compound production process, enriched extract, active enriched fraction fractions, enriched extract production process, plant biomass selection method for enriched extract production, composition and use for treatment of immune disorders
CN115851779B (en) * 2022-10-29 2024-03-26 昆明理工大学 Glucose-6-phosphate dehydrogenase gene RkZWF1 and application thereof

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004132A2 (en) * 1992-08-25 1994-03-03 Lvmh Recherche Use of an ecdysteroid in cosmetics or dermatology
JPH0812549A (en) * 1994-06-29 1996-01-16 Shiseido Co Ltd Skin external preparation
JPH0867616A (en) * 1994-08-31 1996-03-12 Tsuneo Nanba Cosmetic
FR2746303A1 (en) * 1996-03-21 1997-09-26 Fabre Pierre Dermo Cosmetique AMARANTE SEED EXTRACT AND DERMO-COSMETIC COMPOSITION COMPRISING THE SAME
FR2760363A1 (en) * 1997-03-06 1998-09-11 Exsymol Sa Composition for topical treatment of skin disorders
JPH1160467A (en) * 1997-08-15 1999-03-02 Takasago Internatl Corp Inhibitor for melanin production
EP0919218A1 (en) * 1997-03-19 1999-06-02 Shiseido Company Limited Dermatologic preparations for beautifying
FR2784027A1 (en) * 1998-10-05 2000-04-07 Serobiologiques Lab Sa USE OF A BOLDO EXTRACT IN A COSMETIC OR DERMATOLOGICAL PRODUCT AND PRODUCT COMPRISING SUCH AN EXTRACT

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4172887A (en) * 1973-11-30 1979-10-30 L'oreal Hair conditioning compositions containing crosslinked polyaminopolyamides
US5650171A (en) * 1992-04-29 1997-07-22 Penederm, Inc. Retinoic acid-containing polyether-polyurethane compositions
DE4426215A1 (en) * 1994-07-23 1996-01-25 Merck Patent Gmbh Ketotricyclo [5.2.1.0] decane derivatives
DE4426216A1 (en) * 1994-07-23 1996-01-25 Merck Patent Gmbh Benzylidene Norcampher Derivatives
EP1293504A3 (en) * 1996-07-08 2003-11-05 Ciba SC Holding AG Triazine derivatives as UV-filter in cosmetic compositions
ES2246501T3 (en) * 1996-11-29 2006-02-16 Basf Aktiengesellschaft COSMETIC AND PHARMACEUTICAL PREPARATIONS CONTAINING UV-A PHOTOSTABLE FILTERS.
US6060070A (en) * 1997-06-11 2000-05-09 Gorbach; Sherwood L. Isoflavonoids for treatment and prevention of aging skin and wrinkles
JP2001515026A (en) * 1997-08-21 2001-09-18 ジョンソン・アンド・ジョンソン・コンシューマー・カンパニーズ・インコーポレイテッド Use of 17-α-estradiol for the treatment of aging or sun-damaged skin and / or skin atrophy

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994004132A2 (en) * 1992-08-25 1994-03-03 Lvmh Recherche Use of an ecdysteroid in cosmetics or dermatology
JPH0812549A (en) * 1994-06-29 1996-01-16 Shiseido Co Ltd Skin external preparation
JPH0867616A (en) * 1994-08-31 1996-03-12 Tsuneo Nanba Cosmetic
FR2746303A1 (en) * 1996-03-21 1997-09-26 Fabre Pierre Dermo Cosmetique AMARANTE SEED EXTRACT AND DERMO-COSMETIC COMPOSITION COMPRISING THE SAME
FR2760363A1 (en) * 1997-03-06 1998-09-11 Exsymol Sa Composition for topical treatment of skin disorders
EP0919218A1 (en) * 1997-03-19 1999-06-02 Shiseido Company Limited Dermatologic preparations for beautifying
JPH1160467A (en) * 1997-08-15 1999-03-02 Takasago Internatl Corp Inhibitor for melanin production
FR2784027A1 (en) * 1998-10-05 2000-04-07 Serobiologiques Lab Sa USE OF A BOLDO EXTRACT IN A COSMETIC OR DERMATOLOGICAL PRODUCT AND PRODUCT COMPRISING SUCH AN EXTRACT

Non-Patent Citations (7)

* Cited by examiner, † Cited by third party
Title
ADACHI K ET AL: "ACTIVITY OF GLUCOSE-6-PHOSPHATE 1-DEHYDROGENASE IN HAIR FOLLICLES WITH MALE-PATTERN ALOPECIA", BIOSCIENCE BIOTECHNOLOGY BIOCHEMISTRY,JAPAN SOC. FOR BIOSCIENCE, BIOTECHNOLOGY AND AGROCHEM. TOKYO,JP, vol. 63, no. 12, 1999, pages 2219 - 2221, XP000979532, ISSN: 0916-8451 *
PATENT ABSTRACTS OF JAPAN vol. 1996, no. 05 31 May 1996 (1996-05-31) *
PATENT ABSTRACTS OF JAPAN vol. 1996, no. 07 31 July 1996 (1996-07-31) *
PATENT ABSTRACTS OF JAPAN vol. 1999, no. 08 30 June 1999 (1999-06-30) *
R. HOLLIDAY ET AL: "Genetic effects on the longevity of cultured human fibroblasts", GERONTOLOGY, vol. 29, 1983, pages 89 - 96, XP000992138 *
SHINDO Y ET AL: "LOW GLUCOSE-6-PHOSPHATE DEHYDROGENASE ACTIVITY IN CULTURED SKIN FIBROBLASTS FROM WERNER'S SYNDROME", JOURNAL OF DERMATOLOGY,JAPANESE DERMATOLOGICAL ASSOCIATION, TOKYO,JP, vol. 13, no. 5, 1986, pages 396 - 398, XP000980551, ISSN: 0385-2407 *
WANG-NI TIAN ET AL: "Importance of glucose-6-phosphate dehydrogenase activity in cell death", AMERICAN JOURNAL OF PHYSIOLOGY. CELL PHYSIOLOGY, vol. 276, no. 5, May 1999 (1999-05-01), pages c1121 - c1131, XP002164209 *

Also Published As

Publication number Publication date
EP1272155A1 (en) 2003-01-08
JP2003530419A (en) 2003-10-14
US20030175366A1 (en) 2003-09-18
AU2001233739A1 (en) 2001-10-30
EP1145709A1 (en) 2001-10-17

Similar Documents

Publication Publication Date Title
EP1303255B1 (en) Use of composition which inhibits hair growth
WO2001078675A1 (en) Use of natural substances in the production of cosmetic preparations
EP1253904A2 (en) Extracts from residues left in the production of wine
EP1260212A1 (en) Cosmetic composition
WO2001045661A2 (en) Cosmetic and/or pharmaceutical preparations
EP1339421B1 (en) Cosmetic and/or dermopharmaceutical preparations containing native proteins from the plant argania spinosa
EP1213025A1 (en) Cosmetic and/or dermopharmaceutical composition containing extracts obtained from the leaves of Argania spinosa
EP1411890A1 (en) Cosmetic and/or pharmaceutical preparations containing plant extracts
WO2003015738A1 (en) Active ingredient mixtures
EP1170015A1 (en) Use of extracts of the fungus Grifola frondosa
EP1257253A2 (en) Cosmetic preparations containing plant extracts
WO2002003943A1 (en) Method for protecting the skin from aging
EP1253906B1 (en) Cosmetic preparations containing waltheria indica extracts and ferulic acid
EP1276460B1 (en) Use of preparations containing an extract of the plant argania spinosa in cosmetic care products for hair and skin
WO2001045650A2 (en) Cosmetic use of the residues from wine production
WO2001052809A1 (en) Cosmetic and/or pharmaceutical preparations containing an active quantity of an arrabidaea chica extract
DE10207919A1 (en) Anti-Ageingmittel
WO2001006995A1 (en) Cosmetic agents containing hydroxychavicol
EP1292278B1 (en) Preparations that contain an extract of the plant pistia stratiotes
WO2001006996A1 (en) Cosmetic agents containing extracts from plants of the family of piperaceae

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A1

Designated state(s): AU JP US

AL Designated countries for regional patents

Kind code of ref document: A1

Designated state(s): AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
WWE Wipo information: entry into national phase

Ref document number: 2001905732

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 2001233739

Country of ref document: AU

ENP Entry into the national phase

Ref country code: JP

Ref document number: 2001 575977

Kind code of ref document: A

Format of ref document f/p: F

WWP Wipo information: published in national office

Ref document number: 2001905732

Country of ref document: EP

WWE Wipo information: entry into national phase

Ref document number: 10257695

Country of ref document: US

WWW Wipo information: withdrawn in national office

Ref document number: 2001905732

Country of ref document: EP